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Ste l l ingen 
1. Biotransformatie van hexachloorbenzeen door het in het gladde 
endoplasmatisch reticulum van de levercel gelokaliseerde "mixed 
function oxydase" enzymsysteem is de belangrijkste voorwaarde voor 
het ontstaan van leverporfyrie. 
Dit proefschrift. 
2. Primaire culturen van kippeëmbryo-levercellen vormen een ge-
schikt modelsysteem voor het onderzoek naar het werkingsmechanisme 
van porfyrinogene en hepatotoxische stoffen. 
Dit proefschrift. 
3. De conclusie van Goldstein e.a., dat het door biotransformatie 
van hexachloorbenzeen gevormde pentachloorfenol niet verantwoorde-
lijk is voor het ontstaan van leverporfyrie, is onvoldoende gefun-
deerd . 
J.A. Goldstein, M. Friesen, R.E. Linder, P. Hickman, J.R. Hass & 
H. Bergman, Biochem. Pharmacol. 26(1977)1549-1557. 
Dit proefschrift. 
4. Dat celschade door ozon in zoogdiercellen hoofdzakelijk gepaard 
gaat met inductie van mitochondriaal en niet van cytoplasmatisch 
superoxide dismutase suggereert dat superoxide radicalen niet de 
oorzaak maar eerder het gevolg zijn van deze schade. 
5. De conclusie van Knutson en Poland, dat 2,3,7,8-tetrachlorodiben-
zo-p-dioxin (TCDD) niet toxisch is voor 23 verschillende in vitro 
gekweekte cellijnen of primaire celculturen is onjuist, op grond 
van de gekozen parameters en het niet in beschouwing nemen van 
concentraties waarbij meer dan 90% van de cellen dood gaat. 
J.C. Knutson & A. Poland, Toxicol. Appl. Pharmacol. 54(1980)377-383. 
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larvale Teleosten kan vooralsnog beter vervangen worden door de 
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F.F. Richards & J . J . Scott, Clin. Sei. 20(1961)387-400. 
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Sourkes & M.B.H. Youdim, Eds.), John Wiley & Sons Ltd., 1980, pp.139. 
8. De bewering van Andrew e . a . en Cheng & Leblond, dat e n t e r o -
endocriene c e l l e n van entodermale herkomst z i j n , i s n i e t langer 
houdbaar gez ien de bevindingen van Osaka & Kobayashi. 
A. Andrew, B.B. Rawdon & B. Kramer, Gen. comp. Endocr. 40(1980)351. 
H. Cheng & C.P. Leblond, Amer. J. Anat. 141(1974)537-562. 
M. Osaka & S. Kobayashi, In: Endocrine gut and pancreas (T. Fujita, 
Ed.), Elsevier, Amsterdam, 1976, pp. 145-158. 
9. De o r g a n i s a t i e van c y t o s k e l e t a i r e elementen in een systeem van 
microtrabeculae i s n i e t v o l l e d i g t e verklaren u i t de brugvorming 
tussen e i w i t t e n door f i x a t i e met g lutaara ldehyde . 
J . J . Wolosewick & K.R. Porter, J . Cell Biol. 82(1979)114-139. 
J.E. Heuser X M.W. Kirschner, J . Cell Biol. 86(1980)212-234. 
10. Aangezien gechloreerde d ibenzo-p-d iox ines en dibenzofuranen in 
het m i l i e u hoofdzake l i jk voorkomen a l s mengsels van verbindingen 
met v e r s c h i l l e n d c h l o o r g e h a l t e , i s het aan te bevelen om t o x i c i t e i t s -
t e s t e n u i t t e voeren met ex trac ten van de mil ieumonsters waarin 
deze verbindingen voorkomen, in p l a a t s van het bepalen van één van 
deze verbindingen namelijk het 2 , 3 , 7 , 8 - t e t r a c h l o r o d i b e n z o - p - d i o x i n e . 
11. Gezien het f e i t dat de jaaromzet aan voedingsreclame in Nederland 
thans zo'n 100 mi l joen gulden bedraagt en het Voorl icht ingsbureau 
voor de Voeding s l e c h t s één mil joen gulden voor v o o r l i c h t i n g t o t haar 
beschikking h e e f t , i s optimisme over het verbeteren van de voeding 
van de gemiddelde Nederlander n i e t gerechtvaardigd. 
12. Het verd ient aanbevel ing voor toekomstige archeologen t o x i c o l o g i e 
in hun vakkenpakket op t e nemen. 
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General introduction 
Hexachlorobenzene in the environment 
Hexachlorobenzene (HCB, CgCL) has been widely used as a fungicide, 
primarily to control bunt fungi (e .g . Tilletia t r i t i c i , Tilletia brevifaciens). 
However, its residual properties have led to a marked reduction of its ap-
plication in agriculture. For instance in The Netherlands the use of all f un -
gicides containing HCB as an active ingredient has been prohibited since 
January 1973. In the same year too high residues of HCB in milk and milk 
products were found. This problem was attr ibuted to the foddering of cab-
bage leaves treated with quintozene (pentachloronitrobenzene) to prevent 
ro t t ing. The quintozene used at that time contained about 3% HCB as an 
impuri ty. Since the beginning of 1975, the use of quintozene in agriculture 
is permitted only when it contains less than 0.1% HCB. 
HCB is formed as an impurity or by-product in the manufacture of chlo-
r ine, vinyl chloride, carbon tetrachloride, trichloroethylene, perchloroethyl-
ene, other chlorinated solvents, and the following pesticides: dimethyl 
2,3,5,6-tetrachloroterephthalate (Dacthal), mirex, pentachloronitrobenzene, 
pentachlorophenol, and hexachlorocyclohexane isomers [1 -3 ] . The level of 
contamination varies from 1-10% depending on the manufacturing process. 
HCB is also used as a peptizing agent in the manufacture of styrene and 
nitrous rubber for t i res. A rough estimate showed that at least 95% of the 
4 million kilograms of HCB produced annually in the United States are 
formed as an unwanted waste by-product in the synsthesis of solvents and 
pesticides [ 3 ] . Approximately 20,000 kg used to enter the environment as a 
consequence of pecticide use. This may have decreased in recent years, 
thanks to improvements in the production methods. The large-scale produc-
tion of HCB together with disposal of HCB-containing industrial waste has 
led to a ubiquitous occurrence in the environment [ 4 ] . HCB is a white 
crystall ine solid which is volatile and enters the atmosphere by sublimation. 
It is an apolar compound with lipophilic properties, which is metabolized at 
a low rate. Therefore HCB tends to accumulate in the tissues of man and 
animals [5 -7 ] . Although HCB is almost insoluble in water (6.2 pg/l at 
23.5°C [3 ] ) it has been identified as one of the major pollutants in marine 
waters, surface waters and industrial effluents in several countries [4 ,8 ] . 
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Toxicity of hexachlorobenzene 
The acute toxicity of HCB is low in most animal species (> 1500 mg/kg) . 
However it produces a wide range of toxic effects after long-term exposure 
to low doses. Hepatic porphyria so far seems to be the predominant symp-
tom of HCB intoxication in experimental animals and man. Other toxic ef-
fects include: Liver enlargement, neurological changes (tremors and convul-
sions), and cutaneous lesions [ 9 ] . The cutaneous and neurological legions 
develop most commonly at high level exposure to HCB and may precede the 
onset of hepatic porphyria. Studies of Cabrai et al. [10,11] with hamsters 
and a certain strain of mice gave some indications that HCB might be car-
cinogenic. However, the incidence of tumors in these two animal species was 
increased only in the groups receiving HCB at rather high dose levels 
(> 4 mg/kg bw/ day for hamsters, and > 12 mg/kg bw/day for mice. More-
over, HCB showed mutagenic properties in S. cerevisiae test system using 
reversion from histidine and methionine as a measure of the induced muta-
tion [12]. There are a number of studies which refer to immune suppres-
sive, reproductive and teratogenic effects of HCB [9,13] ; but experiments 
in these fields and concerning its possible carcinogenic effect need to be 
continued before definite conclusions can be drawn. 
Hepatic porphyria 
Hepatic porphyria is a disturbance in the biosynthetic pathway of heme 
production in the l iver. It is characterized by an increased excretion of 
intermediates of the heme synthesis (porphyrins and earlier precursors) in 
mainly the urine but also in the feces. In addition, increased levels of por-
phyrins can be measured in the l iver, sk in, hemopoietic t issue, intestinal 
t rac t , and several other tissues. These free porphyrins have no biological 
funct ion. Under normal conditions there is a balance between the production 
of heme (the end product of porphyrin metabolism) and its demand. In 
HCB-induced hepatic porphyria this control mechanism is disturbed and far 
more porphyrins are formed than are converted into heme, so that they ac-
cumulate and are excreted in excess. In man, the syndrome caused by HCB 
is known as Porphyria Cutanea Tarda, because the cutaneous lesions are 
the obvious manifestation of the disease although the underlying cause is 
the disturbed heme biosynthesis. The development of skin lesions in HCB-
induced porphyria is supposedly due to the photosensitising action of por-
phyrins stored in the skin [14] . 
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A classic case of porphyria in man due to chemical exposure is the mass 
poisoning with HCB-treated seed wheat in south-east Turkey from 1955 to 
1959. During that period there was a shortage of wheat for bread and the 
seed wheat was used for food instead of its intended agricultural use. It 
was estimated that 3000 to 5000 people, mostly children in the age of 6 to 
16, developed Porphyria Cutanea Tarda with a mortality rate between 1955 
and 1959 ranging from 3-10% annually [15,16]. Several years later the por-
phyrinogenic effects of HCB were confirmed by the observation that HCB 
feeding produced porphyria in animals under experimental conditions 
[17,18]. Recently it has been reported that even after twenty years a large 
group of people in Turkey stil l have the toxic symptoms of Porphyria 
Cutanea Tarda [19] . Porphyria in man may also occur as a consequence of 
inborn genetic disorders [20] . 
The biosynthetic pathway of heme 
Heme forms the end product of the porphyrin metabolism. It is combined 
with various apoproteins to form hemoproteins such as hemoglobin, myo-
globin, and the enzymes catalase, tryptophane pyrrolase, cytochromes of 
the b-group and cytochrome P-450. Cytochrome P-450 is the terminal ox i -
dase of the hepatic mixed function oxygenase system, which is involved in 
the biotransformation of HCB and other xenobiotics. The apoproteins are 
synthesized on the membranes of the endoplasmic reticulum, whereas the 
synthesis of heme takes place part ly in the mitochondria and part ly in the 
cytoplasm. The major steps of the heme biosynthetic pathway are shown in 
Fig. 1. In the mitochondria, glycine and succinyl CoA are condensed to 
form ô-aminolevulinic acid (ALA) . This rate-limiting step is catalyzed by 
ALA synthase (ALAS). The ALA leaves the mitochondria and enters the 
cytoplasm where 2 molecules ALA are condensed to the monopyrrole por-
phobilinogen (PBG). Four molecules of PBG condens to give uroporphy-
rinogen I I I , a tetrapyrrole containing 8 carboxylic groups. The stepwise 
decarboxylation of the four acetate groups of uroporphyrinogen by uropor-
phyrinogen decarboxylase (UROG-D) yields coproporphyrinogen III (4-COOH 
groups), which re-enters the mitochondria. Coproporphyrinogen III is fu r -
ther decarboxylated to protoporphyrinogen (2-COOH) and finally oxidized to 
protoporphyrin IX. In the last step the mitochondrial enzyme ferrochelatase 
(protoheme ferrolyase) incorporates the ferrous iron into the protoporphyrin 
to form heme. The porphyrinogens do not fluoresce under ultraviolet l ight , 
but within the cells porphyrinogens are readily converted into their corre-
sponding fluorescent porphyrins by autoxidation. 
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Hypotheses on the mechanism of HCB-induced hepatic porphyria 
Under normal conditions the amounts of porphyrins that accumulate in 
the liver or that are excreted in the urine and feces are very small. In 
HCB-induced porphyr ia, the levels of porphyrins in liver and excreta are 
increased manifold. The accumulated porphyrins were found to consist main-
ly of porphyrins containing 8 and 7 carboxylic groups (respectively uro-
and heptacarboxylic porphyr in) [21,22]. It has been shown that a decrease 
of the activity of the enzyme uroporphyrinogen decarboxylase (Fig. 1) 
forms the primary biochemical lesion underlying the disturbance of the he-
patic heme synthesis in HCB-induced porphyria [23] . The inhibition of uro-
porphyrinogen decarboxylase leads at f i rs t to the accumulation of porphy-
rins at the beginning of the decarboxylation chain, thereby indicating the 
site of the enzyme defect. Subsequently, a shortage of heme arises as the 
inhibition of uroporphyrinogen decarboxylase proceeds. Since heme acts as 
an end-product repressor on the synthesis of ALA synthase [24] , a marked 
induction of the activity of this enzyme can be observed in the later stage 
of porphyria. The increase in ALA synthase activity results in an enhanced 
formation of the porphyrin precursor ALA, and in consequence this exacer-
bates the porphyrin accumulation caused by the inhibition of uroporphy-
rinogen decarboxylase. 
The capactity for disturbing the function of uroporphyrinogen decar-
boxylase is not restricted to HCB. The enzyme defect can be induced also 
by several other halogenated aromatic compounds including polybrominated-
and polychlorinated biphenyls, chlorinated dibenzo-p-dioxins and dibenzo-
furans, and chlorinated naphthalenes [25]. The molecular mechanism of 
action underlying the inhibition of UROG-D by this group of halogenated 
aromatic compounds is poorly understood. 
Objectives of the present study 
The studies presented in this thesis were carried out to gain more in -
sight into the mechanism of action of these compounds. Hexachlorobenzene 
was chosen as a model compound in the present investigations, but similar 
results were obtained with other representatives of this group of chemicals, 
as will be pointed out repeatedly. 
The main discussion on the mode of action of polyhalogenated aromatic 
compounds as inducers of hepatic porphyr ia, partially based on the results 
of the present studies, is given in Chapter 1. Chapter 2 describes the ef-
fect of one of the main HCB metabolites - pentachlorophenol - on the indue-
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tion of hepatic porphyria in HCB-treated female rats. The next two Chap-
ters (3 and 4) show that compounds interfering with the drug-metabolizing 
enzyme system in the liver are able to change the porphyrinogenic effect of 
HCB in v i t ro (chick embryo liver cell cultures) as well as in vivo. Chap-
ter 5 deals with the biotransformation and porphyrin- inducing capacity of 
HCB and its main metabolites in a primary chick embryo liver cell cul ture. 
The last Chapter gives the results of our studies on the influence of ant i -
oxidants and glutathione on the fate of HCB in the liver of two strains of 
rats, which dif fer in there susceptibility to the porphyrinogenic effect of 
HCB. 
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Chapter 1 
AN APPROACH TO ELUCIDATE THE MECHANISM OF HEXACHLOROBEN-
ZENE-INDUCED HEPATIC PORPHYRIA, AS A MODEL FOR THE HEPATO-
TOXICITY OF POLYHALOGENATED AROMATIC COMPOUNDS (PHAs) 
1.1. Introduction 
The mechanism of the porphyr inogen^ action of hexachlorobenzene 
(HCB) and other polyhalogenated aromatic hydrocarbons is still unknown. 
Special reference will be given to hexachlorobenzene, the member of this 
group of chemicals that has been most extensively studied as a porphyrino-
g e n ^ agent and as a model for human symptomatic porphyria (also referred 
to as porphyria cutanea tarda, porphyria cutanea tarda symptomatica, 
chronic hepatic porphyria) (Stonard, 1974; Doss et a l . , 1976). A better 
insight in the mechanism of hexachlorobenzene-induced porphyria may serve 
as a model for the hepatotoxic action of other polyhalogenated aromatic com-
pounds (PHAs) (Debets and St r ik , 1979). In recent years i t has been 
shown that biotransformation of PHAs appears to be a prerequisite for the 
development of porphyria (Debets et a l . , 1979). Therefore, special emphasis 
will be given to the role of biotransformation of these compounds in relation 
to the production of porphyria. 
Water-insolubil ity, lipophilic nature, planar or near-planar molecular 
s t ructure, and different degrees of halogenation are the common physico-
chemical properties of this group of compounds. In addition to their por-
phyr inogen^ action in different animal species (Table I) (De Matteis, 1967; 
Vos and Koeman, 1970; Goldstein é t a l . , 1973; Str ik , 1973b; Goldstein 
et a l . , 1974; Str ik and Koeman, 1976), they induce microsomal drug-metab-
olizing enzymes (Wada et a l . , 1968; Sweeney et a l . , 1971; Rajamanickam 
é t a l . , 1972; Alvares é t a l . , 1973; St r ik , 1973d; Grand é t a l . , 1974; 
Stonard, 1974; Stonard and Nenov, 1974; Turner and Green, 1974; 
Stonard, 1975; Stonard and Greig, 1976; Dent et a l . , 1976), are neverthe-
less very slowly metabolized (Parke and Williams, 1960; Vinopal and Casida, 
1973; Kimbrough, 1974; Fishbein, 1974; Villeneuve, 1975; Koss and 
Koransky, 1975; Koss et a l . , 1976; Sundström et a l . , 1976), and accumulate 
in animal (Koeman et a l . , 1969; Koss and Manz, 1976) and human adipose 
tissue (Acker and Schulte, 1970; Brady and Siyali , 1972; Hammond, 1972; 
Curley et a l . , 1973). In the past much attention has been paid to the 
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T A B L E I 
Species d i f fe rences in exper imenta l p o r p h y r i a caused by po lyhalogenated 
a 
aromatic compounds 
Species P o r p h y r i a inc idence 
Man + 
Rat + 
Rat ( y o u n g ) 
Rabbi t + 
Guinea p ig 
b Mouse 
Mink 
Min ip ig 
Japanese quai l + 
Ch icken + 
Ch icken embryo + 
Kest re l 
Cormorant 
Blue Heron 
Pig +C 
Lamb + 
a. S t r i k , 1973d 
b . Mouse p roved to be suscept ib le to the po rphy r i nogen i c e f fec t of TCDD 
(Golds te in et a l . , 1973) 
c. Hansen et a l . , 1977; Den Tonke laar et a l . , 1978 
d . Mull et a l . , 1978 
adapt ive phase of microsomal d rug -me tabo l i z i ng enzyme induc t ion (Wada 
at a l . , 1968; Sweeney et a l . , 1971; Rajamanickam et a l . , 1972; A lva res 
at a l . , 1973; S t r i k , 1973d; Gran t et a l . , 1974; S t o n a r d , 1974; S tonard and 
Menov, 1974; T u r n e r and Green , 1974; S t o n a r d , 1975; S tonard and G r e i g , 
1976; Dent et a l . , 1976) and the detect ion of morphological changes in the 
i ve r by the t ime p o r p h y r i a develops (Benne t et a l . , 1938; M i l l e r , 1944; 
Dckner and Schmid , 1961; Sweeney e t a l . , 1971; K imbrough e t a l . , 1972; 
tfedline e t a l . , 1973; Timme e t a l . , 1974; Mol lenhauer e t a l . , 1975; Mol len-
lauer et a l . , 1976; Kuiper-Goodman et a l . , 1976; Kuiper-Goodman et a l . , 
I977; Schmodt et a l . , 1977). Studies in recent years on the pharmacok in -
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etics of PHAs (Piper et a l . , 1973; Koss and Koransky, 1975; Matthews and 
Anderson, 1975a, 1975b; Mehendale, 1976; Peterson e t a l . , 1976; Koss 
et a l . , 1978a; Jansson and Bergman, 1978) on the identification of metab-
olites (Mio e t a l . , 1976; Koss e t a l . , 1976; Sunderström e t a l . , 1976; 
Jansson and Bergman, 1978; Mizutani, 1978; Renner et a l . , 1978; Koss 
et a l . , 1979a) and their influence on porphyr in metabolism (Lui et a l . , 1976; 
Goldstein e t a l . , 1977a; Kimbrough and Linder, 1978; Koss e t a l . , 1979b), 
and on the toxici ty of the parent compounds (Debets et a l . , 1980), are 
promising. They provide fur ther insight in the mechanism of action of 
PHAs. The theories that have been proposed to explain the porphyrinogenic 
action of polyhalogenated aromatic compounds will be reviewed and discussed 
with the help of the scheme presented in Fig. 1. 
1.2. Induction of ô-aminolevulinic acid synthase (ALAS); increase in u r i -
nary excretion of ô-aminolevulinic acid (ALA) and relative increase 
in ur inary coproporphyrin (see Fig. 1 , Nos. 1 , 5) 
The induction of ALAS after chronic exposure to PHAs can be divided 
into two phases. The f i rs t one is the adaptive phase, characterized by an 
immediate slight (not greater than 2-3-fold) increase in hepatic ALAS activ-
ity after commencement of the treatment. This phase probably reflects a 
greater demand for heme due to the induction of microsomal hemoproteins 
(cytochrome P-450) by PHAs (Granick, 1966; Sweeney e t a l . , 1972; Gold-
stein e t a l . , 1973; St r ik , 1973c, 1973d; Goldstein e t a l . , 1974; Stonard, 
1974; St r ik , 1978). The second or pathological phase, marked by a 10-20-
fold increase in ALAS act iv i ty, coincides with the onset of porphyrin accu-
mulation in the liver and increased urinary porphyrin excretion (Vos et a l . , 
1971c; Goldstein et a l . , 1978). This second phase of ALAS induction is re-
lated to a decrease in the activity of uroporphyrinogen decarboxylase 
(UROG-D) and reflects a regulatory mechanism operating to keep the level 
of the free heme constant, in spite of inhibition of UROG-D (one of the en-
zymes in the pathway of heme synthesis, see Section 1.8). The marked in -
crease in ALAS activity is not essential for porphyrin accumulation, but it 
exacerbates porphyrinuria by indirectly increasing the substrate concen-
tration for the defective UROG-D. Goldstein et al . (1973) reported that 
TCDD produced a gross accumulation of hepatic porphyrins in mice, even 
though ALAS was induced only twofold. 
Induction of ALAS and inhibition of UROG-D leads to an excessive u r i -
nary excretion of accumulating substrates of the defective enzyme, like 
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aminolevulinic acid (ALA) , porphobilinogen (PGB) and porphyrins with 7 
and 8 carboxylic groups (Koss et a l . , 1978a; Goldstein et a l . , 1978) (see 
Fig. 1). 
1.3. Induction of cytochrome P-450 (P-448)-mediated mixed function oxi -
dase activity in relation to porphyria (see Fig. 1 , No. 2) 
Polyhalogenated aromatic compounds increase the concentration of cyto-
chromes P-450 and b-5 and the activity of other components of the mixed 
function oxidase system in the liver of mammals, birds and man (Wada 
et a l . , 1968; Rajamanickam et a l . , 1972; Sweeney et a l . , 1971; Alvares 
et a l . , 1973; St r ik , 1973d; Grant et a l . , 1974; Stonard, 1974; Stonard and 
Nenov, 1974; Turner and Green, 1974; Farber and Baker, 1974; Stonard, 
1975; Lissner é t a l . , 1975; Stonard and Greig, 1976; Dent é t a l . , 1976; 
Str ik and Koeman, 1976; Alvares é t a l . , 1977; Goldstein é t a l . , 1978; 
Puzynska et a l . , 1979; Debets et a l . , 1980a). 
In long-term experiments the increase in the activity of microsomal cyto-
chrome P-450 and mixed function oxidase (aminopyrine N-demethylation; 
ethoxyresorufin O-de-ethylation) reaches a maximum after 2 weeks exposure 
time (Rajamanickam e t a l . , 1972; Stonard, 1974; Debets et a l . , 1980a). 
However, the activity of ethylmorphine N-demethylase, aminopyrine N-de-
methylase and ethoxyresorufin O-de-ethylase decreases upon chronic feeding 
of hexachlorobenzene, by the time porphyria develops (Sweeney et a l . , 
1971; Debets e t a l . , 1980a). Hexachlorobenzene (Stonard, 1975; Debets 
et a l . , 1980a), polychlorinated biphenyls (Alvares et a l . , 1973; Stonard and 
Greig, 1976; Goldstein et a l . , 1977b) and polybrominated biphenyls (Dent 
et a l . , 1976; Babish and Stoewsand, 1977; Dent, 1978) produce a mixed 
pattern of microsomal enzyme induction that shows characteristics of the 
3-methylcholanthrene (P-448) and characteristics of the phénobarbital 
(P-450) classes of inducers. Stonard (Stonard and Greig, 1976) suggests 
that a relationship may exist between the mixed pattern of microsomal en-
zyme induction and the onset of hepatic porphyria. Metabolism of PHAs and 
accumulation of metabolites within the liver may be a prerequisite for the 
observed mixed pattern of enzyme induction and/or the lesion which leads 
to the ultimate porphyric picture. These speculations contrast with the ob-
servation that TCDD - the most potent porphyrinogenic agent known - i n -
duces a pattern of microsomal enzymes identical to that caused by 3-methyl-
cholanthrene (Greig, 1972; Greig and De Matteis, 1973; Lucier et a l . , 
1973). Recently Jones and Sweeney (1977) reported that mice genetically 
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responsive to the induction of aryl hydrocarbon hydroxylase developed 
hepatic porphyria after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD). Nonresponsive mice, on the other hand, did not develop porphyria 
under the same conditions. Uroporphyrinogen decarboxylase activity was 
only depressed in the responsive mice. These observations suggest that in -
duction of cytochrome P-448 and aryl hydrocarbon hydroxylase by PHAs is 
probably necessary for inhibition of uroporphyrinogen decarboxylase and 
hepatic porphyrin accumulation. Simultaneous administration of HCB and 
phénobarbital (an inducer of cytochrome P-450 and mixed-function oxy-
genases) promotes the metabolism of HCB and leads to an enhancement of 
the porphyrinogenic action of the former compound (Kerklaan et a l . , 1979). 
A metabolite or reactive intermediate of the parent compound is suspected to 
be responsible for the disturbance of hepatic porphyrin metabolism (see 
Sections 1.5 and 1.8). 
1.4. Formation of phenolic metabolites (see Fig. 1 , No. 3, and Fig. 2) 
Parke and Williams (1960) were the f i rs t to study the fate of hexachloro-
benzene in rabbits. They fai led, however, to detect metabolites in the feces 
and urine after a single oral dose of HCB suspended in water. A poor ab-
sorption of HCB from the gastro-intestinal tract was probably the cause of 
the fact that no metabolites were detected. Recent studies of the fate of 
HCB in rat (Mehendale et a l . , 1975; Lui and Sweeney, 1975; Koss et a l . , 
1976; Engst et a l . , 1976; Renner and Schuster, 1977; Jansson and Bergman 
1978), mouse, guinea p ig , Japanese quail , laying hen, rainbow trout (Koss 
et a l . , 1978b), green sunfish (Lepomis cyanellus) (Sanborn et a l . , 1977) 
and monkey (Yang et al.,1975; Rozman et a l . , 1975) have proved beyond 
any doubt that HCB in these species is metabolized into more polar com-
pounds. In the rabbit , no phenolic metabolites of HCB have been found 
(Kohli et a l . , 1976). latropoulos et al . (1975) showed that the major part of 
a single oral dose of HCB is slowly absorbed by the lymphatic system of the 
gastro-intestinal tract and deposited in adipose tissue, thus bypassing the 
portal venous transport to the l iver. This may be an explanation for the 
slow metabolic conversion of HCB and the failure of several investigators to 
quantify appreciable amounts of metabolites in urine and feces after a single 
dose of HCB. Pentachlorobenzene (PeCB), tetrachlorobenzene (TCB) and 
trichlorophenols (TCP) were only found after short-term administration of 
HCB to rats (Mehendale et a l . , 1975; Renner and Schuster, 1977; Jansson 
and Bergman, 1978) and rhesus monkeys (Rozman et a l . , 1975) (F ig . 2) . 
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The lower ch lo r ina ted benzenes may be de r i ved p a r t l y f rom HCB as c o n -
taminants (V i l l anueva e t a l . , 1974; Lui et a l . , 1976; and Jansson and 
Bergman, 1978). Pentachlorobenzene could not be detected in a l ong - te rm 
feed ing exper iment (Koss et a l . , 1978a), wh ich is not s u r p r i s i n g because i t 
has been demonst ra ted t h a t pentachlorobenzene is almost completely b iode-
graded in the ra t (Koss and K o r a n s k y , 1978). 
Fig,2.The metabolic fate of hexachlorobenzene HCB in the rat. 
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Pharmacokinet ic s tud ies of Koss et a l . (1978a) showed tha t d u r i n g long-
te rm admin is t ra t ion of HCB to r a t s , about 60% of the xenobio t ic was ex-
c re ted unchanged and about 40% in the form of metabol i tes, once an equ i l i b -
r ium between in take and exc re t ion was es tab l i shed . The ra t io of t he ex-
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creted phenolic metabolites (PCP and TCH; see Fig. 2) to the sul fur-con-
taining metabolites (PCThP and TCThP; see Fig. 2) was 2.8 after long-term 
administration versus 1.3 after short-term administration of HCB (Koss 
et a l . , 1976; and Koss et a l . , 1978a). In all animal species examined so far , 
with the exception of the Japanese quail (Koss et a l . , 1978b), pentachloro-
phenol was identified as the major metabolite of HCB (Koss et a l . , 1976; 
Sanborn et a l . , 1977; Koss et a l . , 1978b). Pentachlorophenol accounted for 
45% of the total amount of metabolites recovered in the body, urine and 
feces of rats treated with a single dose of HCB. Metabolism of hexachloro-
benzene to petachlorophenol is likely to proceed via hydrolytic dechlorina-
tion (Parke, 1968), as has been demonstrated in the metabolic conversion of 
2,4,6-trichloroanil ine to 4-amino- 3,5-dichlorophenol. 
Based on the observations that prolonged administration of pentachloro-
phenol to female rats induces no porphyria, several authors (Lui et a l . , 
1976; Goldstein e t a l . , 1977a; Kimbrough and Linder, 1978; Kószó é t a l . , 
1978) conclude that pentachlorophenol as the major metabolite of HCB plays 
no prominent part in the disturbance of hepatic porphyrin metabolism. How-
ever, recent f indings show that pure pentachlorophenol disturbs hepatic 
detoxification mechanisms (Arrhenius et a l . , 1977b) (see Section 1.5) and 
accelerates the onset of HCB-induced hepatic porphyria (Debets et a l . , 
1980a). In rats treated with a combination of HCB and PCP the onset of 
hepatic porphyria started about 3-4 weeks earlier than in rats treated with 
HCB alone (Debets et a l . , 1980a). In this experiment PCP, when fed alone, 
did not cause porphyria. This f inding is in agreement with the observation 
of others (Lui et a l . , 1976; Goldstein et a l . , 1977a; Kimbrough and Linder, 
1978; Kószó et a l . , 1978). Hence, it appears that PCP is not the metabolite 
that ultimately causes porphyria. However, it should not be ruled out that 
PCP contributes indirectly to the disturbance of the hepatic heme synthesis 
and enhances porphyrin accumulation (see Section 1.5). 
The metabolism of polychlorinated biphenyls (PCBs) has been thoroughly 
investigated by Hutzinger, Safe and co-workers and this subject has been 
reviewed recently (Sundström et a l . , 1976). As with hexachlorobenzene, the 
major metabolites were phenolic compounds (see Sundström et a l . (1976) and 
papers cited therein) . For example, studies on the metabolism of 4 ,4 ' -d i -
chlorobiphenyl in the rat demonstrated the formation of four monohydroxy-, 
four d ihydroxy- and two t r ihydroxy- metabolites (Tulp et a l . , 1976). Hy-
droxylated dérivâtes are also the main metabolic products of bromobiphenyls 
(Safe et a l . , 1976) and polychloronaphthalenes (PCNs) (Ruzo et a l . , 1975; 
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Chu et a l . , 1976; Chu et a l . , 1977a, 1977b). To what extent the formation 
of phenolic metabolites contribute to the porphyrinogenic effects and hepa-
totoxicity of polyhalogenated aromatic compounds remains to be investigated 
fur ther . 
1.5. Disturbance of mixed function oxidase activity as a result of inactiva-
tion of microsomal cytochrome P-450 by phenolic metabolites (see 
Fig. 1 , No. 6) 
Chlorinated phenols have been known for a long time as uncouplers of 
mitochondrial oxidative phosphorylation both in v i t ro (Loomis, 1949; Wein-
bach, 1954) and in vivo (Jacobson and Yllner, 1971). Recently, Arrhenius 
et a l . , (1977b) and Carlson (1978) reported that phenolic compounds e.g . 
pentachlorophenol, d i - , t r i - and tetrachlorophenols exert an inhibitory ef-
fect on another electron transport chain in the smooth endoplasmic reticulum 
of the cell, i .e. the microsomal detoxification enzyme chain. Pentachloro-
phenol strongly inhibited the electron transport between a flavin and cyto-
chrome P-450 in the microsomal mixed-function oxygenase system in v i t ro . 
This resulted in a selective blocking of the cytochrome P-450 dependent 
C-oxygenation of aromatic amines, favouring their flavin-mediated N-oxy-
genation (Arrhenius et a l . , 1977b). This type of change in the detoxifica-
tion pattern appeared to be associated with the formation of reactive elec-
trophil ic intermediates, e .g . epoxides (Arrhenius, 1969/70; Arrhenius, 
1974) which are supposed to be responsible for a disturbing effect upon 
several cell functions, including mutagenic and carcinogenic effects by 
covalent binding to cellular macromolecules. Similar effects were obtained 
with various phenolic metabolites of polychlorinated biphenyls (Arrhenius 
et a l . , 1977b). These results are consistent with our f indings that the inhi-
bition of the P-450 dependent O-demethylation of p-nitroanisole by penta-
chlorophenol in v i t ro is due to a selective inactivation of cytochrome P-450, 
which is converted to its metabolically inactive P-420 form (Förl in and 
St r ik , 1978; Debets e t a l . , 1980a). After the conversion of cytochrome 
P-450 to P-420, the heme prosthetic group of the latter can be oxidatively 
degraded by the microsomal heme oxygenase to form bil iverdin (Maines, 
1977) (F ig . 1) . Bil iverdin becomes subsequently reduced by bil iverdin re-
ductase to b i l i rub in , that can be excreted in bile and ur ine. Similar results 
were also obtained by Carlson, who found that 2,4,5-trichlorophenol at a 
dietary concentration of 400 mg/kg/day decreased hepatic microsomal cyto-
chrome P-450 content. 2 ,3 ,5- , 2,3,6- and 2,4,6-trichlorophenol inhibited the 
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demethylation of p-nitroanisole in v i t ro when added to a final concentration 
of 0.25 mM (Carlson, 1978). The uncoupling effect of chlorophenols on the 
mitochondrial respiratory chain has been interpreted as a change in the 
properties of the lipid membrane, which carries the enzymes of the mito-
chondrial electron transport chain (Van Dam and Meyer, 1971). 
The same might be the case with the smooth endoplasmic reticulum mem-
brane, which carries the enzymes of the mixed-function oxidase system. In-
deed, i t has been reported that compounds with a amphophilic character 
- i .e. having a hydrophilic and hydrophobic (aromatic) part , like penta-
chlorophenol -readily form a complex with amphophilic phospholipids in cel-
lular membranes (Lüllmann et a l . , 1973; Seydel and Wassermann, 1973), 
leading to an alteration in physicochemical properties of the lipid (Hruban, 
1976). The observed inactivation of cytochrome P-450 after incubation of 
microsomes with PCP could therefore reflect a change in physicochemical 
properties of the lipid in which cytochrome P-450 is embedded. As a result 
of th is , cytochrome P-450 might become detached from the microsomal mem-
brane or its catalytic moiety might undergo a conformational change, there-
by losing its metabolic functions. 
Pentachlorophenol formed endogenously by metabolism of hexachloroben-
zene, was demonstrated not only in the excreta, but in the liver as well 
(Koss et a l . , 1978a), Arrhenius et al . (1977a) showed that PCP adminis-
tered in vivo accumulated markedly in the microsomal fraction of the l iver, 
which encloses the drug-metabolizing system. 
Pentachlorophenol generated in the smooth endoplasmic reticulum might 
alter the pattern of metabolism of the parent compound (HCB) or increase 
the turnover rate of cytochrome P-450, as it accumulates in s i tu . 
The results of several investigators discussed above demonstrate clearly 
that phenolic metabolites of polyhalogenated aromatic compounds are able to 
disturb hepatic drug metabolism. The possibility that these phenolic metab-
olites play an essential part in the development of porphyria should there-
fore be seriously considered. 
1.6. Formation of reactive intermediates and sulfur-containing metabolites 
(see Fig. 1 , No. 4; Fig. 2) 
Another pathway of metabolism of polyhalogenated aromatics probably i n -
volving glutathione, leads to formation of sulfur-containing metabolites. 
Pentachlorothiophenol (PCThP), pentachlorothioanisol (PCTA), tetrachloro-
thiophenol (TCThP), tetrachlorothioanisol (TCTA) and tetrachlorodithioanisol 
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(TCdi-TA) could be demonstrated in the excreta of hexachlorobenzene-
treated rats (Koss et a l . , 1976; Jansson and Bergman, 1978; Koss et a l . , 
1979a) (see Fig. 2) . Pentachlorothiophenol and pentachlorothioanisol were 
also present in the livers of rats treated with hexachlorobenzene (Jansson 
and Bergman, 1978; Koss et a l . , 1979a). After short-term administration of 
HCB pentachlorothiophenol accounts for about a th i rd of the total excreted 
amount of metabolites (Koss et a l . , 1976). The major part of the thiophenols 
could be isolated only after alkaline hydrolysis of the excreta. Free penta-
chlorothiophenol was, however, also extracted directly from the excreta 
(Jansson and Bergman, 1978; Koss et a l . , 1979a). A minor amount of this 
metabolite seems to be released from its conjugates with amino acids or pro-
teins in vivo. Chasseaud (1976) and Koss et al . (1978a) suggested that the 
conjugated compounds excreted in the bile could be hydrolyzed in vivo by 
the intestinal enzymes and/or microflora. The metabolites that are split off 
may eventually be excreted in the feces, or they may be reabsorbed and 
undergo enterohepatic circulation. Recently Larsen and Bakke (1978) 
showed that an enzymic conversion of glutathione conjugates to methylthio-
derivatives takes place in the intestine, probably catalyzed by a C-S lyase 
of the intestinal flora or tissues. 
The sulfur-containing metabolites can be part ly derived from conjugation 
with glutathione. The recent detection and isolation of pentachlorophenyl-
mercapturic acid in the urine of hexachlorobenzene-treated rats adds proof 
to this assumption (Renner et a l . , 1978). Another considerable amount of 
sulfur-containing metabolites may stem from a reaction with methionine (Mio 
et a l . , 1976; Koss et a l . , 1979a) or from covalent binding of reactive inter-
mediates to functional sul fhydryl-groups of enzymes (e .g . uroporphyrinogen 
decarboxylase). Since HCB is metabolized slowly, escaping reactive inter-
mediates may react readily with glutathione without lowering its concentra-
tion in the l iver. This may explain why long-term administration of HCB to 
rats causes no appreciable decrease in hepatic glutathione levels (Wolf 
et a l . , 1962; Rimington and Ziegler, 1963; Kerklaan et a l . , 1979). Combined 
administration of HCB and diethylmaleate (a glutathione depleting agent), 
however, enhanced the porphyrinogenic action of HCB (Kerklaan et a l . , 
1979; Koss et a l . , 1979c). The elevated excretion of porphyrins and por-
phyr in precursors in rats chronically exposed to 1,2,4-trichlorobenzene 
could be reduced to almost normal levels by daily i .p . injections of g lu -
tathione, without stopping the treatment with 1,2,4-trichlorobenzene 
(Rimington and Ziegler, 1963). 
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These results suggest that a toxic intermediate formed during HCB me-
tabolism and detoxified by glutathione may be responsible for disturbing the 
heme synthesis. Metabolic hydrolyt ic dechlorination of HCB via highly re-
active arene oxide intermediates does not seem to be the most plausible ex-
planation because of steric hindrance of chlorine on the aromatic r ing . En-
zymatic epoxidation as an intermediate step in HCB metabolism must not, 
however, be ruled out completely, because investigations have shown that 
arene oxides are plausible intermediates in the metabolism of highly substi-
tuted chlorobenzenes, like pentachlorobenzene, by the rabbit (Kohli et a l . , 
1976) and the rat (Koss and Koransky, 1978) (F ig. 3) . Formation of free 
radicals dur ing reductive dechlorination of HCB - as demonstrated by the 
metabolism of carbon tetrachloride to chloroform (Recknagel and Glende, 
1973) - seems to be more probably, since the possibility of reductive de-
chlorination has been reported for hexachlorobenzene (Metcalfe et a l . , 1973; 
Mehendale et a l . , 1975), chlorobiphenylols (Tulp et a l . , 1977) and chloro-
phenols (Ahlborg and Thunberg, 1978). The chlorine atoms of HCB are 
labile against nucleophilic displacement, so that the possibility of a direct 
attack of glutathione on a carbon-chlorine bond of HCB - catalyzed by a 
glutathione chlorotransferase (F ig . 3) (a hypothetical glutathione-trans-
ferr ing enzyme, which displaces chlorine on the aromatic r ing) - should be 
taken into consideration. 
It has been well established that PCBs, PBBs and PCNs are metabolized 
to hydroxylated derivatives via highly reactive arene oxide intermediates: 
compounds in which a formal aromatic double bond has undergone epoxida-
tion via hepatic mono-oxygenase action (Fig. 4) . (Daly et a l . , 1972; Sund-
ström et a l . , 1976; Safe et a l . , 1976; Chu et a l . , 1977a). A low degree of 
chlorination of PCBs facilitates the formation of hydroxylated metabolites 
and, therefore, favours epoxidation. Sulfur-containing metabolites of PCBs 
have been detected in the feces and liver of mice injected once with 2,5, 
2 ' ,5 ' - or 2,4,2',4'-tetrachlorobiphenyl (Daly e t a l . , 1972; Mizutani e t a l . , 
1975; Mio et a l . , 1976; Mizutani, 1978). Two methylthio metabolites (3- and 
4-methylthio-2,5,2',5'-TCB or 5- and 6-methylthio-2,4,2',4'-TCB) and two 
methylsulfone metabolites (at 3- and 4- or 5- and 6-position in the phenyl 
r i ng , respectively) were excreted in the feces (Fig. 4) . The total amount of 
the four sulfur-containing metabolites excreted during 6 days after adminis-
trat ion of 2,4,2' ,4 '-TCB accounted for only 0.12% of the dose (Mizutani, 
1978). The substitution by a methylthio- or methylsulfone group at either of 
two adjacent positions in the phenyl ring points to an intermediate formation 
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F ig . 3. Possible metabolic pathways of pentachlorobenzene in the rat. 
( Gr glutathione) 
GSH 
chloro ? 
transferase 
% excreted 
in 
feces 
urine 1.5 
4.1 
6.2 
GSH chloro transferase 
18 
35 
11.3 
21.6 
values 
from Koss 
and 
Koransky 
(1978) 
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of arene oxides in the metabolism of these PCB isomers. In the liver only 
the methylsulfone metabolites could be detected and Mizutani (1978) sug-
gested that a rapid conversion of the methylthio metabolites to the corre-
sponding methylsulfone metabolites by hepatic mono-oxygenase action could 
be responsible for this phenomenon. It should be noted that methylsulfone 
metabolites of PCBs were also found in seal blubber (Jensen and Jansson, 
1976). The biological and toxicological significance of sulfur-containing me-
tabolites of halogenated aromatic hydrocarbons in relation to hepatic por-
phyria is stil l unknown. In only one instance has the action of the HCB 
metabolite pentachlorothiophenol been investigated in this respect. This 
sulfur-containing metabolite was found to be able to disturb hepatic por-
phyr in metabolism in female rats in the presence of an elevated ALA level 
(Koss et a l . , 1977). 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the most potent inducer 
of ô-aminolevulinic acid synthase and aryl hydrocarbon hydroxylase known 
(Poland and Glover, 1973, 1974). This compound causes porphyria in mam-
mals (Goldstein et a l . , 1973; Cantoni et a l . , 1980), chick embryos (Poland 
and Glover, 1973) and also in man (Bleiberg et a l . , 1964; Jiräsek et a l . , 
1976). No metabolites of TCDD have yet been found, either following in 
vivo administration or after incubation with liver microsomes (Vinopal and 
Casida, 1973). The mechanism by which TCDD exerts its porphyrogenic and 
hepatotoxic action is unknown. Poland and Glover (1973) suggested that 
TCDD is metabolized into reactive intermediates, which might bind covalent-
ly to essential macromolecules ( e .g . uroporphyrinogen decarboxylase) in 
liver cells. Indeed, it has been reported recently that in vi tro binding of 
[1 4C]TCDD to rat liver microsomes is mediated by mixed-function oxygenase 
act iv i ty. Binding to macromolecules could be markedly reduced by inhibition 
of mono-oxygenase action with SKF-525A or addition of glutathione to the 
incubation mixture. The observed binding was, however, not found to be 
covalent (Nelson et a l . , 1977). In the case of metabolic activation of TCDD 
to arene oxide intermediates, as suggested by Poland and Glover (1973), we 
would expect phenolic and dihydro-diol metabolites to be formed. The ab-
sence of these metabolites suggests that binding to macromolecules is medi-
ated through other reactive metabolic products, perhaps radicals. 
It is possible that different forms of cytochrome P-450 are involved in 
the metabolic activation of TCDD and HCB to reactive products, since TCDD 
belongs to the 3-methylcholanthrene (P-448) class of inducers and HCB is a 
mixed type inducer, sharing properties of both the 3-methylcholanthrene 
and phénobarbital class of inducers (Stonard, 1975; Debets et a l . , 1980a). 
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Finally, studies of Poland et al. (1979) have il lustrated that for halo-
genated dibenzo-p-dioxin and biphenyl congeners there was a good correla-
tion between their potency to induce AHH (P-448) and ALAS activity in 
chick embryo liver and their toxic potency. Moreover, all chlorinated b i -
phenyl congeners, which showed a strong potency to induce AHH activity in 
chick embryo l iver, were found to be porphyrinogenic in tissue culture of 
chick embryo liver cells (Kawanishi et a l . , 1978). It remains to be deter-
mined whether a common reactive metabolic intermediate is responsible for 
both the disturbance of hepatic heme biosynthesis and other liver lesions 
such as hepatocellular necrosis. 
1.7. Inactivation, conjugation and excretion of reactive intermediates and 
metabolites (see Fig. 1 , Nos. 7-11; Fig. 4) 
Both hexachlorobenzene (Goldstein et a l . , 1978; Debets et a l . , 1980) and 
polychlorinated biphenyls (Schmoldt et a l . , 1977; Goldstein et a l . , 1977b) 
increase the activity of hepatic glucuronyl transferase. This enzyme cataly-
zes the conjugation of phenolic metabolites with glucuronic acid to form g lu -
curonides that can be excreted easier in bile and urine. Induction of g lu -
curonyl transferase suggests that phenolic metabolites of PHAs are excreted 
part ly as glucuronides. Data concerning the question of to what extent 
phenolic metabolites are excreted free or as conjugates, are very limited. 
Exogenously administered PCP (the major metabolite of HCB) is excreted for 
the greater part in the urine. About 60% of the amount of PCP excreted in 
the urine was found to be present as conjugated PCP in both mice (Jacob-
son and Yllner, 1971) and rats (Ahlborg et a l . , 1974; Jansson and Berg-
man, 1978). 
Conjugation with glutathione and subsequent mercapturic acid formation, 
as a mechanism to inactivate the highly reactive epoxides or free radicals 
arising during the metabolism of PHAs (see Section 1.6), has become more 
plausible since the detection of sulfur-containing metabolites of PCBs (see 
Fig. 4) and the isolation of pentachlorophenylmercapturic acid in the urine 
of hexachlorobenzene-treated rats (Renner et a l . , 1978). Polybrominated 
biphenyls (Dent e t a l . , 1976) and probably also polychlorinated biphenyls 
induce hepatic epoxide hydrolase, another enzyme involved in the inactiva-
tion of electrophilically reactive intermediates of PHA metabolism. Epoxide 
hydrolase is probably localized in the endoplasmic reticulum, forming a com-
plex with the mono-oxygenase system (Oesch and Daly, 1972). It catalyzes 
the hydration of epoxides to the electrophilically unreactive dihydrodiols 
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Electron microscopic examination shows that this liver cell hypertrophy is 
due to a considerable proliferation of the smooth endoplasmic reticulum 
(SER), as a result of drug-metabolizing enzyme induction. The mitochondria 
are often dislocated into scattered clumps, as a consequence of SER proli f-
eration. Most mitochondria appear normal, but sometimes swollen mito-
chondria can be observed. It is believed that some of these mitochondria 
store porphyrins (Böger et a l . , 1979). 
Centrilobular hepatocytes frequently contain lipid vacuoles. Local small 
spots of centrilobular necrosis (De Matteis et a l . , 1961; Sweeney et a l . , 
1971; Vos et a l . , 1971b; Vos and Notenboom-Ram, 1972) or an increase in 
the plasma concentration of liver enzymes, indicating liver cell damage, are 
observed in several studies by the time porphyria develops (Simon et a l . , 
1970; St r ik , 1973c). 
Fig. 5. Electron micrograph, showing the appearance of a large whorl in 
the cytoplam of a hepatocyte from a male Wistar rat after subchronic feed-
ing of 300 ppm HCB for 12 weeks. The whorl consists of a central core of 
lipid droplets ( L ) , surrounded by a thick layer of concentric arrays of 
t ight ly packed smooth membranes (M), x 10,000. 
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The occurrence of eosinophilic concentric membrane arrays (synonyms in 
current use: whorls; myelin f igures; inclusion bodies; hyalin bodies) in the 
cytoplasm of the enlarged hepatocytes is one of the most str ik ing features 
of HCB (Medline et a l . , 1973; Str ik and Koeman, 1976; Mollenhauer et a l . , 
1976; Kuiper-Goodman et a l . , 1976; Kuiper-Goodman et a l . , 1977) and PCB 
(Schmoldt et a l . , 1977; Hacking et a l . , 1978) treatment. Whorls consist of 
concentric layers of t ight ly packed membranes, probably originating from 
SER of which the intracisternal cavity is collapsed. They frequently enclose 
a central core of lipid droplets (Norback and Allen, 1969) (F ig . 5) . Long-
term feeding of HCB to male rats results in the formation of large whorls, 
varying in size from 2 to 20 pm in diameter (Medline et a l . , 1973) and vis-
ible in the l ight microscope (F ig . 5) . Female rats are more susceptible to 
the porphyrinogenic action of HCB (Grant et a l . , 1974; Stonard, 1974; 
Str ik and Koeman, 1976; Kuiper-Goodman et a l . , 1977) and PCBs (Kim-
brough et a l . , 1972), but develop only small whorls ranging from about 
0.2 to 3.0 pm in diameter (F ig . 6) . The capacity to induce the formation of 
Fig. 6. Membrane whorl flanked by two mitochondria (M) in a centrilobular 
hepatocyte from a female rat after chronic feeding of HCB for 8 weeks, x 
80,000. 
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whorls is not restricted to polyhalogenated aromatic compounds. Numerous 
drugs and other lipophilic xenobiotics, such as carbon tetrachloride 
(Stenger, 1966), phénobarbital (Herdson e t a l . , 1964), DDT (Ortega, 
1966), dieldrin (Hutterer e t a l . , 1969), acetaminofluorene (Thys e t a l . , 
1973) and tetrasul (Verschuuren, 1967), are known to evoke whorls in ex-
perimental animals but are not porphyrinogenic (Kimbrough et a l . , 1971). A 
difference existing between compounds that produce both hepatic porphyria 
and whorls and those which induce only whorls is the presence of a great 
deal of brown pigment, which seems to represent lipofuscin or ceroid p ig-
ment. This pigment is thought to be the result at least in part of lipid 
peroxidation (Hartcrof t , 1972). 
The function of whorl formation and its significance in relation to the 
development of porphyria is stil l obscure. However, since many whorls ap-
pear by the time porphyria develops (Medline et a l . , 1973), an interrela-
tionship seems l ikely. Whorl formation may be involved in the elimination of 
fat-stored HCB or other lipophilic xenobiotics (Mollenhauer et a l . , 1976). It 
seems reasonable to suggest that the SER starts to proliferate around lipid 
droplets, probably containing the lipophilic polyhalogenated aromatic com-
pound. In an attempt to metabolize the lipophilic compound into more polar 
products, SER membranes can be damaged by formation of toxic metabolites 
and/or reactive intermediates ( e .g . chlorophenols, arene oxides, free rad-
icals; see Sections 1.4, 1.5 and 1.6). In order to continue the metabolism, 
new SER membranes are concentrated around the damaged membranes en-
closing the central lipid core. A whorl is thus conceived of as a cluster of 
inactive or hypoactive SER membranes enclosing lipid and at the periphery 
surrounded by a few intact concentric membrane arrays. The formation of 
whorls is, moreover, accompanied by a decrease in drug-metabolizing en-
zyme activity in livers of HCB-exposed rats (Kuiper-Goodman et a l . , 1976). 
This observation suggests that the SER becomes hypoactive or even degen-
erative because toxic metabolites of HCB are continuously formed and sub-
sequently accumulated up to a crit ical concentration in situ (see Sections 
1.4 and 1.5). The mechanism of whorl formation may be comparable with the 
formation of myeloid bodies that can be observed in many cell types after 
administration of amphophilic drugs. Myeloid bodies are storage bodies con-
taining membranes that cannot be digested fur ther because of drug action. 
They should be distinguished from whorls because they are surrounded by 
a lysosomal membrane and have no lipid core. This mechanism presupposes 
that amphophilic drugs readily form a complex with membrane phospholipids. 
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Normally, altered membranes are removed by autophagy. In contrast, the 
drug- l ip id complexes impair their own degradation in phagosomes and lyso-
somes and are transformed into myeloid bodies (see Hruban (1976) and pa-
pers cited therein) . Amphophilic metabolites of PHAs, like pentachloro-
phenol, may react in a similar way with phospholipids of cellular membranes 
(see Section 1.5). Amphophilic metabolites of PHAs generated in the SER by 
metabolism of the parent compound may form a complex directly with phos-
pholipids of SER membranes. This not only causes inactivation of cyto-
chrome P-450 (see Section 1.5) and disturbance of liver mixed-function 
oxygenase act iv i ty, but also induces whorl formation. 
1.10. Influence of iron on the porphyrinogenic effect of polyhalogenated 
aromatic compounds (see Fig. 1 , No. 14) 
There has been found no difference in the hepatic non-heme iron concen-
tration between control and HCB-fed female rats (Elder et a l . , 1976a; San 
Martin de Viale et a l . , 1977; Smith et a l . , 1979). However, pr ior iron over-
load before HCB feeding accelerates the development of porphyria in female 
rats (Taljaard et a l . , 1971, 1972; Louw et a l . , 1977). The earlier onset of 
porphyrin accumulation in these siderotic rats is accompanied by an earlier 
and greater decrease in UROG-D activity (Louw et a l . , 1977). A direct ef-
fect of iron on UROG-D seems unl ikely, because iron overload alone has no 
influence on the activity of UROG-D (Louw et a l . , 1977). Elder (1978) sug-
gested that iron might potentiate the action of HCB or a metabolite of HCB 
on UROG-D. 
An inbred strain of female Wistar rats (Agus) that is particularly sensi-
t ive to the porphyrinogenic action of HCB showed a higher level of total 
non-heme iron in their livers than female Porton-Wistar rats (Smith et a l . , 
1979). The inhibition of uroporphyrinogen decarboxylase started earlier and 
proceeded at a faster rate in the Agus rats than in the Porton-Wistar 
s t ra in. The difference in susceptibility to the porphyrinogenic action of 
HCB between the two strains could not be correlated with differences in 
intake or retention of HCB in their l ivers. 
The porphyrinogenic and hepatotoxic action of TCDD to C57B1/6J mice 
could be markedly reduced when these animals were previously made i ron-
deficient (Sweeney et a l . , 1979). However, mice fed the iron-deficient diet 
and treated with TCDD showed a lower activity of cytochrome P-450 and 
aryl hydrocarbon hydroxylase (AHH) than the animals given a normal-iron 
diet and TCDD. In earlier work, Jones and Sweeney (1977) compared the 
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inhibition of UROG-D by TCDD in mice that were genetically responsive or 
nonresponsive to the induction of AHH by TCDD (see Section 1.3). The 
nonresponsive mice developed no porphyria. These results suggest a rela-
tionship between the induction of AHH and the development of hepatic por-
phyria by polyhalogenated aromatic compounds. The lower susceptibility of 
iron-deficient mice to the porphyrinogenic action of TCDD may, therefore, 
be explained in terms of the comparatively lower activity of AHH and cyto-
chrome P-450 observed in this group. 
At present, it seems likely that iron is involved in the metabolic activa-
tion of polyhalogenated aromatics to reactive intermediates that are capable 
of inhibit ing UROG-D and causing porphyria. Moreover, iron accelerates 
heme catabolism by inducing heme oxygenase activity in vivo (De Matteis, 
1976; Maines and Kappas, 1976). Thus, a faster turnover rate of heme in 
siderotic, porphyric rats causes by feed-back stimulation an increase in 
ALAS act iv i ty , leading to a greater accumulation of porphyrins by the 
UROG-D defect. 
1.11. Delayed onset of hepatic porphyr ia: a property inherent to polyhalo-
genated aromatic compounds 
Prolonged administration of PHAs to susceptible animal species leads to 
the development of hepatic porphyr ia. However, the time required for the 
appearance of symptoms may vary from a few weeks to one year, depending 
on the animal species and the administered dose. As yet no explanation for 
the delayed onset of this type of experimental porphyria has been found. 
Elder (1978) suggests that the delay may be due, at least in part , to the 
time required to reach a critical porphyrinogenic concentration of the parent 
compound HCB in the l iver. In this connection he refers to the work of 
Grant et al . (1974) and Vos et al . (1972) who showed that porphyria does 
not develop in female rats and Japanese quail until liver HCB concentrations 
have reached a certain value (30 Mg/g liver for female rats) . However, the 
rate of accumulation of HCB within the liver of female rats is the same as in 
males (Grant et a l . , 1975; San Martin de Viale et a l . , 1976a). The role of 
gonadal steroid hormones in relation to the development of hepatic porphyria 
and the formation of large whorls in the cytoplasm of liver cells (see Sec-
tion 1.9) is still unknown. 
Recently, Graef et al. (1979) reported that feeding of HCB to female 
rats caused alterations in the metabolism of testosterone, leading to an in -
creased production of 5ß-H-steroids. The 5ß-H-steroids are known to be in -
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ducers of the porphyrin biosynthesis (Granick and Kappas, 1967). Similar 
changes in steroid metabolism have been observed following administration of 
TCDD to both male and female rats. The effects of TCDD on steroid metab-
olism in rats were more pronounced in females (Gustafsson and Ingelman-
Sundberg, 1979). It is unlikely that the observed changes in the activities 
of steroid-metabolizing enzymes are the primary cause of accumulation of 
porphyr in , because it has been proved beyond any doubt that inhibition of 
uroporphyrinogen decarboxylase is the ultimate process responsible for the 
disturbance of hepatic porphyrin metabolism (see Section 1.8). The action 
of a reactive product of PHA biotransformation may underly the d is turb-
ances of both metabolic pathways. 
One difference between female and male rats is that the livers of male 
rats contain a great deal more lipids after exposure to PHAs than females. 
This might be another cause of the insusceptibil ity of male rats to the por-
phyrinogenic effect of PHAs, because male rats can store more of the PHAs 
with the lipids in the l iver. Consequently, PHAs stored in fat in the liver 
cell may be not available for biotransformation and this protects the cell 
from damage caused by toxic metabolites of the PHA. 
The hypothesis of a critical porphyrinogenic concentration of HCB in the 
liver is unlikely for another reason: it has been shown that stimulation of 
HCB metabolism with phénobarbital accelerates the onset of hepatic por-
phyria (Kerklaan et a l . , 1979). These results are consistent with earlier 
suggestions of Stonard (Stonard and Greig, 1976) that the slow onset of the 
mixed pattern of enzyme induction, after chronic administration of PHAs, 
may be related to the slow onset of hepatic porphyria (see Section 1.3). 
A more likely explanation for the delayed onset of hepatic porphyria is 
that a critical concentration of one of the metabolites is needed to cause 
damage to intracellular membranes and enzymes (Förlin and St r ik , 1978; 
Debets et a l . , 1980a). This critical level of a given metabolite might, more-
over, alter the detoxification pattern of HCB in a direction that favours the 
formation of reactive electrophilic intermediates. The latter phenomenon has 
already been observed for the influence of chlorophenols on the metabolism 
of aromatic amines (Arrhenius, 1974; Arrhenius et a l . , 1977b). 
The reactive intermediate may be preferentially conjugated with glutathi-
one. An experiment had shown that long-term administration of HCB leads 
to a continuous decrease of the activi ty of glutathione-S-epoxide trans-
ferase, which may catalyze the detoxification of a reactive electrophilic i n -
termediate of the HCB metabolism. The decrease of this enzyme activity was 
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found to be accompanied by a decrease of the activity of the UROG-D in 
the rat l iver. From this it may be concluded that an increasing amount of a 
reactive intermediate, which is not detoxif ied, attacks the uroporphyrinogen 
decarboxylating enzyme and thus inhibits its biological function more and 
more (Koss et a l . , in press). Moreover, liver necrosis, alkylation of cellular 
macromolecules and porphyria occur when glutathione is no longer available 
or when its t ransferr ing enzyme system is disturbed. These findings might 
help to understand the concomitant delayed appearance of centrilobular liver 
necrosis and porphyrin fluorescence in HCB porphyria. 
1.12. Summary and conclusions 
Polyhalogenated aromatic compounds (PHAs) seem to affect the porphyrin 
metabolism by a common mechanism. Increase in the ur inary excretion of 
uroporphyrin and heptacarboxylic porphyrin in chronic hepatic porphyria 
induced by PHAs is accompanied by a decrease of the activity of hepatic 
uroporphyrinogen decarboxylase (UROG-D). These results lead to the con-
clusion that the decarboxylation of uroporphyrin is blocked by inhibition or 
inactivation of this decarboxylase. It has been shown conclusively that the 
porphyrinogenic effect of PHAs is not due to a direct interaction with the 
heme synthesis. A metabolite or reactive intermediate formed by metabolism 
of PHAs is suspected to be responsible for the disturbance of hepatic heme 
synthesis. PCBs, PBBs and possibly also HCB are metabolized via highly 
reactive intermediates. The detection of sulfur-containing metabolites in the 
excreta of animals treated with PCBs or HCB suggests that these unstable 
intermediates may react with catalytic SH-groups of enzymes. 
The main metabolites of PHAs, however, are the hydroxylated deriva-
t ives, which have been found to disturb hepatic drug metabolism in v i t ro 
by a selective inactivation of cytochrome P-450. Damaged SER membranes, 
carrying cytochrome P-450, seem to be removed by formation of whorls. It 
remains to be investigated what metabolites are actually involved in the on-
set of hepatic porphyr ia. The hypothesis that metabolism of PHAs is a pre-
requisite for the development of experimental porphyria does not agree with 
the observations that female rats are more susceptible to the porphyrino-
genic effects of PHAs than are males, although the latter show a more 
marked microsomal drug-metabolizing enzyme induction with these com-
pounds. The delayed onset of hepatic porphyria might be explained in terms 
of time required to build up a critical porphyrinogenic concentration of a 
given metabolite in the l iver, or as a result of th is , by a change in the 
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pattern of metabolism of the PHA. The influence of PHAs or their metab-
olites on the activity of enzymes involved in the inactivation or conjugation 
of electrophilically reactive intermediates needs to be investigated fu r ther , 
because several cases in which a depressed activity was found have been 
reported. Additional studies on the lower chlorinated benzenes have to be 
carried out, because contradictory results have been published concerning 
their abil i ty to induce hepatic porphyria (Rimington and Ziegler, 1963, and 
Carlson, 1977). Experiments with laboratory animals, carried out to gain 
more insight into the mechanism of chronic hepatic porphyria caused by 
PHAs, are time-consuming due to the long period of administration required 
to evoke porphyria. The use of tissue culture of primary liver cells, acting 
as a fast-reacting test system (Granick, 1966; Doss, 1968, 1969; Sassa and 
Granick, 1970; Sinclair and Granick, 1974; Granick e t a l . , 1975; Roomi, 
1975; Kawanishi et a l . , 1978; Grisham et a l . , 1978), may offer a more 
simple and successful alternative. 
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Chapter 2 
EFFECTS OF PENTACHLOROPHENOL ON RAT LIVER CHANGES 
INDUCED BY HEXACHLOROBENZENE, WITH SPECIAL REFERENCE 
TO PORPHYRIA, AND ALTERATIONS IN MIXED FUNCTION 
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SUMMARY 
Hexachlorobenzene (HCB, 1000 ppm) and 500 pprn pentachlorophenol 
(PCP) were fed separately or in combination to fenale Wistar rats. A 
control group was provided with standard food witaout HCB or PCP. 
Subgroups of 4 rats were killed after 1, 2, 4, 6 and 8 weeks. No significant 
difference was found between the amounts of HCB accumulated in the 
livers of the HCB and HCB + PCP fed rats. Administering HCB together 
with PCP caused a noticeable accumulation of PCP in the liver, compared 
to the results after administering HCB and PCP separately. In the HCB and 
HCB + PCP fed groups liver weight increased continuously during the 
experiments. Microsomal cytochrome P-450, NADPH-cytochrome c 
reductase, ethoxyresorufin O-de-ethylase, aminopyrine TV-demethylase, 
and glucuronyl transferase increased to a maximum in 2—4 weeks in HCB 
and HCB + PCP fed rats. Pentachlorophenol accelerates the onset of HCB 
porphyria, in other words it increases the total urinary porphyrin excretion 
and causes an earlier disturbance of the porphyrin pattern. 
INTRODUCTION 
Hexachlorobenzene (HCB) has become a world-wide major environmental 
Address all correspondence to : F.M.H. Debets, Department of Toxicology, Agricultural 
University, Biotechnion, De Dreijen 12, 6703 BC Wageningen, The Netherlands. 
Abbreviations: AHH, aryl hydrocarbon hydroxylase; HCB, hexachlorobenzene; PCP, 
pentachlorophenol; SER, smooth endoplasmic reticulum. 
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pollutant [1—4], since its introduction as a fungicide and its production as 
a by-product in manufacturing many chlorinated solvents and pesticides 
[5—7]. This compound is biodegraded slowly [8—10], and it is extremely 
persistent in body fat [11,12]. Prolonged exposure to hexachlorobenzene 
of susceptible mammals [13,14], birds [1,15—17] and man [18] causes 
massive overproduction of uroporphyrin and heptacarboxylic porphyrin and, 
to a lesser extent, of porphyrins with 6, 5 and 4 carboxylic groups [19—21]. 
The mechanism of the porphyrinogenic action of HCB and other poly-
halogenated aromatic hydrocarbons is still unknown [22,23]. A better 
insight in the mechanism of HCB-induced porphyria may provide an 
explanation of the hepatotoxicity of similar compounds [24]. The recent 
discovery that the activity of hepatic uroporphyrinogen decarboxylase 
(UROG-D) is depressed in HCB porphyria, offers a possible approach to 
these problems [20,25]. 
Recent information indicates that an unstable reactive intermediate or 
metabolite of HCB is suspected to react with the catalytic SH-containing 
part of the uroporphyrinogen decarboxylating enzyme in the liver cytosol 
[26,27]. The possibility that HCB is metabolized via electrophilically 
reactive intermediates, and the toxicological significance thereof, has been 
discussed in a previous paper [24]. Stimulation (by phénobarbital [28]) or 
inhibition (by SKF 525-A [29] or piperonyl butoxide [27]) of drug meta-
bolism, which leads respectively to an earlier development or to a prevention 
of porphyrin accumulation, provides indirect support to the hypothesis that 
a metabolic product of HCB may be the ultimate porphyrinogenic agent. 
However, neither PCP [30—32], the major metabolite of HCB, nor other 
known metabolites of HCB [33], have caused porphyria after prolonged 
feeding of these compounds to rats. Pharmacokinetic causes might be 
responsible for this apparent discrepancy. The absence of porphyria after 
administering PCP or other metabolites of HCB exogenously may be due 
to the fact that these metabolites are rapidly conjugated and excreted before 
they reach the site where they cause damage [34]. On the other hand, after 
feeding HCB, PCP is continously generated endogenously in smooth endo-
plasmic reticulum (SER) and may accumulate in situ. Arrhenius et al. [35] 
demonstrated that PCP administered in vivo is distributed unequally in the 
hepatic cells and accumulated conspicuously in the microsomal fraction, 
i.e. the endoplasmic reticulum. In addition, PCP causes a disturbance of 
hepatic drug metabolism [36]. 
Reviewing the above, it seems reasonable to assume that PCP, as the major 
metabolite of HCB, might contribute to the development of HCB-induced 
porphyria. To obtain information in support of this assumption, experiments 
have been carried out to study the effects of exogenous pentachlorophenol 
on rat liver changes induced by hexachlorobenzene. Examined were the 
accumulation of HCB and PCP in the liver, the onset of hepatic porphyria, 
and changes in mixed function oxygenases. 
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METHODS 
Animals 
Eighty adult female Wistar rats (140—160 g) were obtained from the 
R.I.V. (National Institute of Public Health), Bilthoven, The Netherlands. 
The animals were acclimatized for 2 weeks before the experiment, randomly 
distributed in 4 groups of 20, and had free access to standard powdered 
diets (Hope Farms, Woerden, The Netherlands) containing either 1000 ppm 
pure HCB or 500 ppm pure PCP, or both compounds in the same amounts. 
A control group received food without HCB or PCP, and was kept in a 
separate room under identical conditions to avoid cross-contamination 
[37,38]. Food consumption, body weights and clinical symptoms were 
checked weekly. From 4 animals of each group, the urine was collected 
during 24 h/week in metabolic cages. After 1, 2, 4, 6 and 8 weeks, 4 animals 
of each group were killed by decapitation, the livers rapidly taken out, 
weighed and divided for preparation of microsomes, and for estimating 
microscopic fluorescence of porphyrins. 
Chemicals 
Pure HCB (organic analytical standard) was obtained from BDH Chemicals 
Ltd. (Poole, England), and pure PCP from Aldrich Chemical Co. (lot 
060475). Both proved to be better than 99% pure. PCP was analyzed for 
chlorinated dibenzo-p-dioxins and dibenzofurans by extraction [55] and 
subsequent clean-up and concentration [56] of the impurities. Identification 
and quantitation was carried out by selected ion monitoring gas chromato-
graphy-mass spectrometry (GC-MS). 7-Ethoxyresorufin and resorufin were 
purchased from Pierce Eurochemie B.V. (Rotterdam, The Netherlands). All 
other applied compounds were of reagent grade quality. 
Analytical procedures 
Microsomes were prepared as previously described [39]. The level of 
microsomal cytochrome P-450 was determined in microsomal suspensions 
according to the method of Omura and Sato [40], and expressed per mg 
of microsomal protein [41]. 
p-Nitroanisole O-demethylase [42], aminopyrine AT-demethylase [43], 
NADPH-cytochrome c reductase [44] and p-nitrophenol glucuronyl trans-
ferase [31] were assayed spectrophotometrically in microsomes. The 
specific cytochrome P-448-mediated ethoxyresorufin O-de-ethylation was 
measured with a fluorimetric assay [45], using an Aminco SPF-500 fluori-
meter. Total urinary porphyrin and urinary porphyrin pattern analyses were 
made according to the method of Doss [46], with some modifications of 
Strik and Harmsen [47]. 
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Residue analysis 
Liver tissue samples (0.25 g) and microsomal pellets from 0.75 g wet 
liver tissue were homogenized in 5 ml 0.5% perchloric acid. The homo-
genates were refluxed for 1 h with 15 ml distilled toluene, and 2.5 ;ug 
4-methyl-2',5'-dichlorobiphenyl was added to these mixtures as an internal 
standard. The toluene phases, containing the extracted HCB and PCP 
residues, were reduced by evaporation to 1 ml, and then methylated over-
night with 1 ml ethereal diazomethane before examination with gas chro-
matography-mass spectrometry (GC-MS). 
GC-MS was carried out with a Hewlett-Packard 5984A system, operating 
in the EI mode at 70 eV. The GC-MS operating temperatures were: injector 
250°C, jet separator 250°C, transfer line 280°C and ion source 180°C. The 
gas Chromatograph was equipped with 200 X 0.2 (i.d.) cm all glass column, 
packed with 0.2% Carbowax 20 M on Chromosorb W 100—120 mesh [48] . 
Column temperature 130°C. Selected ions monitored (S.I.M.) were: 278.8 
(C6Cl5OCH3), 285.8 (C6C16) and 236.0 (internal standard). 
Statistics 
Two-way analysis of variance (week vs. diet) was used to analyze the 
results for effects of diet (treatment), time, and their interaction. In view 
of a positive correlation between mean values and corresponding standard 
deviations, logarithmic transformation was applied to equalize variances. 
Significant overall differences between diets and time were assessed by 
using the F-test, in which P < 0.05 was used as the lowest level of signifi-
cance. 
RESULTS 
Gas chromatography-mass spectrometry 
Tetrachlorodibenzo-p-dioxins were not detected in PCP with a detection 
limit of 5 ppb. However, PCP was contaminated with 170 ppm octa- and 
4 ppm heptachlorodibenzo-p-dioxins (Table I). Sixty per cent of the latter 
was the 1,2,3,4,6,7,8-hepta-isomer. 
Table II shows the results of the GC-MS analyses for the HCB and PCP 
concentration in the livers and their microsomal fractions in individual rats 
after 2, 4 and 8 weeks of HCB and/or PCP treatment. Comparing the HCB 
contents in the livers of the HCB and the HCB + PCP treated rats produced 
no appreciable differences. The HCB and PCP concentrations in the livers of 
HCB treated rats appear to have equilibrated more or less after 4 weeks. The 
PCP concentration in the livers and microsomal fractions of rats fed HCB 
in combination with PCP was about twice as high as in PCP treated animals, 
whereas the liver PCP content of the latter exceeded that of the HCB rats 
by factors of about 40, 6, and 6, after 2, 4 and 8 weeks respectively. The 
8 week values of the PCP concentration in the livers and microsomal frac-
tions of all treated rats appear to have decreased when compared with the 
PCP residues after 4 weeks. About 2 0 - 2 5 per cent of the HCB or PCP 
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TABLE I 
QUANTITATION OF CHLORINATED DIOXINS AND DIBENZOFURANS IN "PURE" 
PENTACHLOROPHENOL3 
Dibenzo-p-dioxins 
Tetrachloro-
Pentachloro-
Hexachloro-
Heptachloro-
Octachloro-
<5 ppb 
<10 ppb 
30 ppb 
4 ppm 
170 ppm 
Dibenzofurans 
Tetrachloro-
Pentachloro-
Hexachloro-
Heptachloro-
Octachloro-
<5 ppb 
<5 ppb 
40 ppb 
0.6 ppm 
0.8 ppm 
a
 Analyzed by GC-MS; lower detection limit 5 ppb. 
grams 
250 r Body weight gain 
200 
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Fig. 1. Influence of hexachlorobenzene (HCB) and/or pentachlorophenol (PCP) on body 
weight gain of female rats. Indicated points represent means of 4 animals. S.D. within 
10% of the mean values, not indicated. 
Fig. 2. Consumption of hexachlorobenzene (HCB) and/or pentachlorophenol (PCP) by 
female rats fed different diets. Indicated points represent means of 4 animals. S.D. within 
10% of the mean values. 
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content of the livers of the variously treated rats was always recovered in the 
microsomal fractions. 
Body weight 
The gain in body weight was significantly depressed by feeding the com-
bined HCB and PCP diet, in contrast to the separate HCB and PCP diets. 
The HCB group showed an even higher gain in body weight than the control 
group (Fig. 1). 
Dietary intake of HCB and PCP 
Food consumption expressed as g/rat/day was slightly lower in the 
HCB + PCP treated group and higher in the HCB group. The doses of HCB 
and PCP on a body weight basis were practically equal in the different 
groups (Fig. 2). Control food contained 2 ppb HCB and 0.5 ppb PCP. 
• control 
a HCB 
A PCP 
Liver weight (g) o HCB»PCP 
15r 
10 
5 -
0 1 2 A 6 8 
weeks exposure time 
Fig. 3. Influence of hexachlorobenzene (HCB) and/or pentachlorophenol (PCP) on liver 
weights. Values represent means ± S.D. of 4 animals. 
Fig. 4. Hepatic microsomal cytochrome P-450 content and enzyme activities at different 
time intervals during chronic feeding of HCB and PCP, separately or in combination, to 
female rats for 8 weeks. Mean values ± S.D. of 4 animals are shown. Analysis of variance, 
(A) Cytochrome P-450: diets produced significant overall differences (F*,-test, 
P < 0.001). (B) NADPH-cytochrome c reductase: a positive interaction between HCB 
and PCP treatment (HCB X PCP; F-test, P < 0.05). (C) Aminopyrine AT-demethylase: a 
positive interaction between HCB and PCP treatment (HCB X PCP; F-test, P < 0.05). 
(D) Ethoxyresorufin O-deethylase: diets produced significant overall differences (F^-test, 
P < 0.001). (E) Glucuronyl transferase: a negative interaction between HCB and PCP 
treatment (HCB X PCP; F-test, P < 0.05). 
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Clinical observations, mortality 
In week 5 of the experiment, 6 out of 8 rats in the HCB-group and 2 out 
of 8 of the combined HCB and PCP treated group developed skin lesions. 
These were characterized by small depilated sores with hemorrhagic crusts, 
generally located near the shoulders or under the chin. Development of skin 
lesions coincided with excessive scratching of the animals. Slight chronic 
neurotoxic symptoms (weak tremors) were observed in the HCB treated 
groups during the last 2 weeks of the experiment. None of the treated 
animals died during the experiments. 
Liver weight 
A continuous increase in liver weight with the exposure time was found in 
the group fed HCB and in the group fed the combination of HCB and PCP 
(confirmed by analysis of variance (Fig. 3). 
Effects on microsomal enzymes 
The HCB, PCP, and combined HCB + PCP diets increased the cytochrome 
P-450 concentration to a maximum of 1.8-, 1.4-, and 2.7-fold, respectively 
(Fig. 4A). HCB fed alone and in combination with PCP caused a blue shift in 
the Soret maximum of the reduced hepatic cytochrome P-450 —CO complex 
of approx. 1 nm. In the PCP rats the blue shift in the Soret maximum 
Activity (7. of control) 
100 AT o 
\ O cyt. P-450 
A O-demeth. 
0 0.03 0.10 0.30 1.00 3.00 
mM PCP 
Fig. 5. Effect of PCP on cytochrome P-450 and O-demethylation of p-nitroanisole in 
vitro. Microsomes prepared as described under methods. Incubations for determination 
of O-demethylase activity, made at 37°C in 0.05 M Tris—HCl buffer (pH 7.4) for 10 min, 
contained (in a final vol. of 4 ml) 1.55 Mmol NADPH; 17.5 iimol G-6-P;4 I.U. G-6-PDH; 
20 Aimol MgCl2; 4 nmol p-nitroanisole; 4 mg microsomal protein and PCP. Indicated 
points are the means of duplicate determinations. 
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amounted to 0.5 nm. In HCB + PCP exposed rats hepatic ethoxyresorufin 
O-de-ethylase, aminopyrine AT-demethylase, p-nitrophenol glucuronyl trans-
ferase and NADPH-cytochrome c reductase increased to a maximum of 60-, 
2-, 5-, and 2-fold respectively (Fig. 4). In the livers of HCB exposed animals 
the following maximal increases were found: 50-, 1.6-, 5.6-, and 1.3-fold 
respectively (Fig. 4). Pentachlorophenol treatment caused an increase only 
of ethoxyresorufin O-de-ethylase (20-fold) and glucuronyl transferase 
(3-fold). 
Pentachlorophenol inhibited the cytochrome P-450 dependent O-deme-
thylation of p-nitroanisole in vitro by inactivating cytochrome P-450 (Fig. 5). 
The in vitro addition of 1 mM PCP to microsomes causes a conversion of 
cytochrome P-450 into its metabolically inactive P-420 form, thus inhibiting 
p-nitroanisole demethylation by 80 per cent. This inactivation of cyto-
chrome P-450 by PCP added in vitro could not be prevented by previous 
addition of 1 mM a-tocopherol or 1 mM reduced glutathione. The level of 
cytochrome b-5 was unaffected by addition in vitro of PCP to microsomes, 
whereas HCB had no effect in vitro on cytochrome P-450 or b-5. 
Porphyrins in urine and liver 
Microscopic liver porphyrin fluorescence (centrilobular foci) has been 
detected after 8 weeks in the HCB (2 out of 4) and HCB + PCP (3 out of 4) 
rats. An increase in the urinary excretion of total porphyrins was noticed 
as early as 3 weeks in the HCB + PCP treated rats (Fig. 6). The urinary total 
nmol total porphyrins 
in urine / 2A hr 
10 
• control 
• HCB 
A PCP 
o HCB.PCP 
2 4 6 
weeks exposure time 
Fig. 6. Urinary total porphyrin excretion during chronic feeding of HCB and PCP, 
separately or in combination, to female rats for 8 weeks. Mean values of 4 animals 
plotted against time. Coproporphyrin used as an internal standard. 
G 
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Fig. 7. (a—c) Relative distribution of porphyrins with different numbers of carboxylic 
groups (% of total porphyrins, open bars) at different time intervals during chronic 
feeding of HCB and PCP, separately or in combination, to female rats for 8 weeks. Total 
urinary porphyrin excretion in hatched bars and number of carboxylic groups indicated 
at the base of open bars. Control represents porphyrin pattern of urines collected on the 
first day of the experiment. Values represent analyses of pooled urine samples from 
4 animals/treatment group. 
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porphyrin excretion of the HCB group, however, hardly began to rise after 
6 weeks. An increase in the urinary excretion of uroporphyrin (8-carboxylic 
groups) and a decrease of porphyrins with 2 and 3 carboxylic groups, 
indicative of the onset of porphyria, began about 3 weeks earlier in the 
HCB + PCP treated rats than in HCB treated animals (Figs. 7a—c). 
DISCUSSION 
We suggest that the prophyrinogenic effects of HCB are enhanced by 
pentachlorophenol. This enhancement is reflected in an earlier increase 
in the urinary porphyrin excretion, and an earlier change in the 
pattern or urinary porphyrins. These results seem to contrast with the 
findings in this study and earlier reports [31,32] that pure PCP alone is not 
porphyrinogenic. However, the conclusion that PCP, as the major metabolite 
of HCB, plays no prominent part in the expression of HCB-induced hepatic 
porphyria is premature. Pentachlorophenol, when introduced exogenously, 
is rapidly conjugated or directly eliminated from the body [34] . Exogenous 
PCP loads the conjugation and excretion mechanisms in the liver cells (e.g. 
expressed by an increase of glucuronyl transferase, Fig. 4E). Under the latter 
circumstances, PCP formed by metabolism of HCB may be excessively 
accumulated in SER membranes. The results presented in this paper 
(Table II) correspond with earlier findings [35,36] that PCP has a high 
affinity for binding to membranes of the endoplasmic reticulum and disturbs 
hepatic drug metabolism by destroying cytochrome P-450 (Fig. 5). This 
increases the turnover rate of this hemoprotein, and may result in a lack of 
cytochrome P-450, thus stimulating indirectly the heme synthesis. As a 
result, an increased production of heme exacerbates the porphyria caused by 
the inhibition of uroporphyrinogen decarboxylase. 
The distinct extra accumulation of PCP in the livers and microsomal 
fractions of the HCB + PCP treated rats may be caused by an enhanced bio-
transformation, as a result of a comparatively higher mixed function 
oxygenase activity than in rats treated only with HCB. 
Results presented in this paper (Fig. 4) and those obtained by Stonard 
[49] prove that HCB produces a mixed pattern of microsomal enzyme 
induction, combining inducing properties of both the phénobarbital (P-450) 
and 3-methylcholanthrene (P-448) classes of inducers. These results are not 
in agreement with earlier observations of Goldstein et al. [50] and Carlson 
[ 5 1 ] . Their results suggest that HCB is an inducer of the phénobarbital type. 
The HCB-induced mixed type of enzyme induction found in the present 
study was not appreciably changed by an additional supply of PCP, but HCB 
and PCP administered together induced a higher apparent activity of amino-
pyrine A/-demethylase. Our experimental results show that pure pentachloro-
phenol increases hepatic P-448-mediated ethoxyresorufin O-de-ethylation, 
which is induced preferentially by 3-methylcholanthrene [55] . This is not 
in accordance with Goldstein et al. [31] , who reported that 500 ppm pure 
PCP induces no cytochrome P-448 and aryl hydrocarbon hydroxylase 
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(AHH), even after an 8-months feeding period. Comparing the purity of our 
PCP with that used by Goldstein et al. shows a comparable or even higher 
purity, regarding the presence of the potent inducers of AHH, e.g. tetra-, 
penta- and hexachlorodibenzo-p-dioxins. It is unlikely that the higher 
amount of octachlorodibenzo-p-dioxin found in our PCP is responsible for 
the induction of P-448-mediated mixed function oxygenase activity. Octa-
chlorodibenzo-p-dioxin induces no AHH in the chick embryo, even at a very 
much higher dose level [56] . 
We have shown that PCP may contribute indirectly to the porphyrino-
genic action of HCB. PCP is widely distributed in the environment. More-
over, PCP may be considered as a common contaminant of the human body, 
since it was found in 85% of urine samples from a representative group of 
the general American population [54] . The possibility that PCP might 
enhance also the toxicity of other environmental pollutants should, there-
fore, be seriously considered. 
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Chapter 3 
METABOLISM AS A PREREQUISITE FOR THE PORPHYRINOGENS ACTION 
OF POLYHALOGENATED AROMATICS, WITH SPECIAL REFERENCE TO 
HEXACHLOROBENZENE AND POLYBROMINATED BIPHENYLS 
(FIREMASTER BP-6)a 
F.M.H. DEBETS, W.J.H.M.B. HAMERS AND J.J .T.W.A. STRIK 
Department of Toxicology, Agricultural University, Biotechnion, 
De Dreijen 12, 6703 BC Wageningen, The Netherlands 
ABSTRACT 
Pretreatment of chick embryo liver cell cultures with inducers of the 
drug-metabolizing enzyme system markedly stimulates the accumulation of 
porphyrins after exposure to polyhalogenated hydrocarbons. Inhibition of 
hepatic drug metabolism or addition of compounds which are known to trap 
electrophiles or radicals protects against the porphyrinogenic action of 
polyhalogenated hydrocarbons in v i t ro . A reactive intermediate formed by 
metabolism of the polyhalogenated hydrocarbon is suggested to react with 
the catalytic SH-containing part of the uroporphyrinogen decarboxylating 
enzyme in the liver cytosol. The consequent inhibition of uroporphyrinogen 
decarboxylase, which leads to porphyrin accumulation, may be a very f i rs t 
indication of cellular damage caused by toxic metabolites of these com-
pounds. The results of this work with the chick embryo liver cell system 
are in good agreement with the observations in animal experiments. 
INTRODUCTION 
The molecular mechanism of action of porphyrinogenic polyhalogenated 
aromatics (PHA's) has not yet been elucidated. However, these compounds 
seem to affect the heme biosynthesis by a common complicated mechanism 
Int . J . Biochem. ( In press) 
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(Debets and St r ik , 1979). The increase in the ur inary excretion of uropor-
phyr in and heptacarboxylic porphyrin in chronic hepatic porphyria induced 
by PHA's is accompanied by a decrease of the activi ty of hepatic uropor-
phyrinogen decarboxylase (UROG-D) (San Martin de Viale et a l . , 1976; 
Elder et a l . , 1976; Blekkenhorst et a l . , 1976; Louw et a l . , 1977). These 
results lead to the conclusion that the decarboxylation of uroporphyrinogen 
is blocked by inhibition or inactivation of UROG-D. 
Accumulation of uroporphyrin caused by PHA's was prevented by treat-
ment with SKF 525-A and piperonyl butoxide, two inhibitors of hepatic drug 
metabolism (Sinclair and Granick, 1974). The porphyrinogenic action of 
hexachlorobenzene (HCB) in female rats could be enhanced by promoting its 
metabolism with phénobarbital (PB) (Kerklaan et a l . , 1979; Debets et a l . , in 
p rep . ) . Administering HCB together with diethylmaleate (DM), a glutathione 
depleting agent, also led to an enhancement of the porphyrinogenic action 
(Kerklaan et a l . , 1979; Koss et a l , 1979b). These findings and the isolation 
of sulfur-containing metabolites from the urine of rats treated with HCB and 
polychlorinated biphenyls (PCB's) (Jansson and Bergman, 1978; Koss et al . 
1979a; Mio et a l . , 1976, Mizutani, 1978), strongly suggest that an electro-
philic metabolic product of PHA's reacts with sul fhydry l -groups. The cata-
lytic part of hepatic UROG-D, which contains also sul fhydryl-groups 
(Mauzerall and Granick, 1958; Romeo and Levin, 1971), could be inactivated 
through a reaction with electrophilic metabolites or intermediates of PHA's. 
Experiments with laboratory animals, carried out to gain more insight 
into the mechanism of chronic hepatic porphyria caused by PHA's, are time 
consuming due to the long period of administering the compound required to 
induce porphyria. An in v i t ro model test system based on the use of p r i -
mary tissue cultures of chick embryo liver cells, responding within a time 
span of 24 hours, offers a sensitive and much more simple experimental 
model for studying the mechanism of chemical porphyria. 
In the present study the effects of several compounds interfering with 
the biotransformation reactions of PHA's on the porphyrin accumulation in -
duced by PHA's were investigated in primary liver cell cultures of chicken 
embryos. These experiments were performed in order to provide indirect 
support for the hypothesis that a direct attack of a reactive intermediate or 
metabolic of the PHA on UROG-D is responsible for disturbing the heme 
synthesis. 
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MATERIALS AND METHODS 
Chemicals 
Williams E medium and fetal calf serum were purchased from Gibco Bio-
Cult , Glasgow, Scotland. Hexachlorobenzene (organic analytical standard) 
was obtained from BDH Chemicals Ltd. (Poole, England); piperonyl butox-
ide, DL-a-tocopherolacetate, and N, N'-diphenyl-p-phenylendiamine from 
Riedel-De Haën AG, Seelze-Hannover, W-Germany; TCPO (1,1,1-tr ichloro 
-2-propeneoxide, 1,1'-azobis (N , N'-dimethylformamide) (diamide) and penta-
chlorophenol (better than 99% pure) from Aldr ich. Hemin (type I I I , equine) 
and 3-methylcholanthrene were purchased from Sigma; tetrahydrofuran and 
ascorbic acid from Merck, Darmstadt, W-Germany. Diethylmaleate was pro-
cured from Fluka, Buchs, Switzerland; ß-naphthoflavone from ICN Pharma-
ceuticals, Inc. , Planview, N.Y. and phénobarbital (sodium salt) was ob-
tained from O.P.G. , Utrecht, The Netherlands. HBB (Firemaster BP-6, 
lot No. 11081), a commercial mixture of hexabromobiphenyl isomers was a 
g i f t from Michigan Chemical Co. , Michigan, USA. 
Preparation of a primary culture of chick embryo liver cells 
Chick embryo liver cell cultures were prepared according to the pro-
cedure of Granick et al . (1975) with the following modifications. Fertilized 
eggs from white chickens (Hubbard strain) were obtained from a commercial 
supplier. After an incubation period of 15-18 days the eggs were opened 
under aseptic conditions in a laminar flow cabinet. The embryos were per-
2+ 
fused through the heart with a sterile (Ca - f ree) . Hanks solution, contain-
ing HEPES (20 mM) and EDTA (0.04%), to wash out red cells. The livers 
from four embryos were cut into small pieces with a pair of scissors. The 
fragments were transferred into an Erlenmeyer flask and enzymatically dis-
2+ sociated (under slow st i r r ing at 37°C for 20 min.) with 30 ml (Ca -free) 
Hanks solution, containing 1 U/ml Dispase-ll (a neutral protease from 
Bacillus polymyxa, [EC 3.4.24.4] , Boehringer Mannheim) and 20 mM HEPES. 
The dissociated cells were sedimented by centrifugation at 200 g for 3 min. 
Remaining red blood cells were removed by washing the pellet with buffered 
ammonium chloride according to Sassa and Kappas (1977). The isolated he-
patocytes were finally resuspended (4 livers/100 ml) in Williams E medium 
supplemented with 10% fetal calf serum and without the supply of any ant i -
biotics. 
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Standard incubation procedure 
Cell suspensions of 2 ml containing about 1.5-2x10 cells were trans-
ferred into 3 cm <(> plastic petri dishes (Costar). The cells were incubated 
at 37°C in a humidified incubator in an atmosphere of 5% CO„ in air. The 
liver cells attached to the bottom of the culture dish within 2-4 hours after 
plating and at that time appeared as monolayer colonies. Some of the cul-
tures were pretreated with drug enzyme-inducing compounds (ß-naphthofla-
vone (ß-NF), phénobarbital (PB) and 3-methylcholanthrene (3-MC)) between 
the 4th and 24th hour of culture. After 24 hours of culture the medium was 
replaced by 2 ml fresh medium. Thereafter the porphyrin- inducing chemi-
cals, dissolved in ether (HCB) or ethanol (HBB), were administered at a 
concentration of 10 pg/ml medium. The cells were then re-incubated for an-
other 24 hr period. The maximal concentrations of the solvents in the me-
dium were: 0.33% (ethanol), 0.05% (dimethyl sulfoxide), 0.20% (diethyl 
ether) . 
TABLE 1 
SEMIQUANTITATIVE ASSESSMENT OF THE INTENSITY OF PORPHYRIN 
FLUORESCENCE AFTER TREATMENT OF CHICK EMBRYO LIVER CELL CUL-
TURES WITH PORPHYRINOGENS COMPOUNDS 
Definition Score 
no fluorescence 0 
some liver cell colonies fluoresce partially 1 
most liver cell colonies fluoresce partially 2 
most liver cell colonies fluoresce intensely 3 
all l iver cell colonies fluoresce intensely 4 
all l iver cell colonies fluoresce very intensely 5 
all l iver cell colonies fluoresce very intensely 6 
and the fluorescence quenches slowly, indicating large amounts 
of stored porphyrins 
Determination of porphyrin fluorescence 
The morphology of cultured liver cells was examined with a phase-con-
trast microscope. The porphyrin fluorescence intensity of the liver cell col-
onies was determined semiquantitatively by fluorescence microscopy at dif-
ferent times after administration of the porphyrinogenic compounds 
(Table 1) . 
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Analysis of the pattern of porphyrin accumulation 
Porphyrins in liver cells were extracted into 100% ethanol as described 
by Str ik (1973). The culture medium of the cells was treated as described 
for the ur inary porphyrin pattern analysis (Str ik and Harmsen, 1979). Es-
ter i f icat ion, separation of the porphyrins by thin layer chromatography and 
quantification of the spots was carried out according to the method of Doss 
(1974), with some modifications of Str ik and Harmsen (1979). 
RESULTS AND DISCUSSION 
Phénobarbital (PB) , ß-naphthoflavone (ß-NF) and 3-methylcholanthrene 
are able to induce cytochrome P-450 and mixed function oxygenase in a p r i -
mary culture of chick embryo hepatocytes (Althaus et a l . , 1979). 
Pre-exposure induction of the drug enzyme system by PB, 3-MC or ß-NF, 
markedly stimulates the porphyrinogenic action of hexachlorobenzene (HCB) 
and hexabromobiphenyl (HBB) in a chick embryo liver cell cul ture: the on-
set of porphyr in accumulation within the pretreated cells occurs at an earl i -
er time and porphyrins appear in larger amounts than in cultures treated 
with HCB or HBB only (Table 2) . These results obtained in a cell culture 
system are in agreement with the observation that stimultaneous administra-
tion of HCB and phénobarbital to female rats leads to an enhancement of the 
porphyrinogenic action of the former compound (Kerklaan et a l . , 1979; 
Debets et a l . , in p rep . ) . Pretreatment of the cell cultures with ß-NF has 
the most stimulating effect on the porphyrinogenic activity of HCB, whereas 
PB can enhance the porphyrinogenic effect only when administered together 
with HCB (Table 2B). Pre-exposure inducation with PB or simultaneous ad-
dition of HBB and PB results in the same stimulating effect on the onset of 
porphyrin accumulation (Table 2A). 
The monooxygenase-inhibitor piperonyl butoxide strongly inhibits the ac-
cumulation of porphyrins in liver cell cultures treated with HCB or HBB. 
Even when the drug enzyme system is pre-induced by ß-NF, piperonyl bu-
toxide is found to be able to inhibit the porphyrin accumulation in the pre-
sence of HCB or HBB (Table 2C). These results with inducers or inhibitors 
of the drug enzyme system, add indirect proof to the hypothesis that re-
active intermediates or metabolites formed by metabolism of the polyhaloge-
nated aromatic compound are the ultimate porphyrinogenic agents. 
Metyrapone, a specific inhibitor of the PB-induced mixed function oxy-
genases, inhibits the porphyrinogenic activi ty of HBB in a chick embryo 
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TABLE 2 
PORPHYRINOGENIC ACTIVITY OF HEXACHLOROBENZENE AND HEXABRO-
MOBIPHENYL (BP-6) IN PRIMARY CULTURES OF CHICK EMBRYO LIVER 
CELLS AFTER INDUCTION OR INHIBITION OF LIVER DRUG-METABOLIZING 
ENZYME SYSTEMS3-* 
Compound(s) ' 
(24-48 hr of cu l ture) 
A) 
HBB 
HBB . 
HBB + PB(50) C ; 
HBB 
HBB 
HBB 
HBB 
HBB + metyrapone(20) 
HBB 
HBB + metyrapone(20) 
B) 
HCB 
HCB + PCPOO) 
HCB 
HCB + PB(100) 
HCB 
HCB 
HCB 
HCB + metyrapone(20) 
C) 
HBB 
HBB + p i p . b u t . ( 5 ) 
HBB 
HBB + p i p . b u t . ( 5 ) 
HCB 
HCB + p i p . b u t . ( 5 ) 
Pretreatment 
(20 hr 
PB 
ß-NF 
period) 
( 50) 
( 3) 
TCPO ( 5) 
3-MC 
PB 
PB 
PB 
3-MC 
ß-NF 
PB 
PB 
ß-NF 
ß-NF 
ß-NF 
ß-NF 
( 1) 
(100) 
(100) 
(100) 
( 1) 
( 3) 
(100) 
(100) 
( 3) 
( 3) 
( 3) 
( 3) 
Microscopic f l 
of 
uorescence 
e) 
cell cul tures 
Exposure time ( h r ) 
8 
0 
0 
0 
2 
0 
0 
1-2 
0 
1 
0 
0 
0 
0 
0 
1 
2-3 
0 
0 
0 
0 
2 
0 
2 
0 
14 
0 
1 
1 
3 
2 
2 
4 
1 
3 
1-2 
0 
trace 
trace 
2 
1-2 
2-3 
0 
trace 
1 
0 
2-3 
0 
2 
0 
24 
3 
4 
> 
4 
6 
6 
4 
6 
5 
trace 
1-2 
trace 
3 
^ 
trace 
0-1 
3 
°-
1
« 4 f ) 
1-2 
2 
trace 
a) The results of the experiments with liver cells isolated on different days 
are separated by dashed lines. The results obtained with tissue cultures 
prepared on different days are not comparable, because of the biological 
variation in responsiveness of the cell cultures. 
All control cultures without HCB and HBB, but containing their respect-
ive solvents and other test compounds (PB,MC,ß-NF, metyrapone, hemin, 
diamide e tc . ) , showed no porphyrin fluorescence within 24 hr . 
b) HBB and HCB were added after 24 hr of culture at a concentration of 
10 ng/ml medium and incubation was extended to 48 hr . 
c) The concentration (pg/ml) of all other compounds used is indicated in 
parentheses. 
d) Liver cells were pretreated with various inducers of microsomal d rug -
metabolizing enzymes between the 4th and 24th hr of culture. 
e) Intensity of red fluorescence was determined semiquantitatively according 
to the classification given in Table 1. 
f ) Porphyrins in liver cells were part ly leaked out into the surrounding 
medium. 
Abbreviations: HBB, a mixture of hexabromobiphenyl isomers (Firemaster 
BP-6); HCB, hexachlorobenzene; PB, phénobarbital; ß-NF, 
ß-naphthoflavone; 3-MC, 3-methylcholanthrene; TCPO, t r i -
chloropropene oxide; PCP, pentachlorophenol; p ip .bu t . , 
piperonyl butoxide. 
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l iver cell culture (Table 2A). In contrast, no inhibition of the HCB-induced 
porphyrin accumulation is found after combined treatment with HCB and 
metyrapone (Table 2B). These results suggest that there may exist di f fer-
ent enzyme systems (mixed function oxygenases), which are responsible for 
the metabolic activation of HCB and HBB to porphyrinogenic metabolites or 
intermediates. 
Pentachlorophenol, the main metabolite of HCB in all animal species exam-
ined so far (Koss et a l . , 1976; 1978), accelerates the HCB-induced por-
phyr in accumulation in tissue culture (Table 2B) as well as in experimental 
animals (Debets et a l . , 1980). Pentachlorophenol, when administered alone, 
is not porphyrinogenic in tissue culture of chicken embryo hepatocytes up 
to a concentration of 40 pg/ml medium. Long-term exposure to PCP induces 
no porphyria in female rats either, as has been reported by several inves-
tigators (Lui et a l . , 1976; Goldstein et a l . , 1977; Kimbrough and Linder, 
1978). The possible role of PCP in the HCB-induced disturbance of the 
hepatic porphyrin metabolism has been discussed extensively in a previous 
paper (Debets and St r ik , 1979). 
Pretreatment of the liver cell culture with trichloropropene oxide (TCPO) 
- an uncompetitive inhibitor of expoxide hydrolase (Oesch and Daly, 1972) -
enhances the HBB-mediated induction of porphyrin fluorescence (Table 2A). 
Diethylmaleate (DM) and 1,1'-azobis {N , N'-dimethylformamide} (diamide) 
- both depleting intracellular glutathione - enhance the cytotoxicity of HBB 
(Table 3B,C) . With DM this is expressed in a higher porphyrin f luor-
escence. Combined diamide and HBB treatment has a much more drastic ef-
fect: within a few hours a rounding up and swelling of the hepatocytes, f i -
nally leading to detachment of the cells from the bottom of the culture dish. 
Porphyrin fluorescence was even weaker or completely absent in this case 
(Table 3C). Control cultures, treated with diamide only, showed neither 
morphological abnormalities nor fluorescence of porphyrins within 24 hours. 
The cause of this effect of HBB + diamide treatment may be that a fast 
depletion of glutathione leads to an increasing amount of reactive intermedi-
ates of HBB metabolism which cannot be detoxified by glutathione. Covalent 
interaction of reactive intermediates with cellular macromolecules may cause 
mitochondrial damage, resulting in a complete blocking of the heme syn-
thesis. In consequence of th is , an inhibition of the cytoplasmic uropor-
phyrinogen decarboxylating enzyme finds no expression in an accumulation 
of uro- and heptacarboxylic porphyr in . Therefore we may consider hepatic 
porphyrin accumulation as a very early indication of GSH shortage, result-
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ITABLE 3 
NFLUENCE OF ANTIOXIDANTS AND GLUTATHIONE-DEPLETING AGENTS 
3N PORPHYRIN ACCUMULATION INDUCED BY HEXACHLOROBENZENE AND 
HEXABROMOBIPHENYL IN CHICK EMBRYO LIVER CELL CULTURE3^ 
Compound(s) 
(24-48 hr of culture) 
Pretreatment 
(20 hr period) 
Microscopic fluorescence 
e) of cell cultures 
Exposure time (h r ) 
8 14 24 
A ) 
HBB 
HBB+ascorbic acid(0.5 mM) 
HBB+Vit.E.acetate(0.5mM) 
HBB+DPPED (0.1 mM) 
HCB ß-NF (3) 
HCB+ascorbic acid(0.5mM) ß-NF (3) 
HCB+Vit.E.acetate(0.5mM) ß-NF (3) 
HCB+DPPED (O.ImM) ß-NF (3) 
c) 
0 
0 
0 
0 
2-3 
2 
trace 
1-2 
0 
2-3 
trace 0-1 
1-2 1-2 
1 1 
4 
trace 
3 
0 
2-3' 
0-1 
2 
1-2 
, f ) 
B) 
HBB 
HBB+DM (10) 
C) 
HBB 
HBB+Diamide (40) 
HBB 
HBB+Diamide (40) 
ß-NF (3) 
ß-NF (3) 
, 9 ) 
, 9 ) 
g) 
9) 
a , b ) , d - f ) See footnote, Table 2. 
c) In parentheses the concentration of the added test compound in ug/ml 
medium, unless otherwise indicated, 
g) Most liver cells appeared to be rounded up or swollen. Many liver cell 
colonies had detached from the bottom of the culture dish. 
Abbreviations: DPPED, N,N'-diphenyl-p-phenylendiamine; Vi t . E.acetate, 
DL-a-tocopherolacetate; diamide, 1,1'-azobis (N,N'-dimethylformamide). 
ig in cellular damage caused by escaping reactive intermediates generated 
ur ing metabolism of the polyhalogenated aromatic compound. The inhibition 
f uroporphyrinogen decarboxylase probably precedes all other known i r re -
ersible effects which may be induced by this group of compounds after 
ubacute or short term exposure. 
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The antioxidants ascorbic acid, vitamin E and N,N'-diphenyl-p-phenyl-
endiamin strongly inhibit the accumulation of porphyrins in chick embryo 
liver cell cul ture, when added together with HCB or HBB (Table 3A). 
Granick (1966) showed that the inhibitory effect of ascorbic acid was not 
due to its reducing properties, which might have prevented the intracellular 
autoxidation of porphyrinogens (non fluorescent) to porphyrins ( f luor-
escent). Granick attr ibuted the effect of ascorbic acid to a more rapid ox i -
dation, i.e. inactivation of the porphyr inogen^ compound. We presume that 
these antioxidants trap electrophilic intermediates or radicals generated by 
metabolic activation of HCB and HBB. These toxic intermediates may bind 
preferentially to the nucleophilic catalytic sul fhydryl-groups of uroporphy-
rinogen decarboxylase, thereby inhibit ing its biological funct ion. The pro-
cess of inhibition proceeds under normal circumstances very slowly, since 
TABLE 4 
EFFECT OF HEMIN-MEDIATED INHIBITION OF Ô-AMINOLEVULINIC ACID 
SYNTHASE INDUCATION ON THE ONSET OF PORPHYRIN ACCUMULATION 
IN CHICK EMBRYO LIVER CELL 
CULTURE*^ 
INDUCED BY HEXACHLOROBIPHENYL 
-a) 
Compound(s) 
(24-48 hr of culture) 
Pretreatment 
(20 hr period) 
Microscopic fluorescenc« 
e) of cell cultures 
Exposure time (h r ) 
8 14 24 
HBB 
HBB + Hemin (0.5) 
HBB + Hemin (1.0) 
HBB + Hemin (5.0) 
HBB + Hemin (10) 
HBB 
HBB + Hemin (0.5) 
HBB + Hemin (1.0) 
HBB + Hemin (5.0) 
HBB + Hemin (10) 
h ) 
ß-NF(3) 
ß-NF(3) 
ß-NF(3) 
ß-NF(3) 
ß-NF(3) 
c ) 
0 
0 
0 
0 
0 
2 
1-2 
1-2 
1-2 
0-1 
1 
1 
1 
0-1 
trace 
2-3 
2-3 
2 
2 
1-2 
3 
3 
3 
2-3 
2 
4 
4 
4 
3 
2-3 
a-e) See footnote, Table 2. 
h) Concentration of hemin in [jM indicated in parentheses. 
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HCB and o ther po lyhalogenated aromatics possess a h igh res is tance to me-
tabo l ism. Deplet ion of g lu ta th ione can accelerate the whole process and 
may cause f u r t h e r damage to o the r pa r t s of the ce l l . Koss et a l . , (1979b) 
observed in exper iments w i th rad ioact ive labeled HCB tha t metabolic p r o -
duc ts of HCB were bound to l i ve r cytosol p r o t e i n s . 
porphyrin 
(»/. of total) 
60-1 
40-
20 
H C B - ß - N F 
porphyrin 
(%> of total ) 
80 
60 
40 
20-
U U _ D
 0. 
8 7 6 5 4 
HBB 
• = t= 
8 7 6 5 4 
Fig. 1 . The relative distr ibution of porphyrins with different numbers of 
carboxylic groups accumulated in chick embryo liver cells, maintained in 
Williams E medium (plus 10% fetal calf serum) and exposed to HCB (10 )jg/ 
ml) + ß-NF (3 pg/ml) or HBB (Firemaster BP-6, 10 pg/ml) for 24 hr . The 
accumulation of the intermediates is expressed as the percentage of total 
porphyrins formed (mean values of 4 plates). Non-exposed cultures con-
tained only coproporphyrin. 
The intermediates are: 8, uroporphyr in; 7, heptacarboxylic porphyr in ; 6, 
hexacarboxylic porphyr in ; 5, pentacarboxylic porphyr in ; 4, coproporphy-
r i n . 
Inhibition of the induction of 6-aminolevulinic acid synthase (ô-ALAS) 
with increasing concentrations of hemin, did not change the time of onset of 
porphyr in accumulation after treatment of chick embryo liver cells with HCB 
(Table 4) . Moreover, inhibition of ô-ALAS induction has only l itt le influence 
on the rate of porphyrin accumulation, as indicated by the intensity of f l u -
orescence reached after 24 hours of incubation with HBB + hemin as com-
pared to HBB treatment only (Table 4) . Similar results were also found in 
Japanese quail (Coturnix c. japonica), where daily i .p . injections of hemin 
could not prevent HBB-induced porphyrin accumulation (St r ik , 1973). These 
experiments show that induction of ô-ALAS is not responsible for porphyrin 
accumulation, but contributes to the expression of the uroporphyrinogen 
decarboxylase defect by an accelerated production of ô-ALA. Inhibition of 
the enzyme uroporphyrinogen decarboxylase also appears to be the primary 
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lesion in the disturbance of the heme synthesis induced by HCB and HBB 
in a chick embryo liver cell cul ture. This is indicated by the pattern of 
porphyrin accumulation in chick embryo liver cells, which consists mainly of 
uro- and heptacarboxylic porphyrin after treatment with HCB or HBB 
( f i g . 1). 
The results obtained with regard to the porphyrinogenic potential of 
chemicals in the chick embryo liver cell culture system are in good agree-
ment with the findings in animal experiments. This conclusion is based on 
the experience with a large number of compounds, including drugs, indus-
tr ial chemicals and a few pesticides (Marks, 1978; Str ik et a l . , 1980; Koe-
man et a l . , 1980). Results similar to those described in the present paper 
for the porphyrinogenic activity of HCB and HBB under variable conditions 
in chick embryo liver cell cul ture, are obtained also with other polyhaloge-
nated aromatics, like chlorinated naphthalenes and chlorinated biphenyls 
(Debets and St r ik , in p rep . ) . The chick embryo liver cell system may, 
therefore, be considered as a useful and sensitive system for the elucida-
tion of the mechanism of chemical porphyria. 
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Chapter 4 
EFFECTS OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE ON THE 
INDUCTION OF HEPATIC MIXED FUNCTION OXYGENASES AND PORPHYRIA 
IN HEXACHLOROBENZENE-TREATED RATS3 
F.M.H. DEBETS, J .H. REINDERS, W.J.H.M.B. HAMERS AND J.J .T.W.A. 
STRIK 
Department of Toxicology, Agricultural University, Wageningen, 
The Netherlands 
SUMMARY 
Female Wistar rats were treated with a dietary concentration of 1000 ppm 
hexachlorobenzene (HCB) alone or together with either phénobarbital (PB, 
0,05% in dr inking water) or 3-methylcholanthrene (MC, weekly i .p . injection 
80 mg/kg body weight). Control groups fed standard feed without HCB, 
were treated with PB or MC. Subgroups of 4 rats were killed at 1,2,4,6 
and 8 weeks. The increase in body weight was depressed in the MC and 
HCB+MC treated rats, whereas the HCB and HCB+PB treated rats showed a 
higher gain in body weight than the controls. The liver weight to body 
weight ratios were significantly increased in all treated groups. Neither PB 
nor MC interfered with the liver uptake of HCB. Pentachlorophenol (PCP; 
one of the main metabolites of HCB) showed a high aff inity for membranes 
of the endoplasmic reticulum, since 50 to 70% of the PCP content of the 
liver appeared to be bound to the microsomal fract ion. Microsomal cyto-
chrome P-450, ethoxyresorufin O-de-ethylase, ethylmorphine N-demethylase, 
and glucuronyl transferase increased to a maximum in 4-6 weeks in the 
HCB, HCB+PB, and HCB+MC treated rats. Ethylmorphine N-demethylase was 
not induced by MC treatment but responded to PB, whereas MC, but not 
PB, increased ethoxyresorufin O-de-ethylase act iv i ty. These results indi-
Submitted to Chem.-Biol. Interactions 
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cate that HCB produces a pattern of microsomal enzyme induction which 
shares properties of the MC and PB class of inducers. Simultaneous treat-
ment with HCB and PB, but not with HCB and MC, enhanced the porphy-
rinogenic effect of HCB. This was reflected in an earlier and more marked 
increase in the ur inary excretion of uro- and heptacarboxylic porphyrins in 
the HCB+PB treated group. Our results point to a specific role for the PB 
inducible form of cytochrome(s) P-450 in the biotransformation of HCB and 
the onset of hepatic porphyr ia. 
INTRODUCTION 
Hexachlorobenzene (HCB) induces, like many other xenobiotics [ 1 ] , the 
activity of mixed function oxygenases in the liver of mammals and birds 
[2 -4 ] . Inducers of hepatic mixed function oxygenases can be divided into 
two classes [1 ,5 ,6 ] : The phenobarbital-type inducers increase the concen-
tration of cytochrome P-450 and the biotransformation of a large range of 
compounds, like barbiturates and aliphatic compounds. 3-Methylcholanthrene 
and benzo(a)pyrene belong to the second class, which induces cytochrome 
P-448 and increases the activity of xenobiotic-metabolizing enzymes involved 
in the activation of many carcinogenic polycyclic aromatic hydrocarbons. 
The Soret maximum of the CO-difference spectrum of the cytochrome P-450 
subspecies induced by MC is shifted from 450 to 448 mm. Today, there is 
considerable evidence for multiple forms of cytochrome P-450 in the mono-
oxygenase system of PB- and MC-induced microsomes [7-10] . 
However, the major form of cytochrome P-450 isolated from PB treated ani-
mals differs from the major form isolated from MC treated animals; although 
both classes have overlapping substrate specificities. 
There stil l is much controversy about the species of cytochrome P-450 
induced by HCB. Several reports refer to cytochrome P-450 as the major 
microsomal hemoprotein induced by HCB [11,12]. However, there is also 
evidence that HCB produces a mixed pattern of microsomal enzyme induc-
t ion, combining inducing properties of both the PB (P-450) and MC (P-448) 
classes of inducers [13-15]. 
In addition to the abil ity of HCB to induce microsomal mixed function 
oxygenases, it produces a defect in the biosynthesis of heme which is char-
acterized by the excretion of large amounts of mainly uro- and heptacar-
boxylic porphyrins in urine and feces [16-20]. It has been proved beyond 
any doubt that inhibition of the enzyme uroporphyrinogen decarboxylase 
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(UROG-D) [EC 4.1.1.37] , involved in the heme biosynthetic pathway, 
underlies the observed accumulation of porphyrins [21-24]. Moreover, there 
is considerable evidence to show that biotransformation of HCB by the 
mixed function oxygenase system forms a prerequisite for the onset of the 
disease [25] . A metabolic intermediate of HCB capable of reacting with the 
active site of hepatic UROG-D is suspected to be responsible for enzyme 
inhibition [26]. In this context it is important to determine which from of 
cytochrome P-450 is involved in the activation of HCB, thus causing por-
phyr ia. Since simultaneous treatment of rats with PB and HCB enhanced the 
porphyrinogenic effect of the latter compound [27] , the PB-induced form of 
P-450 seems predominant in the formation of reactive products of HCB. This 
assumption contrasts with the observation that 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), the most potent porphyrinogenic polyhalogenated aromatic 
compound known, induces a pattern of microsomal enzymes identical to that 
caused by MC [28,29]. 
To obtain more evidence in support of the hypothesis that the porphy-
rinogenic effect of HCB is exerted by reactive metabolic products formed 
preferentially by the PB class of induced cytochrome(s) P-450, we have 
studied the effects of combined administration of HCB with either PB or MC 
on female rat l iver. We examined the accumulation of HCB and pentachloro-
phenol (PCP) in the liver and liver microsomal fract ion; the onset of hepatic 
porphyr ia; and the induction of mixed function oxygenases. 
METHODS 
Animals and treatments 
Hundred and twenty adult female SPF Wistar (WAG/Cpb) rats (120-140 g) 
were obtained from the Central Institute for the Breeding of Laboratory 
Animals TNO, Zeist, The Netherlands. The animals were randomly d is t r ib -
uted over 6 groups of 20, housed in wire bottom cages, and had unlimited 
access to standard powdered diets (Hope Farms, Woerden, The Netherlands) 
supplemented with 1000 ppm HCB when required. Of the 3 groups treated 
with HCB, one additionally received 0.05% phénobarbital in dr ink ing water, 
and a second group was weekly injected intraperitoneally with 3-methylcho-
lanthrene (80 mg/kg of body w t . ) in arachis (peanut) oil (1% solution). 
Three control groups - kept in a separate room to avoid cross-contamination 
with HCB - were fed on a diet without HCB, one group received PB and a 
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RESULTS 
Body weight 
The gain in body weight was significantly depressed in both groups 
treated with MC. All groups receiving HCB, with the exception of the 
HCB+MC group, showed a higher gain in body weight than the control 
group (Fig. 1) ; this phenomenon has also been observed in an earlier ex-
periment [15] . 
Dietary intake of HCB 
The dietary intake of HCB expressed in mg/kg body weight/day, in the 
HCB+MC treated group was about 20% lower than in the other HCB groups 
(F ig . 2) . This was due to a decreased food consumption in both MC 
groups. 
Clinical observations 
Skin lesions were f i rs t observed in the 4th week of the experiment in 
the HCB group (8 out of 12). In the HCB+PB group only one animal de-
veloped skin lesions, whereas no skin lesions were found in the rats ex-
posed to HCB+MC. Skin lesions were characterized by small depilated sores 
with hemorrhagic crusts located in the neck region. The development of 
skin lesions went together with excessive scratching by the animals at the 
places where skin lesion arose. There was no correlation between the light 
intensity in the animal cages and the number of rats in a treatment group 
developing skin lesions, as the light intensity in all cages was very low 
and nearly the same (5-15 Lux) . Chronic neurotoxic symptoms (weak 
tremors) were observed in the HCB group during the last 4 weeks of the 
experiment. In the HCB+PB and HCB+MC groups tremors appeared in the 
6 th week of the experiment, but to a lesser degree. 
Liver weight 
A significant elevation in liver weight to body weight ratio occurred in 
all treated groups (Fig. 3) . The increase in relative liver weight of the 
MC, PB, and combined HCB+PB treated rats remained constant over the 
period of treatment. However, a continuous increase in relative liver weight 
with the exposure time was found after treatment with HCB alone and with 
the combination of HCB and MC (F ig . 3) . The greatest increase in relative 
liver weight was induced in the HCB+MC group. This increase was approxi-
mately additive when compared with the effects of HCB and MC separately. 
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Fig. 3. Effects of phénobarbital (PB) and 3-methylcholanthrene (MC) on 
the l iver/body weight ratios of female rats fed either a normal diet or a diet 
containing 0.1% hexachlorobenzene (HCB). Values represent means ± S.D. 
of 4 animals. 
Effects on liver microsomal enzymes 
Hexachlorobenzene, HCB+PB, and HCB+MC increased the microsomal 
cytochrome P-450 concentration to a maximum of approximately 2 .0- , 2.4-
and 3.7-fold, respectively (F ig . 4a). The cytochrome P-450 concentration in 
animals treated with PB or MC alone was increased approximately 1.7- and 
2.0-fold. Thus the effect of PB and MC on the cytochrome P-450 level in 
the combined treatments was at least additive. Both the combined HCB+PB 
treatment and MC alone caused a blue shift in the Soret maximum of the re-
duced cytochrome P-450-CO complex of 1 nm (maximal at 6 weeks). In 
microsomes from HCB and HCB+MC treated rats this blue shift amounted to 
1.5 nm. at 6 weeks. PB alone shifted the \ for the reduced P-450-CO 
complex 0.8 nm towards the red part of the spectrum. In HCB+PB treated 
rats the activities of hepatic glucuronyl transferase, ethoxyresorufin O-de-
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ethylase, and ethylmorphine N-demethylase were enhanced to a maximum of 
3.9- , 41- and 2.3- fo ld, respectively (F ig. 4) . For liver microsomes of 
HCB+MC treated rats these values were: 4 .5- , 77- and 3.4-fold; and for 
HCB treated rats 3 . 1 - , 62- and 1.7-fold. Phénobarbital preferentially in -
duced ethylmorphine N-demethylase (2.7-fold) but ethoxyresurufin O-de-
ethylase was not increased; on the other hand in MC treated rats, ethoxy-
resorufin O-de-ethylase was induced to a maximum of 135-fold and ethy l -
morphine N-demethylase activity was comparable to the control level 
(F ig. 4) . 
Total porphyrins and pattern of porphyr in accumulation in urine 
The total porphyrin excretion in the urine from HCB+PB treated rats i n -
creased abruptly after 6 weeks to a level that reached approx. 7-fold the 
control level after 8 weeks (Fig. 5) . The increase in the total porphyrin 
excretion in this treatment group was accompanied by a change in the pat-
tern of the accumulated urinary porphyrins indicative of an inhibition of 
uroporphyrinogen decarboxylase. The amount of uro- and heptacarboxylic 
porphyrin in the total porphyrin excretion markedly increased relative to 
the amount of copro- and protoporphyrin. The distr ibution of porphyrins 
shows that after 8 weeks uroporphyrin had already become the predominant 
type of porphyrin in the urine of HCB+PB treated rats (F ig. 6b). The in -
crease in total porphyrin excretion could, therefore, be attr ibuted primarily 
to an accumulation of uro- and heptacarboxylic porphyr ins. In contrast, the 
total porphyrin excretion and porphyrin pattern of the HCB+MC and HCB 
treated groups began to change slowly at 8 weeks (Figs. 5; 6a,c),and at 
that time coproporphyrin was still the predominant porphyr in . This was also 
found in control, PB and MC treated rats. 
Fig. 4 . (a-d) Hepatic microsomal cytochrome P-450 concentration and enzyme 
activities in female rats in response to various treatments as in legend 
Fig. 1. Mean values ± S.D. of 4 animals are shown. Analysis of variance, 
(b) Glucuronyl transferase: a negative interaction between HCB and MC 
treatment (HCBxMC; F-test, P < 0.05). (d) Ethylmorphine N-demethylase: a 
positive interaction between HCB and MC treatment (HCBxMC; F-test, 
P < 0.05), and a negative interaction between HCB and PB treatment 
(HCBxPB); F-test, P < 0.05). 
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Fig. 5. Effects of phénobarbital (PB) and 3-methylcholanthrene (MC) on 
the total ur inary porphyrin excretion of female rats fed either a normal diet 
or a diet containing 0.1% hexachlorobenzene (HCB). Mean values of 4 rats 
are plotted against time. Coproporphyrin used as an internal standard. 
Fig. 6 . (a- f ) The pattern of ur inary porphyrin excretion of female rats ir 
response to various treatments as in legend Fig. 1. The excretion of por-
phyrins with dif ferent numbers of carboxylic groups is expressed as th« 
percentage of total porphyrins excreted. Points represent analyses of poolec 
urine samples from groups of 4 rats. The porphyrins are: u ro - , heptacar-
boxylic, copro-, t r icarboxyl ic, and proto-porphyr in. 
- 97 -
distribution Ol porphyrins (°/o) 
80 -, 
1 HCB 
a. 
75 
\ 
\ r \i 
V v 
\ ' N> coprc 
Q-,^-% proto 
^ / Z ^ hepto 
8 0 
distribution ol porphyrins (alo) b. 
Y 
i \ 
:x . 
> hepta 
—proto 
exposure t ime (weeks) exposure timetweeks) 
distribution ol porphyrins CM 
HCB + MC 
80 
X 
/ 
/ 
f / 
V 
- • - \ 
distribution ol porphyrins (7o) 
exposure time (weeks) exposure time(weeks) 
distribution of porphyrins (°M Qt 
90-1 
85 
80 - i ^ - ' y V--
distribution ot porphyrins (%>) 
\ «- PB 
W I 
\ I 
V" 
r- \ A \ / \ A v \ / \ 
exposure time(weeks) exposure time (weeks) 
98 
Li. 
O 
z 
o 
H 
< 
Z i 
U 
U 
< 
LU 
I 
H 
Z 
O 
r-s 
U 
5 
LU 
Z 
LU 
et 
X 
H 
z 
< 
O 
X 
u 
_ l 
> 
X 
1-LU 
1 
oo 
Q 
Z 
< 
CÛ 
CL 
'
v
-' 
_ l 
< H 
Cû 
ce 
< 
eu 
o 
z 
LU 
X 
CL 
LL 
o 
B
LE
 
1 
FE
C
TS
 
< u. 
H tu 
/-N 
Q. 
u Q. 
s ^ 
_ l 
O 
z 
LU X CL 
O 
er 
O 
i 
u 
< 
h 
z 
LU CL 
O 
Z 
< 
/—N 
CÛ 
u I 
LU 
z 
LU 
NI 
Z 
LU 
CÛ 
O 
CC 
O 
I 
U 
< X 
LU 
X 
10 
* 
LU 
LU 
5 
00 
Lu 
O 
LL 
CQ 
U 
X 
Û 
LU 
LL 
10 
H 
< 
ce 
LU 
_ l 
< 
W. 
LU 
U . 
LL 
O 
Z 
o 
I -
u 
< 
ce 
LL 
_ i 
< 
O 
to 
o 
cc 
u 
S 
Q 
Z 
< 
ce 
LU 
> 
— 
_J 
z 
o\° 
o O 
r-
<U 
D 
U) 
4-» 
S_ 
> 
— 
•M 
(U 
5 
ai 
\ ai 
n. 
s ^ 
4-» 
a> 
•M 
c 
o 
u 
Q. 
U 
CL 
X 
!_ t -
u 
'm. 
fc 
o 
.c 
<D 
o 
5 
ro 
E _ 
o £ 
«1 o 
O J_» 
h u o ni 
I t 
<p 
4-> 
ra 
c 
dj 
ü g1 
0\° 
O 
O 
(U 
D 
V) 
V) 
4-> 
£_ 
<D 
> 
— 
•M 
(U 
ai 
ai 3 . 
v—• 
•4-» 
c 
a> 
•M C 
o 
u 
CQ 
u 
X 
X 
L. 
u 
É 
E 
o 
(1) 
0 
.c S 
ra 
en O 
O p 
s- u 
W. <£ 
4-> 
ra c (U 
a> 
S- / -s 
3 « 
O ... fl) 
a <g S 
LU + j ^y 
•M 
C 
(U 
E 
4-> 
S_ 
H 
• * 
< ï 
<tf 
o 
+1 00 
t— 
CM 
+1 
oo 
M -
r^  
f— 
oo 
+l LD 
LO 
ra r~-
~^ T— 
+l 
co 
oo 
• * 
CÛ 
U 
I 
LT) 
00 
m 
CM 
+ 1 
ro 
ro 
(O 
"3" 
+1 O0 
PO 
-^
T -
1 
+ 1 
^ cr> 
x— 
r--\— 
+i LO 
00 
CÛ 
u X 
oo LT) 
CM 
O 
+1 0D 
x— 
CM 
+1 
LO 
0 0 
CM 
LD 
+1 00 
00 
00 
(D 
+1 HO 
00 
• * 
CÛ 
CL 
+ CO 
u I 
co LO 
CM 
o 
+1 
r~ 
*— 
a> 
+i LD 
CM 
r^  
i n 
+i t— 
LO 
00 
LD 
+1 LT) 
O 
0 0 
00 
CÛ 
CL 
+ CO 
u X 
LD 
CM 
O 
x— 
+1 i n 
CM 
i n 
+i 
o 
o 
x— 
oo 
+i (£> 
•t 
CM 
00 
*— +1 i n 
c^ 
U 
S 
+ Cû 
o X 
(O 
-^
i n 
o 
+i 
r^  
oo 
LO 
LO 
+i 
o 
00 
CM 
CM 
"^ 
+ 1 i n 
(O 
LO 
T 
*— +1 
r--
oo 
CM 
00 
<J 
2 
+ 
CÛ 
u I 
l/> 
ra 
0 
E 
o 
H-
Q 
L0 
+1 
c 
ro <U 
E 
4-> 
c 
d) 
L0 
<U 
S-
a 
(U 
L. 
(U 
3 
ro 
> 
£. 
U 
ro 
LU 
ro 
- 99 -
The maximum in total porphyrin excretion observed at 4 weeks in the 
HCB+MC treated rats was due to an increase in the excretion of copropor-
phyrin (F ig . 6c), as a result of an enormous induction of microsomal hemo-
oroteins (F ig . 4a). This excretion pattern is not characteristic of HCB-in-
duced experimental hepatic porphyria and is referred to as coproporphyrin-
uria. Coproporphyrinuria was also noticed in the group treated with MC 
(Fig. 6e). PB alone had no effect on either the total ur inary porphyrin 
content or the pattern of excreted porphyrins (Figs. 5 and 6 f ) . 
Content of hexachlorobenzene and pentachlorophenol in the liver 
Both MC and PB had no significant effect on the intake or retention of 
HCB in the l iver: HCB concentrations in the livers of all HCB treated 
groups were about the same (Table I ) . Twenty per cent of the HCB found 
in the livers of HCB treated groups could be recovered from the microsomal 
fraction. The content of PCP in the livers from rats administered the com-
Dination of HCB and MC was about 2-3 times higher than in the livers from 
HCB and HCB+PB treated rats (Table I ) . The major part (70-80%, at 
B weeks) of the PCP in the livers from HCB and HCB+PB treated rats had 
accumulated in the microsomal fractions (Table I ) . In the HCB+MC group 
this microsome-bound PCP amounted to 25% and 45% of the total PCP content 
Df the l iver, after 4 and 8 weeks respectively. 
DISCUSSION 
The combined treatment of female rats with HCB and PB, markedly en-
Tanced the prophyrinogenic effect of HCB. In contrast, MC had no s igni f i -
cant effect on the porphyrinogenic effect of HCB. This is so, in spite of 
the fact that the simultaneous administration of HCB and MC induced the 
highest cytochrome P-450 concentration and mixed function oxygenase activ-
i ty. Previous experiments had shown that the monooxygenase inhibitors 
SKF-525A [39] and piperonyl butoxide [25] completely prevented HCB-in-
duced accumulation of porphyrins in a primary culture of chick embryo liver 
oells. Evidently, biotransformation of HCB by the mixed function oxygenase 
system forms a prerequisite for the porphyrinogenic effect of HCB. The 
oresent results suggest a key role for the phénobarbital inducible form of 
:ytochrome(s) P-450 in the metabolism of HCB and the onset of porphyr ia. 
The PB-mediated alteration of HCB metabolism, resulting from a functional 
:hange in cytochrome P-450, may favour the formation of reactive metabolic 
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intermediates capable of reacting with the catalytic center of uroporphyrin 
decarboxylase, thus causing porphyr ia. 
Effects of PB and MC, similar to those found in this study with HCB, 
have been reported in studies concerning the hepatotoxicity of monobromo-
benzene and carbon tetrachloride. Phénobarbital pretreatment enhanced the 
hepatotoxic effects of both compounds, whereas MC treatment even pro-
tected against CCI. - and monobromobenzene - induced liver necrosis 
[40-42]. Moreover, i t has been established for both agents that their toxic-
i ty is mediated through reactive metabolic products of the parent compound 
[43,44]. 
In contrast to rats, both PB and MC were able to enhance the porphy-
r inogen^ effect of HCB in a primary culture of chick embryo liver cells 
[25] . This discrepancy may be due to a difference in the pattern of micro-
somal enzymes induced by MC in both systems [45]. 
The present results prove beyond any doubt that HCB itself induces a 
pattern of microsomal hemoproteins, which shares characteristics of both the 
MC- and PB-induced pattern. HCB increased ethylmorphine N-demethylase 
(not induced by MC) to about half the value induced by PB. Moreover, 
HCB increased ethoxyresorufin O-de-ethylase (preferentially induced by 
MC) up to 62 times that of control values. These findings are in accordance 
with previously published data [14,15]. 
Both HCB and MC increased the microsomal cytochrome P-450 concentra-
tion in the liver and when these treatments were combined, the increase in 
cytochrome P-450 was additive. The same effect has been observed with 
combined PB and MC treatment [46] . Ethylmorphine N-demethylase was not 
induced by MC but the activity of this enzyme was increased by HCB. 
Moreover, when administered together, HCB and MC induced to a higher 
apparent activi ty than HCB alone. This contrasts with the effect on glucu-
ronyl transferase act iv i ty, where the combination of HCB and MC induced a 
lower apparent act iv i ty, than MC alone. We have no explanation for this 
phenomenon. 
The levels of PCP in the livers of HCB+MC treated rats were compara-
t ively higher than those in the livers of animals of the HCB and HCB+PB 
group. This may result from an enhanced dechlorination of HCB by MC 
treatment, as has been reported for the stimulating effect of MC on the de-
chlorination of PCP [47]. Consistent with earlier observations [15,48], PCP 
preferentially accumulates in the endoplasmic reticulum, i .e. the site where 
PCP is formed by metabolism of HCB. The role of this high aff ini ty binding 
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of PCP in disturbing hepatic drug metabolism and in stimulating HCB-in-
duced accumulation of porphyrins has been discussed in a previous paper 
[15]. 
Considering the potentiating effect of PB, as found in the present 
study, it should be mentioned that exposure to HCB or other polyhaloge-
nated aromatics may constitute a special hazard to those population groups 
that regularly use PB or other barbiturates as a medicine, e .g . as an 
anti-epileptic or hypnotic d rug . 
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SUMMARY 
Hexachlorobenzene (HCB) is metabolized in a primary culture of chick 
embryo liver cells and causes porphyrin accumulation within 24 hours after 
administration. The HCB-metabolites, pentachlorothiophenol, pentachloroben-
zene and pentachlorophenol identified in liver cell culture are already known 
from long-term experiments with rats. The pattern of accumulated por-
phyrins is comparable with the pathological porphyrin pattern observed in 
oral feeding studies with warmblooded laboratory animals. Protein bound 
14 radioactivity was found in cell cultures treated with [ C]HCB. Addition of 
the monooxygenase-inhibitor piperonyl butoxide or ascorbic acid decreased 
14 
the irreversible binding of C-metabolites. The results show that biotrans-
formation of HCB fulf i ls an essential role in the onset of porphyria. Since 
none of the main HCB-metabolites could induce a pathological porphyrin 
pat tern, a reactive intermediate capable of reacting with glutathione or 
thiol-groups of uroporphyrinogen decarboxylase (UROG-D) is believed to be 
A part of this study has been presented at The International Conference 
on Xenobiochemistry, Bratislava, Czechoslovakia, June 9-13, 1980. 
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responsible for the inhibition of UROG-D. The chick embryo liver cell sys-
tem may be considered as a useful and sensitive system for studying the 
metabolism of xenobiotics in relation to their toxic i ty. 
INTRODUCTION 
Hexachlorobenzene (HCB) produced an extensive outbreak of porphyria 
in people of south-eastern Turkey between 1955 and 1960 [1 ] . Since that 
Turkish calamity, HCB-induced porphyria in animals has been used as an 
experimental model for studying the stages of development of human 
symptomatic porphyr ia, and for the elucidation of the mechanism of toxic 
porphyria induced by the group of organohalogen compounds [2 -4 ] . 
Despite extensive studies the mechanism of this type of chemical porphyr ia, 
which is characterized by an accumulation of uro- and heptacarboxylic por-
phyrins in the liver and ur ine, remains to be ful ly clarif ied. There is 
strong evidence that inhibition of the enzyme uroporphyrinogen decarboxy-
lase (UROG-D) forms the key process in this disturbance of the heme syn-
thesis [5 -7 ] . Moreover, biotransformation of HCB appears to be a prerequi-
site for its porphyrinogenic action, suggesting that a metabolic product 
rather than the parent compound is responsible for causing porphyria [ 8 ] . 
Studies on the metabolism of HCB in rats showed several phenolic and 
sulfur-containing metabolites to be formed [9-10]. However, neither penta-
chlorophenol [11,12] (the main metabolite of HCB) nor several other HCB-
metabolites [13] administered to rats, could induce porphyria in this animal 
species. 
In addition to different animal species ( ra t , rabbit , Japanese quai l ) , 
HCB produces accumulation of porphyrins in a primary culture of chick em-
bryo liver cells [8,14] . The chick embryo liver cell culture system proved 
to be a sensitive experimental model to study HCB-porphyria, obviating time 
consuming animal experiments by responding within 24 hours after addition 
of HCB to the cell cul ture. So far nothing is known about the biotransfor-
mation of HCB in this cell culture system and the pattern of porphyrin ac-
cumulation. This, however, is part icularly important for extrapolating the 
results to the animal model and for obtaining additional evidence that a 
reactive metabolic product of HCB inhibits UROG-D in the l iver. 
The biotransformation of HCB has been investigated in primary cultures 
of chick embryo liver cells, in order to f ind out whether the liver culture 
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system resembles in all respects the animal model. The main metabolites of 
HCB identified in rat experiments were tested for their porphyrinogenic ac-
t iv i ty in chick embryo liver cell cul ture. Porphyrin patterns were analysed 
and compared with the porphyric mammalian l iver. 
METHODS 
Chemicals 
Hexachlorobenzene was purchased from BDH Chemicals Ltd. (Poole, Eng-
land); pentachlorophenol (PCP) and pentachlorothiophenol (PCThP) from 
Aldrich Chemical Co.; pentachlorobenzene (PeCB) and ascorbic acid from 
Merck (Darmstadt, W-Germany); tetrachlorohydroquinone from Ferak AG, 
W-Germany. The HCB-metabolites pentachlorothioanisol (PCTA), 2,3,5,6- te-
trachlorothioanisol (TCTA) , 1-methyl- [2,3,4,5,6-pentachlorophenyl] sulfox-
ide (PCTA-0) and 1-methyl-[2,3,4,5,6-pentachlorophenyl] sulfone (PCTA-
0_) were synthesized and purif ied by recrystallization as described by Koss 
et al . [10] . All compounds proved to be better than 99.5% pure after re-
crystall ization. Piperonyl butoxide was obtained from Riedel-De Haën AG, 
W-Germany; ß-naphthoflavone (ß-NF) from ICN Pharmaceuticals, Inc. , USA, 
and 6-aminolevulinic acid (ALA) from Sigma. 
7-Ethoxyresorufin and resorufin were procured from Pierce Eurochemie BV 
14 (Rotterdam, The Netherlands). Uniformly labeled C-HCB with a specific 
radioactivity of 1.1 pCi/mg was used in binding studies of HCB to cell pro-
te in. The labeled compound (cf. Koss and Koransky, [15]) and the 2,4,5, 
2',4',5'-hexachlorobiphenyl were prepared by Dr. P.E. Schulze from 
Schering AG (W-Germany). Following recrystallization from n-hexane the 
melting point of the hexachlorobiphenyl proved to be 102°C. Test by means 
of GC-MS revealed a pur i ty of more than 99.7%. The impurities detected 
were not identical with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). 
Cell culture 
Liver cells were isolated from 15-day old chick embryos as described 
previously [ 8 ] . The cell cultures were pretreated with ß-naphthoflavone (3 
pg/ml culture medium) for 18 h from the 6th h after isolation, to pre-induce 
the mixed function oxygenase system. Thereafter, the culture medium was 
replaced by fresh medium, containing HCB or one of its metabolites (d is-
solved in diethyl ether) at a concentration of 10 pg/ml medium. The concen-
tration of diethyl ether in the medium did not exceed 0,2%. 
r 
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After an incubation period of 24 h, the cells were harvested with a rub 
ber policeman and used for measuring the total amount of porphyr ins, fo 
analysing the porphyrin pattern, for assaying the activity of mixed function 
oxygenases, and for identification of HCB metabolites by gas chromato-
graphy-mass spectrometry (GC-MS). 
Identification and quantitation of HCB-metabolites 
Liver cells and culture medium were sonicated and brought at pH 13 with 
a 10% solution of sodium hydroxide. The alkaline samples were kept at 65°C 
for 1 h to split the conjugates of metabolites. Thereafter, the pH of the 
samples was adjusted to 1 with concentrated hydrochloric acid. The digested 
samples were extracted twice with an equal volume of diethyl ether for 1 h. 
Aliquots of the combined and concentrated extracts were mixed with ethereal 
diazomethane to methylate the phenols and thiophenols. After 24 h the 
methylated extracts were submitted to column chromatography to remove the 
biological materials. A (13 cm x 1 cm2) glass column, packed with silica gel 
60: 70-230 mesh ASTM (Merck, W-Germany) in benzene and anhydrous so-
dium sulfate on the top (2 cm x 1 cm2) , was eluted with benzene. The f i r s t 
20 ml of the eluate were taken and reduced in volume by evaporation. Micro-
liter samples of the methylated ether extracts were subjected to gas chroma-
tography (GC) or to combined gas chromatography-mass spectrometry 
(GC-MS). 
GC was carried out with a Hewlett Packard 5750 G or 5730 A equipped 
with an electron capture detector and a 150 x 0.22 ( i . d . ) cm or 270 x 0.22 
( i . d . ) cm all glass column, packed with respectively 3% QF-1 or 3% OV-1 on 
Chromosorb Q 100-120 mesh. All other chromatographic conditions were the 
same as described by Koss and Koransky [15] . GC-MS was performed with 
an LKB 2091 instrument connected with a Digital PDP 11 computer. GC-MS 
analyses were carried out under the conditions described by Koss et al . 
[10] . 
Analysis of total porphyrin and porphyrin pattern 
Analysis of the total porphyrin concentration in the cell culture medium 
was performed following as 20- to 50-fold dilution of the medium with an 
acid-alcohol solution of chloranil (2,3,5,6-tetrachloro-1,4-benzoquinone), as 
described for total porphyrin analysis in urine samples [16]. Excitation 
spectra (A. : 350-500 nm, A. : 652 nm) of diluted samples of culture me-
^ ex ' e m 
dium were recorded on an Aminco-Bowman Model J4-8960 spectrofluorometer 
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equipped with a 150-watt xenon lamp and a red sensitive photomultiplier 
tube type Super S-20 R4465. A solution containing equimolar amounts of 
8,7,6,5,4 and 2 carboxylic porphyrins (Porphyrin Products, Logan, USA) 
was used as standard. Porphyrins accumulated in liver cells were deter-
mined by extraction into the acid-alcohol solution of chloranil. 
The pattern of porphyrins accumulated in the culture medium was ana-
lysed as described for urine samples by Doss [17] , with some modifications 
of Str ik and Harmsen [18] . Liver cells were f i rs t digested with 100% ethanol 
and dried under a stream of nitrogen, prior to the esterification and sepa-
ration of porphyrins by thin layer chromatography. The porphyrin methyl 
esters of medium and cells were pooled. 
Ethoxyresorufin O-de-ethylation was measured according to Burke and 
Mayer [19] . Protein concentration was determined by the method of Lowry 
et al . [20] with bovine serum albumin as a standard. 
Binding to cell protein 
Liver cell cultures, pretreated with ß-NF during the f i rs t 24 h of cul-
14 tu re , were exposed to C-HCB (1.1 |jCi/mg, 10 |jg/ml in medium) for 24 h. 
Solvent extractions were performed as described by Kappus and Remmer 
[21] with the following modifications: Cells and medium (7 ml/culture dish) 
were harvested; protein was precipitated with 2 volumes of absolute etha-
nol. Protein precipitate was extracted with 7 ml 70% ethanol; twice with 100% 
ethanol (7 ml) and twice with diethyl ether (7 ml). Extracted protein was 
solubilized in Soluene (Packard) and after addition of Instafluor (Packard), 
radioactivity was determined by liquid scintillation counting using an exter-
nal standards channel ratio programme to correct for quenching. To one cell 
14 culture C-HCB has been added just before solvent extraction, to serve as 
a control. 
RESULTS AND DISCUSSION 
Total porphyrin and the pattern of porphyrin accumulation 
When added alone to the cell cul ture, HCB induced only l itt le porphyrin 
accumulation (100-200 pmol/mg total cell protein), but pre-induction of the 
cell cultures with the cytochrome P-450 inducer ß-NF markedly enhanced 
porphyrin accumulation (Table I ) . Addition of the monooxygenase inhibitor 
piperonyl butoxide (p ip . bu t . ) completely prevented the accumulation of por-
phyrins in cultures treated with HCB (Tabel I ) . These results suggest that 
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TABLE I 
EFFECT OF ß-NAPHTHOFLAVONE (ß-NF) AND PIPERONYL BUTOXIDE (PIP. 
BUT.) ON PORPHYRIN ACCUMULATION IN CHICK EMBRYO LIVER CELLS 
TREATED WITH HCB 
Compound Total porphyrins 
(pmol/mg cell protein) 
HCB 
HCB + ß-NF pretreatment 
HCB + p ip .but . (10 ng/ml) 
Control 
100-200 
600-700 
10-20 
10-20 
the rate of HCB-metabolism has to be above a critical level before UROG-D, 
the enzyme playing the key role in HCB-induced porphyr ia, becomes in -
hibited and porphyrins start to accumulate. 
The porphyrin pattern in cell culture corresponds with the porphyrin 
pattern found in the HCB-induced porphyric mammalian liver [2,22,23]. The 
pattern consists mainly of porphyrins containing 8 and 7 carboxylic groups 
(F ig . 1a). After addition of the porphyrin precursor ALA (25 pg/ml) to the 
culture medium the porphyrins accumulating in the liver cells consisted 
mainly of proto- and coproporphyrin (F ig. 1b). It has been assumed that 
porphyrins accumulate as a result of the inability of the enzymes of the 
heme biosynthesis pathway to cope with an increased f lux of intermediates 
through the pathway [14] . The rate of protoporphyrin formation is probably 
too fast to convert all the protoporphyrin into heme by incorporation of iron 
in the protoporphyrin molecule. However, stimulation of the porphyrin syn-
thesis by addition of ALA together with addition of HCB to liver cell cu l -
tures pretreated with ß-NF, produced a pathological porphyrin pattern with 
mainly uro- and heptacarboxylic porphyrins (F ig . 1c). This indicates that 
Fig. 1a-h. Patterns of porphyrin accumulation by chick embryo liver cells 
maintained in serum-containing Williams E medium in response to different 
compounds added to the medium. 
Abbreviations and concentrations (pg/ml culture medium) of compounds 
added to the cell culture medium: ß-NF, pretreatment with ß-naphthoflavone 
(3| jg/ml); HCB, hexachlorobenzene (10(jg/ml); p ip .bu t . , piperonyl butoxide 
(5 or 10 ng/ml); ô-ALA, ô-aminolevulinic acid (25 | jg/ml); PCTA, pentachlo-
rothioanisol (10 pg/ml). The accumulation of porphyrins is expressed as a 
percentage of the total porphyrins formed. Values represent means of four 
experiments; S.D. within 10-15% of mean values, not indicated. The por-
phyrins are: 8, u ro - ; 7, heptacarboxylic; 6, hexacarboxylic; 5, pentacar-
boxylic; 4, copro-; 3, t r icarboxyl ic; 2, protoporphyrin. 
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porphyrin 
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t h e presence of HCB d i s t u r b s the stepwise decarboxy la t ion of u r o p o r -
p h y r i n o g e n to p r o t o p o r p h y r i n o g e n , or in o the r words i n h i b i t s UROG-D. T h e 
pathological p o r p h y r i n pa t t e rn could be a l tered in a pa t t e rn observed a f te r 
add i t ion of A L A , by s imultaneous appl icat ion of p i pe rony l bu tox ide at a c o n -
cen t ra t ion of 10 | jg /ml medium ( F i g . 1 f ) . P iperony l bu tox ide obv ious ly p r e -
ven ts the i nh ib i t i on of UROG-D in l i ve r cell cu l t u res t rea ted w i th H C B . A 
p o r p h y r i n p a t t e r n , in termediate between a pathological and A L A - p a t t e r n , 
appears when a lower concent ra t ion of p ipe rony l bu tox ide (5 pg/ml medium) 
was used ( F i g . 1e ) . 
Similar resu l t s were obta ined w i th 2 , 4 , 5 , 2 ' , 4 ' , 5 ' - hexach lo rob ipheny l ( 2 , 4 , 
5 , 2 ' , 4 ' , 5 ' - H C B ) , another rep resen ta t i ve of the g r o u p of p o r p h y r i n o g e n i c 
po lyhalogenated aromatic compounds (Tab le I I ) : Increas ing concent ra t ions of 
p ipe rony l bu tox ide added toge the r w i th 2 ,4 ,5 ,2 ' , 4 ' - , 5 ' -HCB to l i ve r cell c u l -
t u res caused an i nh ib i t i on of t he p o r p h y r i n o g e n i c a c t i v i t y of t h i s po l ych lo -
r ina ted b i p h e n y l . The decrease of p o r p h y r i n accumulat ion was accompanied 
by a lower ing of t he mixed f u n c t i o n oxygenase a c t i v i t y ( i . e . , e t h o x y -
reso ru f i n O - d e - e t h y l a t i o n ; E R R - O - D ) . The po rphy r i nogen i c ef fect of 2 , 4 , 5 , 
T A B L E II 
I N H I B I T I O N OF PORPHYRINOGENIC A C T I V I T Y OF 2 , 4 , 5 , 2 ' ,4 ' . 5 ' -HCB 
( lOpg /m l ) IN LIVER CELL CULTURE, BY ADDIT ION OF THE MONOOXY-
GENASE INHIB ITOR PIPERONYL BUTOXIDE 
P iperony l bu tox ide concent ra t ion (pg /ml medium) 
0 10 25 
ERR-O-D 
induc t ion fac to r 
( x c o n t r o l ) 
Tota l 
p o r p h y r i n s 
(pmo l /mg p r o t e i n ) 
6.0 
1400-1600 
of to ta l 
P o r p h y r i n 
p a t t e r n 
60 
itO 
20 I 
5.7 
200-500 
3.7 
10-20 
h . i l 
1.4 
10-20 
.1.1 
7 6 5 ' * 3 2 8 7 6 5 *• 3 2 8 7 6 5 't 3 2 
number of ca rboxy l i c g roups 
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2 ' , 4 ' , 5 ' - H C B could a l ready be completely p reven ted at a concent ra t ion of 
10 ( jg/ml p ipe rony l b u t o x i d e . The p o r p h y r i n pa t t e rn changed w i t h i nc reas -
ing p i p . b u t . concent ra t ions f rom pathological ( w i t h main ly u r o - and hep ta -
ca rboxy l i c p o r p h y r i n s ) , v ia an in termediate p a t t e r n to a normal p o r p h y r i n 
p a t t e r n . The la t te r could be revealed on ly by add ing exogenous ALA to the 
c u l t u r e medium of the hepatocytes (Tab le I I ) , in o r d e r to show to what e x -
t e n t UROG-D decarboxy lase was i n h i b i t e d . These resu l ts s u p p o r t the h y -
po thes is , as suggested a l ready by S inc la i r and Gran ick [ 2 4 ] , t h a t a metab-
o l i te o r react ive in termediate of the ch lo r ina ted hyd roca rbon i nh ib i t s 
UROG-D, t hus caus ing the accumulat ion of u r o p o r p h y r i n . 
Among several HCB-metabol i tes tes ted in the l i ve r cell c u l t u r e system 
(see l i s t of chemicals in me thods) , on ly pentachloroth ioaniso l ( P C T A ) and 
te t rach lo ro th ioan iso l ( T C T A ) were able to cause an accumulat ion of po r -
p h y r i n s . Examination of the pa t te rn of p o r p h y r i n accumulat ion revealed co-
CL 
CL-
IO.-
CL CL 
0-CH3 
, -
a W C L 
i i CIAACL 
* 
ii 
M 
M 
M 
I I 
HCB treated liver cell culture 
S-CH 
nt- ./•. _: ,
:
_.y;v, _ . _ . <s. _ . _ . 280 
compound 
PCTA 
PCP-me 
...'.til.;..' :-:"^ '•'• 
\>\\ 
278 
284 
282 
250 
248 
HCB 
PeCB 
8 10 
retention time (min.) 
F i g . 2 . Mass f ragmentogram of p u r i f i e d and methy la ted e ther e x t r a c t of a 
ch ick embryo l i ve r cell c u l t u r e , wh ich was exposed to HCB (10 HQ/ml me-
d ium) f o r 24 h . Selected ions were charac te r i s t i c f o r compounds of i n t e r e s t : 
PeCB: m/e = 248 and 250; H C B : m/e = 282 and 284; PCP-me: m/e = 278 and 
280; PCTA: m/e = 294, 296 and 298. GC cond i t i ons : A 270 x 0.28 ( i . d . ) cm 
glass column packed w i t h 3% QF-1 on Gas Chrom Q 100-120 mesh, c a r r i e r 
gas : hel ium (30 m l / m i n ) , in jec t ion p o r t : 210°C, o v e n : 180 ° C . 
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proporphyrin as the predominant type of porphyrin (F ig. 1g) ; but when 
the cultures were pre-induced with ß-NF a pathological porphyrin pattern 
developed after administering PCTA or TCTA to the culture medium (F ig . 
1h). Since PCTA does not accumulate in the liver of rats treated with PCTA 
and is not porphyrinogenic, in rats [13] , the results of the present in 
v i t ro experiments suggests that PCTA can be porphyrinogenic, but that the 
in vivo liver concentrations never reach the required level to induce hepat-
ic porphyria. 
Identification and quantitation of HCB-metabolites in chick embryo liver cell 
culture 
Fig. 2 shows the gas chromatograms for mass fragments characteristic of 
some known HCB-metabolites, which were derived from liver cells treated 
with HCB for 24 h. Besides HCB, PCTA and pentachlorobenzene (PeCB), 
pentachlorophenol (PCP) could be identified in the sample. The amount of 
PCP, however, was too small to get a clear mass spectrum. Our experience 
with liver material of rats is that PCP is bound very strongly to macromol-
ecules and not easily extractable with ether, even after alkaline treatment 
of the sample (unpublished results). The HCB used in this study contained 
100 
PCTA liver cell culture 
60-
a 
at 
20-
-
294 
244I 
I,I | 
261 
i J 
279, 
I III ,ll III 
Fig. 3. Partial mass spectrum of 
pentachlorothioanisol (PCTA) in pu-
r i f ied, methylated ether extract of 
HCB-treated chick embryo liver 
cells. 
300 m/e 
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some PeCB, but the relative amounts of PeCB to HCB were higher in ex-
tracts of HCB treated cells, indicating that the PeCB part ly originates from 
metabolism of HCB. A clear mass spectrum of PCTA (= methylated PCThP) 
was obtained (F ig . 3 ) , which confirms that HCB is converted into PCThP as 
such or in the form of a conjugate. Unmethylated ether extracts contained 
no detectable amounts of HCB metabolites in methylated form, and neither 
HCB nor HCB metabolites were detected in control cultures. The HCB me-
tabolites identified in chick embryo liver cell culture are the same as found 
in the excreta of different animal species after administration of HCB 
[9,25] . 
Piperonyl butoxide, which binds to the heme part of cytochrome P-450, 
could reduce the formation of PCThP by 50% (Table I I I ) . Although it shows 
that piperonyl butoxide has an effect on the biodégradation of HCB, the in -
hibition was not complete at the concentration of piperonyl butoxide chosen 
n this experiment (10 (jg/ml medium). A higher concentration of piperonyl 
butoxide would have blocked the biotransformation of HCB to a greater ex-
tent. However, this reduction in the rate of metabolism of HCB was prob-
ably enough to prevent the binding of reactive metabolic intermediates to 
UROG-D, which supposedly causes the disturbance of the hepatic heme syn-
thesis in HCB porphyria. 
TABLE III 
EFFECT OF PIPERONYL BUTOXIDE ON THE METABOLIC FORMATION OF 
'PCTA" IN HCB-TREATED CHICK EMBRYO LIVER CELL CULTURES3 
Additions "PCTA" on QF-1 "PCTA" on OV-1 
(pmol/6.106 cells) (pmol/6.106 cells) 
None not detected not detected 
"recovery" not detected not detected 
HCB 43 71 
HCB + p ip .but . 20 35 
Amounts of "PCTA" found in methylated ether extracts of alkaline-
treated samples of chick embryo liver cell cultures, as detected by GC 
on a QF-1 and OV-1 column and calculated by means of an external stan-
dard. 
HCB was added immediately before harvesting the liver cells. 
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14 Irreversible binding of C-HCB 
When a primary culture of chick embryo liver cells was exposed for 24 h 
14 to C-HCB, some radioactivity became t ight ly bound to cell protein and 
was not extractable by organic solvents. The binding was equivalent to 
59 pmol/ 6.106 cells (Table IV) . 
TABLE IV 
EFFECTS OF PIPERONYL BUTOXIDE AND ASCORBIC ACID ON THE IRRE-
VERSIBLE BINDING OF 14C-HCB TO PROTEIN 
tissue culture 
treatment 
radioactivity 
(d .p 
39 
76 
39 
48 
.m 
7 
5 
9 
3 
) 
14 radioactivity C-metabolite 
•"control" bound» 
(d .p .m . ) (pmol/6.10 cells 
b 
C-HCB 
control 
14 
14 
14 
C-HCB+Asc.acid (0.5 mM) 
C-HCB+pip.but. (5 ng/ml) 
36.8 
8.6 
59 
14 
All cell cultures were pretreated with ß-naphthoflavone (3 pg/ml medium) 
for 18 h from the 6th h after isolation. 
14C-HCB has been added to this "control" cell culture immediately before 
solvent extraction. 
The protein-bound radioactivity could be reduced approximately four times 
by addition of piperonyl butoxide (5 mg/ml). Addition of the antioxidant 
ascorbic acid to the culture medium (0.5 mM) did prevent irreversible bind-
ing of radioactivity completely (Table IV) . Moreover, earlier studies showed 
already that ascorbic acid could protect chick embryo liver cells against 
the porphyrinogenic effect of HCB [ 8 ] . 
After combining these results with the f inding that no stable metabolite 
of HCB could induce a HCB-type of porphyr ia, it seems very plausible that 
a reactive metabolic intermediate is involved in the binding to UROG-D. The 
recent [26] discovery of a pentachlorophenyl-mercapturic acid in the urine 
of HCB-treated rats leaves no doubt, that the PCThP found in HCB-treated 
chick embryo liver cell cultures partly originates from conjugation with 
glutathione. 
14 Since the amount of i rreversibly bound C-metabolites and the amount 
of PCThP determined in chick embryo liver cell cultures lie in the same 
order of magnitude (Tables III and IV ) , it seems that radicals formed by 
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metabolism of HCB and capable of reacting with catalytic SH-groups of en-
zymes and glutathione are responsible for the inhibition of UROG-D. 
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Chapter 6 
EFFECTS OF DIETARY ANTIOXIDANTS ON THE BIOTRANSFORMATION AND 
PORPHYRINOGENS ACTION OF HEXACHLOROBENZENE IN TWO STRAINS 
OF RATS3 
I. Induction of mixed function oxygenases, hepatic porphyria, glutathione-
s-transferase act iv i ty, and liver glutathione levels 
FELIX DEBETS, JAN-HENDRIK REINDERS, GÜNTER KOSS*, 
JUTTA SEIDEL* AND ANJO STRIK 
Department of Toxicology, Agricultural University, Wageningen, 
The Netherlands; i n s t i t u t e of Toxicology and Pharmacology, 
Phil ipps-University, Marburg, Federal Republic of Germany. 
SUMMARY 
Groups of female Agus or Wistar rats were given hexachlorobenzene 
(HCB) (50 mg/kg bw) in olive oil by stomach tube every other day. HCB-
treated animals were fed either on a basal powdered diet without extra 
added antioxidants or on the same basal diet supplemented with 0.15% ascor-
bic acid and 0.12% DL-a-tocopherolacetate. One of the HCB-treated Agus 
groups and one control group of Agus rats (both on a low-antioxidant diet) 
received by stomach tube 25 mg/kg bw of 3 ,5-d i - ter t -buty l -4-hydroxy-
toluene (BHT) every other day. Autopsies were made after 1,2,5 and 
8 weeks. The Agus rats were highly porphyric after 8 weeks of HCB treat-
ment, whereas the Wistar rats showed no symptoms of hepatic porphyria 
within that period. HCB, significantly decreased the hepatic glutathione 
concentration in both the Wistar strain and the Agus group fed on a low-
antioxidant diet. Agus rats were found to possess lower levels of hepatic 
glutathione than Wistar rats. 
Presented at The Seventh European Workshop on Drug Metabolism, Zu-
r ich/Switzerland, October 5-10, 1980. 
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Moreover, the induction of ethoxyresorufin O-de-ethylase activity was 1.5 
to 1.7-fold higher in the HCB-treated Agus rats than in the corresponding 
Wistar rats; whereas Agus rats showed less induction of glutathione-S-
transferease act iv i ty. The difference between Agus and Wistar rats in their 
susceptibility to the porphyrinogenic effect of HCB is discussed in the l ight 
of the above f indings. In contrast to earlier observations in v i t ro , dietary 
antioxidants could not protect against the porphyrinogenic action of HCB in 
vivo. The dietary antioxidants even stimulated the onset of porphyria in 
HCB-fed Agus rats. 
INTRODUCTION 
An inbred strain of rats (Agus) proved to be particularly susceptible to 
the porphyrinogenic effect of hexachlorobenzene (HCB). These Agus rats 
were found to possess higher levels of total non-heme iron in their livers 
than randomly bred Wistar derived Porton rats [ 1 ] . Since it has been re-
ported that iron overload potentiates the porphyrinogenic effect of HCB 
[ 2 , 3 ] , Smith et al. [1] suggested that the higher liver iron content of the 
Agus rats might be responsible for their increased susceptibility to HCB. 
Although the exact mechanism is not known, it has been observed also that 
iron influences the induction of hepatic mixed function oxygenases [ 4 ] . It 
was of interest therefore to examine to what extent a difference in the pat-
tern of induction of hepatic microsomal enzymes underlies this difference 
between Porton-Wistar and Agus rats for HCB porphyria; the more so as 
recent studies showed biotransformation of HCB to be a prerequisite for its 
porphyrinogenic effect [ 5 ,6 ] . 
According to one of the current hypotheses on the mechanism of HCB 
porphyria [7] the disturbance of hepatic porphyrin metabolism is attr ibuted 
to the inhibition of uroporphyrinogen decarboxylase (UROG-D) by reactive 
metabolic intermediates of HCB. The isolation of more than a dozen sul fur-
containing metabolites of HCB from the urine of rats treated with HCB [8,9] 
suggests that a reactive intermediate of HCB may react with SH-groups of 
proteins and peptides, like UROG-D and glutathione. However, contradic-
tory results about hepatic glutathione levels in HCB porphyria have been 
reported by several workers: Goerz et al . [10] found an abrupt drop of the 
hepatic glutathione level in male rats by the time porphyrins started to ac-
cumulate in the urine. In contrast, several other reports make no mention 
of altered liver glutathione concentrations in HCB porphyria in rats 
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[11-13]. Furthermore, very recently Koss et al. [14] found in HCB-treated 
female rats a decreased activity of hepatic glutathione-S-transferase, which 
catalyzes the conjugation of electrophilic metabolic products with glutathione 
yielding less reactive glutathione conjugates. 
In view of these findings and the inconsistencies therein , this study 
was undertaken to fur ther evaluate the role of glutathione and glutathione-
S-transferase in HCB-induced hepatic porphyria. We compared the effects of 
long-term HCB treatment on female rats of the Agus and Wistar strains, 
with special reference to induction of mixed function oxygenases, gluta-
thione-S-transferase act iv i ty, and hepatic glutathione content. The present 
paper shows that in addition to i ron, some other factors can be responsible 
for the greater susceptibility of Agus rats to the porphyrinogenic effect of 
HCB. 
Our previous studies with primary cultures of chick embryo liver cells 
demonstrated that the addition of antioxidants ( e . g . , ascorbic acid, DL-a-
tocopherol or N, N'-diphenyl-p-phenylendiamine) completely prevents the 
HCB-induced accumulation of porphyrins in v i t ro [ 5 ] . In addition, ascorbic 
acid could reduce the irreversible binding of radioactivity to protein of 
primary liver cell cultures treated with 14C-HCB to control values [15]. To 
investigate whether the protective effect of antioxidants applies also to the 
situation in v ivo, the present experiments on the porphyrinogenic effects of 
HCB in Agus and Wistar rats were performed on animals fed either on a 
low-antioxidant diet or on a diet rich in antioxidants. 
METHODS 
Animals and treatments 
Th i r ty two female (S.P.F. ) Wistar rats (12 weeks o ld; 150-170 g ) , ob-
tained from the Central Institute for the Breeding of Laboratory Animals 
TNO (Zeist, The Netherlands), were randomly distr ibuted in 2 groups of 
16. Both groups received 178 pmoLkg (50 mg/kg bw) of HCB in olive oil 
DAB 8 (1% solution) by stomach tube every other day. One group was fed 
on a basal powdered low-antioxidant diet [ -A] (without extra added ant i -
oxidants, Table I) and the second group was kept on the same basal diet 
supplemented with the antioxidants ascorbic acid (0.15%) and DL-a-toco-
pherolacetate (0.12%) [+A] (diets mixed by Hope Farms, Woerden, The 
Netherlands). 
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TABLE I 
COMPOSITION OF BASAL LOW-ANTIOXIDANT (-A) DIET 
Ingredient 
Wheat 
Corn 
Casein 
a-Cellulose 
Sunflower o i l , without 
ethoxyquin and BHT 
Brewer's yeast 
Vitamin premix, without ascorbic 
acid and DL-a-tocopherolacetate 1.0 
40 
33 
16 
2 
2 
I 
0 
5 
0 
0 
U 
U 
Mineral premix 
DL-methionine 
Choline 
Magnesium sulphate 
Calcium phosphate 
Calcium carbonate 
Sodium chloride 
Potassium chloride 
1.0 
0.15 
0.2 
0.2 
1.5 
0.8 
0.4 
0.3 
Three groups of 16 female Agus [16] ( inbred; 12 weeks old, 150-170 g) 
rats, derived from a breeding nucleus from the MRC Laboratory Animals 
Centre (Carshalton, Surrey, U.K.) and bred at the Laboratory Animals 
Centre (C .K .P . ) in Wageningen (The Netherlands), were treated with HCB 
as described above for the Wistar rats. Two of these HCB-treated Agus 
groups were fed on a low-antioxidant diet (Table I) and the th i rd group 
received the diet rich in antioxidants. One of the HCB-treated groups and 
one control group of Agus rats (both on a low-antioxidant diet) received by 
stomach tube 25 mg/kg bw of the food antioxidant 3 ,5-d i - ter t -buty l -4-hy-
droxytoluene) (BHT) in olive oil DAB 8 (1% solution) every other day. 
Olive oil without HCB was administered to control groups. The animals were 
acclimatized for 2 weeks before administering HCB; during that period they 
were fed already on their respective low-antioxidant or antioxidant-rich 
diets. 
Animals were housed in groups of 4 in stainless steel cages with wire-
netting bottoms to avoid the intake of excrements. Consumption of feed, 
body weights, and clinical symptoms were recorded several times a week. 
After 1,2,5 and 8 weeks, subgroups of 4 rats from each treatment group 
were killed by decapitation. The livers were rapidly taken out, weighed and 
divided for preparation of microsomes, for determination of HCB and its 
metabolites, for porphyrin analyses, and for measuring glutathione content. 
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Chemicals 
HCB (organic analytical standard) was purchased from B.D.H. Chemicals 
Co. L td . (Poole, Dorset, U .K . ) ; BHT (98%) and 1,2-dichloro-4-nitrobenzene 
(DCNB) from Merck (Darmstadt, F .R.G. ) ; 1,2-epoxy-3-(p-nitrophenoxy) 
propane (EPNN) from Eastman-Kodak (U .S .A . ) and ethylmorphine-HCI from 
Brocacef B.V. (Maarssen, The Netherlands). 7-Ethoxyresorufin and reso-
ruf in were obtained from Pierce Eurochemie B.V. (Rotterdam, The Nether-
lands). All compounds used were of analytical grade quali ty. 
Analytical procedures 
Liver microsomes were prepared as previously described [17]. The micro-
somal cytochrome P-450 concentration was calculated from the sodium 
dithionite difference spectrum of CO-saturated samples, using an extinction 
-1 -1 coefficient of 91 mM. cm between A and A.nn [181. Ethoxyreso-max 490 nm. L J ' 
ruf in O-de-ethylase activity [19] and the concentration of reduced gluta-
thione (GSH) in the liver [20] were measured with a fluorometric assay. 
Ethylmorphine N-demethylase was assayed spectrophotometrically according 
to Van den Berg et al. [21] . The activity of GSH-S-transferases in liver 
cytosol was measured on the basis of the increase in conjugate concentration 
with GSH (2 mM) as co-substrate and 1,2-dichloro-4-nitrobenzene [DCNB] 
(1 mM) and 1,2-epoxy-3-(p-nitrophenoxy)propane [EPNN] (0.5 mM) as sub-
strates [22]. Conjugate formation at 37°C in the incubation mixture contain-
ing 20 pi (DCNB) or 50 pi cytosol (EPNN) was recorded spectrophotome-
tr ical ly at 345 nm (DCNB) or 360 nm (EPNN). Microsomal protein concentra-
tion was determined by the method of Lowry et al. [23] with serum albumin 
as a standard. 
Total ur inary porphyrins were determined spectrofluorometrically [24] , 
using an equimolar solution of 8,7,6,5,4 and 2 carboxylic porphyrins as a 
standard (Porphyrin Products, Logan, U .S .A . ) . Freshly passed urine 
(0.2 ml) was diluted with 4.8 ml of a solution of chloranil [2,3,5,6- tetra-
chloro-1,4-benzoquinone] (25 mg/l) in 0.6 N hydrochloric acid/acetic acid/ 
ethanol ( 2 : 1 : 1 , v / v / v ) . Excitation spectra (A. : 350-500 nm; À : 
652 nm) of diluted urine samples were recorded on a Aminco Bowman f luoro-
meter equipped with a 150-watt xenon lamp and a red sensitive photomulti-
plier tube type Super S-20 R446S; the peak maximum at 403-405 nm was 
compared to the standard. Total porphyrins in the liver were measured 
after extracting liver homogenate (0.5 ml) with 1 N perchloric acid/ethanol 
( 1 : 1 , v / v , 10 ml) and subsequently recording the fluorescence spectrum 
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of the supernatant from centrifuged samples, as described above for ur ine. 
The pattern of porphyrins accumulated in the urine was analysed as de-
scribed by Doss [25] , with some modifications made by Str ik and Harmsen 
[26] . Pooled urine samples from 4 animals/group, containing 1 nmol total 
porphyrin/animal, were used for analysis. The pattern of liver porphyrins 
was determined according to Seubert and Seubert [27]. 
RESULTS 
Body weight and feed consumption 
The HCB-treated Agus groups showed a higher gain in body weight than 
2451-
230 
215 
ID 
>-
S 200 
CO 
185 
170 
Wistar,-A,HCB 
Wistar,+A, HCB 
Agus,-A,HCB 
Agus,+A,HCB 
Agus,-A,BHT,HCB 
Agus.-A.BHT 
Agus,-A 
Agus, +A 
11 15 19 23 27 31 35 39 43 47 51 55 
DAYS EXPOSURE TIME 
F i g . 1 . Gain in body we igh t of female Agus and Wistar ra ts t rea ted w i t h 
hexachlorobenzene ( H C B ) and fed e i ther a basal l ow-an t iox idan t d ie t ( - A ) 
o r a d ie t ( +A ) supplemented w i t h the an t iox idan ts ascorbic acid (0.15%) and 
DL-of- tocopherolacetate (0.12%). Points rep resen t means of at least 4 a n i -
mals. S . D . w i t h i n 10% of the mean va lues , not i nd i ca ted . A b b r e v i a t i o n s : 
H C B , hexachlorobenzene 50 m g / k g o ra l l y e v e r y o ther d a y ; B H T , 3 , 5 - d i -
t e r t - b u t y l - 4 - h y d r o x y t o l u e n e 25 m g / k g o ra l l y e v e r y o the r d a y ; - A , low-
an t i ox idan t d i e t ; +A, a n t i o x i d a n t - r i c h d ie t . 
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the control Agus groups during the second part of the experimental period. 
The gain in body weight in both Wistar groups treated with HCB was sig-
nif icantly higher than in the HCB-treated Agus rats throughout the ex-
periment (F ig . 1). There were no significant differences in body weight 
gain between rats fed on a low-antioxidant diet ( -A) and rats fed a diet 
rich in antioxidants (+A). Feed consumption during the experiment was not 
significantly different for all groups. 
Clinical observations 
In week 4 of the experiment, all Wistar rats treated with HCB developed 
skin lesions. In contrast, Agus rats developed no skin lesions even after 
8 weeks treatment with HCB. Skin lesions were characterized by small de-
pilated sores with hemorrhagic crusts located near the shoulders or under 
the chin. Development of skin lesions coincided with excessive scratching of 
the animals in the neck region. After 3 weeks the fur of all HCB-treated 
animals became shaggy, was neglected and showed loss of hair. The HCB-
treated rats (Agus and Wistar) exhibited weak tremors after the 5th week. 
In the 8th week one Wistar rat of the -A, HCB group and one Agus rat 
treated with HCB+BHT suddenly lost 20-30 g of weight within 2 days, and 
came in a poor condition. Consequently, they had to be killed before the 
end of the experiment. 
Liver weight 
Liver/body weight ratios significantly increased in HCB-treated Agus 
rats (-A diet) after 2 weeks. In the Agus groups treated with HCB 
(+A diet) and HCB+BHT, and both Wistar groups a significant increase in 
liver weight to body weight ratio was observed after 5 weeks of treatment. 
At 8 weeks, the l iver/body weight ratios of HCB-treated Agus and Wistar 
rats receiving a +A diet or BHT were significantly higher than in the cor-
responding treatment groups fed a -A diet (P<0.05; Table I I ) . 
Effects on liver mixed function oxygenases and glutathione-S-transferase 
HCB treatment significantly increased liver microsomal cytochrome P-450 
concentration in Agus and Wistar rats at all time points studied. The maxi-
mum concentrations of cytochrome P-450 in Agus rats receiving a -A diet, 
+A diet or -A+BHT in combination with HCB treatment amounted to 157%, 
147% and 173% of control values, respectively (Table I I I ) . No significant di f-
ferences in cytochrome P-450 concentration were found between HCB-treated 
Wistar and Agus rats at all time intervals studied. 
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At 5 weeks, ethoxyresorufin O-de-ethylase was induced maximally in 
HCB-treated Agus rats (Table I I I ) . The different dietary conditions di t not 
influence the maximum activity of ethoxyresorufin O-de-ethylase in the 
HCB-treated Agus rats (induced 75-fold; Table I I I ) . At 5 and 8 weeks the 
activities of ethoxyresorufin O-de-ethylase in HCB-treated Agus groups 
were about 50-70% higher than in corresponding Wistar groups (Table I I I ) . 
HCB dit not significantly increase ethylmorphine N-demethylase activi ty in 
either strain of rats (results not shown). 
The activity of glutathione-S-transferase towards the glutathione-binding 
substrates DCNB and EPNN was increased in HCB-treated rats of both 
strains (F ig . 2) . The model substrate DCNB is conjugated with glutathione 
by displacement of a chlorine atom, whereas EPNN is transformed to a g lu -
substrate conjugation 
% 
400 
300 
200 
100 
lWis tar ,eA,HCB 
>Wistar , sA,HCB 
D—a Agus,eA,HCB 
O - O Agus,eA, HCB 
A - A A g u s , ® A , H C B + B H T 
A ~ A A g u s , e A , B H T 
D C N B 
0
 1 2 3 4 5 6 7 8 
time of treatment (weeks) 
substrate conjugation 
% 
400T 
300 
200-
100-
E P N N 
1 2 3 4 5 6 7 8 
time of treatment (weeks] 
Fig. 2. Effects of dietary antioxidants on glutathione-S-transferase activity 
in liver cytosol of female rats of the Agus and Wistar strains, dosed orally 
with 50 mg/kg HCB every other day for 8 weeks. Conjugation of 1,2-di-
chloro-4-nitrobenzene (DCNB) and 1,2-epoxy-3-(p-nitrophenoxy) propane 
(EPNN) with glutathione is expressed as the % of the mean activity in the 
corresponding Agus control group. Points represent means of 3 or 4 ani-
mals. Two-way analysis of variance (time vs. strain) showed significant 
overall differences between HCB-treated Agus and Wistar groups (F- test , 
P<0.01). 
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p-mol QSH/ g l iver 
6 r i 
f. 
eA ;HCB ®A ; HCB 
\ ., i 
Wistar 
* I 
1 2 5 8 
eA 
m 1 
1 2 5 8 
ï 
®A 
1 2 5 8 
I 
eA ; BHT 
Agus Q control 
H HCB 
Fig. 3. Liver glutathione (GSH) content of female Agus and Wistar rats 
treated with hexachlorobenzene (HCB) and fed either a low-antioxidant diet 
( -A) or a diet rich in antioxidants (+A). Weeks exposure time indicated at 
the base of bars. Bars represent means ± S.D. of 4 rats. Closed asterisk 
denotes significant difference from control group: one-sided Student's 
t - tes t , P<0.05. Open asterisk denotes significant difference from 1 week 
values, P<0.05. (Consult legend Fig. 1 for more detai ls.) 
tathione conjugate by cleavage of the epoxide bond. Testing for overall sig-
nificance of differences between Agus and Wistar groups by analysis of 
variance showed that HCB-treated Agus rats had less induced glutathione-
s-transferase activities than correspondingly treated Wistar rats. Agus rats 
administered BHT only were found to possess a moderately increased activ-
i ty of glutathione-S-transferase towards the substrates DCNB (at 2 weeks) 
and EPNN (at 1,2 and 5 weeks) (F ig. 2) . 
Liver glutathione content 
The glutathione contents of the livers of HCB-treated Wistar rats killed 
after 5 and 8 weeks were significantly lower than the values found after 
1 week of treatment. After 8 weeks, the concentration of glutathione was 
decreased in HCB-treated Wistar rats fed either on a -A diet or on a 
+A diet to 72% and 79% of the one week values, respectively (F ig. 3). In 
contrast, the glutathione concentration in the livers of the HCB-treated 
Agus rats significantly decreased only in the group administered the low-
antioxidant diet. Moreover, the glutathione contents of the livers of Agus 
rats were generally about 20% lower than those of the Wistar rats after 1 or 
2 weeks of treatment. 
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Total liver porphyrins 
nmol /g wet tissue 
" 
•—• 
•—• 
D D 
0 O 
A — A 
D—--a 
o—0 
A — A 
Wistar.eA.HCB P 
Wistar,«A,HCB / 
Agus.eA,HCB 1Ù 
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Agus.eA, control / / 
Agus,®A, control / / 
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Total urinary porphyrins 
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18 r 
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Time (weeks) 
2 4 
Time (weeks) 
Fig. 4. Effects of dietary antioxidants on the total ur inary porphyrin ex-
cretion and the total porphyrin concentration in the livers of female rats of 
the Agus and Wistar strains after oral dosing of hexachlorobenzene (HCB) 
every other day for 8 weeks. Points represent means of 4 animals. (Consult 
legend Fig. 1 for more details). 
Porphyrins in urine and liver 
Figure 3 shows that after 5 weeks the porphyrin concentration in the 
liver and urine of HCB-treated Agus rats began to increase rapidly, ind i -
cating the onset of porphyria (F ig . 4) . At the same time the pattern of 
liver and urinary porphyrins changed, resulting in an increase in the 
amount of porphyrins with 8 and 7 carboxylic groups relative to those with 
4 and 2 carboxylic groups (Table IV) . After 8 weeks uroporphyrin (8 car-
boxylic groups) was the predominant type of porphyrin (35-45% of total) in 
the urine of HCB-treated Agus rats. Those changes were more pronounced 
in the Agus rats receiving a +A diet or BHT than in the Agus rats kept on 
a low-antioxidant diet (Figs. 3,4; Table IV) . 
Even after 8 weeks, no symptoms of hepatic porphyria could be detected 
in HCB-treated Wistar rats. The 2-fold increase in the ur inary excretion of 
porphyrins in the Wistar rats shown at week 8 represented predominantly 
coproporphyrin (85% of total ; Table IV) , not uroporphyrin as is typical of 
the inhibition of uroporphyrinogen decarboxylase in HCB porphyria. 
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DISCUSSION 
Female rats proved to be more susceptible to the porphyrinogenic effect 
of HCB than female Wistar rats. After 8 weeks of treatment the Agus rats 
showed a ur inary porphyrin pattern with uroporphyrin as the predominant 
intermediate, whereas in the Wistar rats mainly coproporphyrin was ex-
creted. This corresponds with earlier observations of Smith et al. [ 1 ] , who 
reported that Agus rats developed hepatic porphyria at a much faster rate 
than animals of the Porton strain when treated with HCB. This difference in 
susceptibil ity is probably not only restricted to Agus and Porton strains, 
but exists also between Agus and Wistar rats. 
We have shown that during HCB treatment the hepatic glutathione con-
centration significantly decreased in the Wistar strain and in Agus rats fed 
a low-antioxidant diet. On the other hand, no significant changes were 
found in the remaining two HCB-treated Agus groups, which were the most 
Porphyrie groups at the end of the 8-week period of HCB treatment. The 
above findings seem to contrast with the hypothesis that glutathione plays 
an important role in the inactivation of reactive metabolic intermediates in -
volved in causing HCB porphyria [ 7 ] . However, recently Smith and co-
workers [28] were able to show by quantitative cytochemistry that the 
glutathione concentration in the centrilobular hepatocytes is approximately 
50% lower than in the periportal hepatocytes. Moreover, the centrilobular 
l iver cells are more active in the biotransformation of xenobiotics [29,30] 
and contain more cytochrome P-450 [31] than the periportal liver cells. The 
higher rate of xenobiotic metabolism in the centrilobular cells leads to the 
formation of more reactive intermediates, which are not adequately detoxi-
fied by glutathione. Consequently, reactive metabolic intermediates of HCB 
will attack nucleophilic groups of enzymes including uroporphyrinogen de-
carboxylase, the key enzyme found to be inhibited in HCB porphyria. The 
above arguments would also explain why in the f i rs t stage of HCB por-
phyria the accumulation of porphyrins is restricted to the centrilobular re-
gions of the liver [32,33]. Assuming fur ther that a lowering of the gluta-
thione content f i r s t takes place centri lobularly, a litt le decrease of the 
glutathione concentration in the affected centrilobular liver cells might have 
been underestimated, or even completely overlooked in studies where the 
decrease was so small that it lost in the standard deviation [11-13]. 
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In our study a moderate decrease (10-15%) of the glutathione concentration 
in the total liver (as found in the HCB-treated Agus rats on a -A diet) 
means a 30-45% decrease in the centrilobular part . 
In contrast to earlier reports [14] , no inhibition of the activity of gluta-
thione-S-epoxide transferase in HCB-treated rats was observed in the pre-
sent study. However, the Agus rats which appeared to be more susceptible 
to the porphyrinogenic effect of HCB had less induced activities of gluta-
thione-S-transferases than animals of the Wistar strain after treatment with 
HCB. This may be significant in terms of having less protection against 
electrophilic metabolites formed by biotransformation of HCB. The different 
dosage levels of HCB used in our experiments as compared to those of Koss 
et al . [14] may explain why our results did not confirm the previously re-
ported depressed activity of glutathione-S-epoxide transferase in HCB por-
phyr ia. This clearly requires fur ther investigation. 
The induction of ethoxyresorufin O-de-ethylase was not equal in both 
strains of rats. The maximum activities of ethoxyresorufin O-de-ethylase 
were 1.5 to 1.7-fold higher in the HCB-treated Agus rats than in the HCB-
treated Wistar rats. Hence, more reactive metabolic products may be formed 
in the Agus rats via hepatic monooxygenase act iv i ty, leading to an earlier 
inhibition of uroporphyrinogen decarboxylase, and therefore to porphyr ia. 
In conclusion, based on these apparent differences between both strains 
of rats, it appears that in addition to the higher non-heme iron contents in 
the livers of the Agus rats [1] some other factors may contribute to their 
increased susceptibility to the porphyrinogenic effect of HCB: (1) a lower 
level of hepatic glutathione; (2) less induction of glutathione-S-transferase; 
(3) a higher mixed function oxygenase act iv i ty. 
In contrast with our earlier observations in primary liver cell cultures 
[ 5 ] , the results of the present experiments indicate that dietary antioxi-
dants are not able to protect against the porphyrinogenic effects of HCB in 
v ivo; i t would even appear that the reverse is t rue . Two possible explana-
tions can be offered. First ly, the antioxidants (ascorbic acid and DL-a-
tocopherol) in vivo never reach the concentration attainable in primary liver 
cell culture (0.5 mM in culture medium [ 5 ] ) . Secondly, liver weights of 
HCB-treated animals receiving a diet supplemented with antioxidants were 
higher than liver weights of those fed on a low-antioxidant diet; cytochrome 
P-450 content and ethoxyresorufin O-de-ethylase activity tended to be 
higher in the HCB-treated groups kept on a diet with extra antioxidants. 
This suggests that in vivo dietary antioxidants did enhance the biotrans-
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formation capacity of the l iver, resulting in a higher rate of formation of 
reactive metabolic products and in consequence an earlier onset of porphy-
rin accumulation. 
BHT stimulated the porphyrinogenic action of HCB in Agus rats. A l -
though BHT at the dosage applied here produced neither enlargement of the 
liver nor induction of mixed function oxygenases, it may have altered the 
functional state of cytochromes P-450 towards the phenobarbital-inducible 
forms of P-450 [34]. Since we demonstrated already that phénobarbital in -
duction enhanced the porphyrinogenic effect of HCB in rats [35] , this 
might explain the stimulating effect of BHT on HCB porphyria. 
Finally, recent information indicates the existence of a close correlation 
between the responsiveness of mice to the induction of aryl hydrocarbon 
hydroxylase (AHH) and their susceptibility to the porphyrinogenic effects 
of halogenated aromatic compounds [36]. It should therefore be fur ther i n -
vestigated whether Agus rats possess a higher AHH responsiveness than 
Wistar rats, the more so as in the present study the highest activities of 
the cytochrome P-448 dependent O-de-ethylation of ethoxyresorufin were 
found in the HCB-treated Agus rats. 
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I I . Formation and excretion of metabolites 
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SUMMARY 
Groups of female rats of the Agus and Wistar strains were dosed orally 
with hexachlorobenzene (HCB) (178 pmol. kg ) every other day for 
8 weeks. Animals were fed either on a basal low-antioxidant diet or on a 
diet supplemented with ascorbic acid (0.15%) and DL-a-tocopherolacetate 
(0.12%). One group of Agus rats additionally received every other day a 
dosage of 25 mg. kg 3,5-d i - ter t . -butyl-4-hydroxytoluene (BHT) . The ex-
cretion of HCB metabolites in urine and feces was determined after 1,2,5 
and 8 weeks. Twenty % of the compounds excreted by the Agus rats after 
8 weeks consisted of unchanged HCB, whereas 80% was excreted as metab-
olites. For the Wistar rats these percentages amounted to 30% and 70%, re-
spectively. The ratio of the excreted amounts of phenolic metabolites to the 
sulfur-containing metabolites increased from about 0.05, after the f i rs t 
week, to 0.3 after the 8th week. There was no difference in the accumula-
tion of HCB in the liver between the two strains. However, Agus rats were 
found to possess significantly higher concentrations of HCB metabolites in 
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their livers than the Wistar rats; in addit ion, the capacity for methylating 
the thiophenolic metabolites in vivo appeared to be greater in the former 
stra in. Neither dietary antioxidants not BHT had an effect on the contents 
of HCB or its metabolites in the l iver. On the other hand, Wistar rats fed 
on a low-antioxidant diet excreted 2-3 times less metabolites than Wistar 
rats kept on a diet rich in antioxidants. It is suggested that differences in 
the biotransformation of HCB between Wistar and Agus rats part ly explain 
the increased susceptibility of the Agus strain to the porphyrinogenic action 
of hexachlorobenzene. 
INTRODUCTION 
Hexachlorobenzene (HCB) produces a disturbance of the hepatic heme 
biosynthesis when administered to mammals, birds and man [1 ] . This bio-
chemical disorder, referred to as hepatic porphyr ia, proved to be a t t r ibu-
table to a decrease in the activity of the enzyme uroporphyrinogen decar-
boxylase (UROG-D), which is involved in the biosynthetic pathway of heme 
formation [2 ,3 ] . The enzyme defect is reflected in a specific pattern of por-
phyr in overproduction. Porphyrins that accumulate in liver and urine mainly 
consist of uro- and heptacarboxylic porphyrins [ 4 ] . 
The porphyrinogenic action of HCB is restricted to certain species and 
strains of animals [ 5 ] . Recently Smith et al. [6] reported that female rats 
of the Agus strain are particularly sensitive to the porphyrinogenic effect 
of HCB. In female Agus rats the inhibition of UROG-D started earlier and 
proceeded at a faster rate than in female rats of the Porton-Wistar strain 
when treated with HCB. Since previous studies [7,8] showed biotransforma-
tion of HCB to be a prerequisite for its porphyrinogenic action, a di f fer-
ence in the way of biotransformation or pharmacokinetic behaviour of HCB 
may underly the difference in susceptibility to HCB between these two 
strains of rats. To investigate th is , we compared the biotransformation of 
HCB in Agus and Wistar rats fed on diets with different antioxidant concen-
trat ions. We examined the accumulation of HCB and its main metabolites in 
the l iver, the pattern of excretion of metabolites, and the rate of biotrans-
formation of HCB. 
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METHODS 
Female rats of the Agus and Wistar strains, weighing 150-170 g , were 
randomly divided in groups of 16. Animals were treated with oral doses of 
HCB (178 pmol.kg ) in olive oil and fed on either a basal low-antioxidant 
diet [-A] or a basal diet supplemented with the antioxidants ascorbic acid 
(0.15%) and DL-a-tocopherolacetate (0.12%) [+A] , as detailed in the preced-
ing paper [ 9 ] , Twenty four h collections of urine and feces were made 
weekly from 4 animals per treatment group in metabolism cages. Rats were 
put individually in metabolism cages on a day when they received no HCB, 
but were allowed access to feed and water. Total volume of urine and total 
weight of feces excreted dur ing 24 h were measured. Samples of urine and 
feces were kept frozen (-18°C) until analysis. 
Determination of HCB and its metabolites were performed by means of 
gas chromatography as described elsewhere [10-12]. 
Significant differences between Agus and Wistar groups were assessed by 
Student's t - test at P<0.05. 
HC B content of liver 
u. mol/g 
1.5-
1.0-
0.5-
Ç&M 
o Wistar, ® A 
a Agus.eA 
• Agus, ©A 
• Wistar, e A 
+ Agus.eA.BHT 
2 3 4 5 6 7 
time of treatment (weeks ) 
Fig. 1. Content of hexachlorobenzene (HCB) in the livers of two strains of 
female rats. Animals were dosed orally with HCB (50 mg/kg) every other 
day for 8 weeks, and fed either a basal low-antioxidant diet ( -A) or a diet 
(+A) supplemented with the antioxidants ascorbic acid (0.15%) and DL-a-
tocopherolacetate (0.12%). Points represent means of 4 rats. S.D. within 15% 
of the mean values, not indicated. Liver tissue of controls contained 
0.2 nmol/g HCB at 5 weeks and 0.8 nmol/g HCB at 8 weeks. 
Abbreviations: HCB, hexachlorobenzene 50 mg/kg orally every other day; 
BHT, butylated hydroxytoluene 25 mg/kg orally every other day; -A, low-
antioxidant diet; +A, antioxidant-r ich diet. 
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RESULTS 
The accumulat ion of HCB and i ts main metabol i tes in the l i ve r 
The resu l ts presented in F ig . 1 show tha t no d i f fe rences in the concen-
t r a t i o n of HCB in the l i ver were observed between Agus and Wistar r a t s . 
A t 8 weeks of t rea tment the content of HCB in the l i ve r amounted to about 
1.5 f jmo l /g . In con t ras t to the l i ve r HCB con ten t , the content of metabol i tes 
in the l i ve r was s ign i f i can t l y h igher in the Agus rats than in the Wistar 
ra ts a f te r 5 weeks of HCB t rea tment ( F i g . 2 ) . Moreover , the capac i ty f o r 
methy la t ing the th iophenol ic metabolites of HCB in v i vo appeared to be 
g rea te r in the Agus rats than in the Wistar ra ts ( F i g . 2 ) . The d ie ta ry 
an t iox idan ts and 3 , 5 - d i - t e r t . - b u t y l - 4 - h y d r o x y toluene ( B H T ) in f luenced 
ne i the r the accumulat ion of HCB in the l i ve r nor the content of HCB metab-
ol i tes in the l i ve r ( F i g s . 1 , 2 ) . 
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Fig. 2. Contents of the main HCB metabolites in the livers of female Agus 
and Wistar rats after 5 weeks of HCB administration. Bars represent mean 
values + S.D. of 4 animals. Controls contained about 0.3 nmol/g PCP. 
Sulfur-containing metabolites were not detected in the control samples. 
(Consult legend Fig. 1 for more detai ls.) 
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The biotransformation rate of HCB and the pattern of excretion of its main 
metabolites 
After 8 weeks of HCB administration, in the Agus rats about 20% of the 
xenobiotic was excreted unchanged and almost 80% as metabolites. The per-
centage of metabolites excreted in the urine and feces of the Wistar rats 
was significantly lower at that time (approximately 70%, Table I ) . Hence it 
appears that after 8 weeks the rate of biotransformation of HCB in the 
Agus strain was higher than in the Wistar strain. This difference was not 
observed after 1 and 5 weeks; at those times the biotransformation rate was 
found to be approximately equal then for all treated groups (50-60%). 
The total amount of excreted xenobiotics consisted for 50-60% of sul fur-
containing metabolites (pentachlorothioanisol [PCTA] and tetrachlorodithio-
anisol [TCd i -TA ] ) , whereas the relative amount of phenolic metabolites 
(pentachlorophenol [PCP] and tetrachlorohydroquinone [TCH]) increased 
from 5% after 1 week to 15-20% at the end of the experiment (8 weeks) 
(F ig. 3) . When the relative amounts of phenolic- and sulfur-containing 
relative amounts 
of metabolites 
% 
60H A 
40 
20 
—i 1 r -
1 2 3 
S-containing 
metabolites 
# I phenolic 
Ä I metabolites 
4 5 6 7 8 
time of treatment (weeks) 
o Agus.eA 
• Agus, ®A 
• Agus.eA.BHT 
a Wistar,eA 
A Wistar,®A 
Fig. 3. Relative amounts of phenolic- and sulfur-containing metabolites of 
hexachlorobenzene (HCB) in the excreta (urine + feces) of female rats of 
the Agus and Wistar strains after oral administration of HCB every other 
day for 8 weeks. Values represent means of 4 rats and are expressed as 
the % of the sum of the amounts (pmol/day) of unchanged HCB and HCB 
metabolites excreted in urine and feces. (Consult legend Fig. 1 for more 
details. ) 
- 144 -
metabolites excreted in the urine plus feces from Agus and Wistar rats were 
compared, no appreciable differences could be observed (F ig . 3) . However, 
after 8 weeks the total amounts of metabolites excreted by the Wistar rats 
fed a low-antioxidant diet were approximately 2-3 times lower than the 
amounts excreted by the Wistar rats fed a diet rich in antioxidants and the 
amounts excreted by the three HCB-treated Agus groups (Table I ) . This 
effect of dietary antioxidants on the total excretion of metabolites in the 
Wistar rats was not noticed within the Agus groups. 
DISCUSSION 
Based on the relative amounts of HCB and its metabolites in the excreta, 
the rate of biotransformation of HCB calculated in the present study was 
found to be almost 2-fold higher than in previous experiments [13,14]. 
Moreover, the ratio of the excreted phenolic metabolites to the sul fur-con-
taining metabolites was at the end of this experiment 0.3, whereas previ -
ously a ratio of 2.8 had been determined [13]. These apparent inconsist-
encies may be due to the fact that the amount of the HCB metabolite tet ra-
chlorodithiophenol had not been measured in the earlier studies. The pre-
sent study showed, however, that this metabolite accounted for more than 
65% of the total amount of excreted metabolites (Table I ) . 
The higher content of metabolites in the liver of Agus rats and their 
higher relative amount of metabolites in the excreta (Table I) as compared 
to that in Wistar rats, may be attr ibuted to the higher activity of hepatic 
ethoxyresorufin O-de-ethylase noted in the former strain (see preceding 
paper). 
The higher rate of HCB biotransformation in the Agus rats may have con-
tr ibuted to their increased susceptibility to the porphyrinogenic effect of 
HCB (preceding paper), since several of our previous experiments showed 
metabolic conversion of HCB to be a prerequisite for inducing porphyria 
[7 ,8 ] . The occurrence of sulfur-containing metabolites in HCB-treated rats 
part ly may stem from a reaction with glutathione [16]. Moreover, the large 
amount (60% of total amount, Fig. 3) and variety of these sulfur-containing 
metabolites [12] are indicative of the aff ini ty of HCB or its intermediate 
metabolic products which may possess electrophilic properties, also to mer-
capto groups of proteins. Since the enzyme UROG-D contains functional 
SH-groups [17] , the binding of such conversion products of HCB to this 
enzyme is possible. Indeed, experiments with 14C-labeled HCB showed 
radioactivity to be irreversibly bound to cytoplasmic proteins [7,15] . 
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Based on the above results and the observations that the livers of Agus 
rats contained less glutathione and possessed less induced activities of 
glutathione-S-transferase than those of Wistar rats (preceding paper), we 
suggest that in Agus rats more reactive intermediates of HCB biotrans-
formation are binding to functional SH-groups of uroporphyrinogen decar-
boxylase, instead of being inactivated by glutathione and glutathione-S-
transferase. We therefore propose that th is , together with the comparatively 
high non-heme iron content of the liver of Agus rats [ 6 ] , explains the 
peculiar susceptibility of the Agus strain to the porphyrinogenic effect of 
HCB. 
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Conclusions 
- Biotransformation of hexachlorobenzene by the hepatic microsomal mixed 
function oxygenase system proved to be a prerequisite for its porphyrino-
gen^ action. 
Pentachlorophenol, as well as the other major metabolites of hexachloro-
benzene, are not responsible for the porphyrinogenic action of hexachloro-
benzene. 
The results show that unstable reactive intermediates formed by biotrans-
formation of hexachlorobenzene supposedly are responsible for the distur-
bance of the heme biosynthesis, and not hexachlorobenzene itself. 
- Antioxidants protected in v i t ro against the porphyrinogenic action of 
hexachlorobenzene, whereas this protective effect of antioxidants could not 
be established for the in vivo situation. 
The foregoing conclusions most probably apply to all other porphyrino-
genic polyhalogenated aromatic compounds as well. For some members of this 
group of chemicals the present investigation has shown that this is the 
case. 
A primary culture of chick embryo liver cells provides a suitable model 
system to eludicate the mechanism of action of porphyrinogenic and hepato-
toxic xenobiotics. 
- It stil l is not definitely established that hexachlorobenzene is metabolized 
via reactive intermediates and that these reactive species bind to functional 
SH-groups of the uroporphyrinogen decarboxylating enzyme in the cyto-
plasm of the liver cells. This requires fur ther studies, in which these re-
active intermediates are identified by using spin trap and electron spin res-
onance (ESR) techniques. In addition, the complex of the reactive species 
with the enzyme uroporphyrinogen decarboxylase has to be isolated by im-
muno-adsorption with specific antibodies against the enzyme. 
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General summary 
Polyhalogenated aromatic hydrocarbons are known to cause hepatic por-
phyria in man and in various species of animals. This disorder in porphyrin 
metabolism is attr ibuted to a defect in the activi ty of the intermediary en-
zyme uroporphyrinogen decarboxylase in the heme biosynthetic parhway and 
leads to an accumulation ( in the l iver) and excretion ( in urine and feces) of 
large amounts of mainly uroporphyr in. However, the mechanism underlying 
this block in the hepatic heme biosynthesis is not known. 
The present studies have been carried out to fur ther elucidate the me-
chanism of action of polyhalogenated aromatic compounds (PHAs) on the he-
patic heme biosynthesis. Hexachlorobenzene (HCB),. a member of this group 
of foreign chemicals, was used as a model compound in our investigations. 
Chapter 1 gives a review of l i terature data on those aspects of the tox i -
cology, pharmacokinetics and biotransformation of PHAs that are relevant to 
explain their effects on the hepatic heme synthesis. Special emphasis is 
given to HCB. 
Chapter 2 describes the effects of pentachlorophenol (one of the main 
metabolites of HCB) on the induction of hepatic porphyria and mixed func-
tion oxygenases in female rats administered HCB. The porphyrinogenic ef-
fect of HCB was enhanced by simultaneous treatment with pentachloro-
phenol, whereas rats receiving pentachlorophenol alone developed no symp-
toms of hepatic porphyria. Pentachlorophenol showed a high aff ini ty for 
membranes of the endoplasmic reticulum (see also Chapter 4) and it was 
found to destroy cyrochrome P-450 in v i t ro . From these results it is con-
cluded that pentachlorophenol is not the metabolite that ultimately causes 
hepatic porphyr ia. However, pentachlorophenol may contribute indirectly to 
the porphyrinogenic action of HCB by stimulating the heme biosynthesis as 
a result of an accelerated breakdown of cytochrome P-450 heme. The con-
comitant increased production of heme exacerbates the porphyria caused by 
the defect of uroporphyrinogen decarboxylase. 
Chapter 3 deals with the effects of several compounds interfering with 
the biotransformation reactions of PHAs on the accumulation of porphyrins 
in primary cultures of chick embryo liver cells treated with PHAs. Pre- in-
duction of the enzyme system involved in the biotransformation of PHAs 
markedly enhanced the porphyrinogenic effect of PHAs in chick embryo 
liver cells. Inhibition of the induction of 6-aminolevulinic acid synthase with 
increasing concentrations of hemin could not prevent PHA-induced porphy-
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r in accumulation. Inhibition of the mixed function oxygenase system or ad-
dition of elec trophi le-trapping agents protected chick embryo liver cells 
against the porphyrinogenic effect of PHAs. A decrease of the level of in -
tracellular glutathione with glutathione-depleting agents led to an enhance-
ment of the cytotoxicity of PHAs in chick embryo liver cell cultures. It is 
suggested that a reactive intermediate, formed by biotransformation of the 
PHA, reacts with the catalytic SH-containing part of the uroporphyrinogen 
decarboxylating enzyme in the cytoplasm of the liver cells. 
Chapter 4 gives a report of the effects of combined administration of 
HCB with either phénobarbital or 3-methylcholanthrene on female rat l iver. 
The results presented in this Chapter and in Chapter 2 show that HCB in -
duces a pattern of hepatic mixed function oxygenases which shares charac-
teristics of the enzyme pattern induced by both phénobarbital and 3-methyl-
cholanthrene. Simultaneous treatment with HCB and phénobarbital, but not 
with HCB and 3-methylcholanthrene, markedly enhanced the porphyrinogenic 
effect of HCB in female rats. These results suggest a key role for the 
phenobarbital-inducible form of cytochrome(s) P-450 in the biotransformation 
of HCB and the induction of hepatic porphyria. 
Chapter 5 shows that HCB is metabolized in chick embryo liver cell cu l -
tures. The HCB-metabolites identified in chick embryo liver cell culture are 
the same as those found in HCB-treated rats. Since none of the major phe-
nolic- and sulfur-containing metabolites of HCB were able to cause por-
phyr in accumulation in chick embryo liver cell cul ture, an unstable reactive 
intermediate capable of reacting with SH-groups of proteins is suspected to 
be responsible for the inhibition of uroporphyrinogen decarboxylase and the 
14 
onset of hepatic porphyria. In liver cell cultures treated with [ C] HCB 
some radioactivity became irreversibly bound to cell protein. Addition of the 
monooxygenase-inhibitor piperonyl butoxide or ascorbic acid reduced the 
14 protein binding of C-metabolites. Based on the results, it appears that 
the rate of biotransformation of HCB has to be above a critical level before 
the enzyme uroporphyrinogen decarboxylase becomes inhibited and hepatic 
porphyria develops. 
In Chapter 6 a comparison is made of the effects of dietary antioxidants 
on the biotransformation and porphyrinogenic action of HCB in two strains 
of female rats, which dif fer in their susceptibility to HCB. Female Agus 
rats were much more susceptible to the porphyrinogenic effect of HCB than 
female rats of the Wistar strain. The following differences between the 
Wistar and Agus strains of rats in their responses to HCB were noticed: 
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(1) HCB induced in Agus rats a higher mixed function oxygenase activi ty 
than in Wistar rats. In addit ion, the biotransformation rate of HCB appear-
ed to be higher in the Agus rats. (2) Glutathione-S-transferase activity 
was less induced in HCB-treated Agus rats than in correspondingly treated 
Wistar rats. (3) Agus rats had significantly lower levels of glutathione in 
their livers than the Wistar rats. These differences may be responsible for 
the increased susceptibility of the Agus strain to the porphyrinogenic effect 
of HCB. Moreover, these findings support the hypothesis that binding of 
reactive intermediates of HCB biotransformation to functional SH-groups of 
uroporphyrinogen decarboxylase forms the key process in the disturbance 
of the hepatic heme biosynthesis. The observation that HCB was excreted in 
this experiment for almost 60% as sulfur-containing metabolites again con-
firmed the aff ini ty of intermediate metabolic products of HCB for SH-
groups. 
In contrast to the results obtained with primary chick embryo liver cell 
cultures (Chapter 3) , dietary antioxidants could not protect against the 
porphyrinogenic effect of HCB in vivo. Some possible explanations for this 
discrepancy are given in the discussion of the final Chapter. 
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Conclusies 
- Biotransformatie van hexachloorbenzeen door het in het gladde endoplas-
matisch reticulum van de levercel gelokaliseerde "mixed function oxydase" 
enzymsysteem bl i jkt een eerste voorwaarde te zijn voor het ontstaan van 
leverporfyr ie. 
- Zowel pentachloorfenol als de belangrijkste overige stabiele metabolieten 
van hexachloorbenzeen blijken niet verantwoordelijk te zijn voor de na 
chronische blootstelling aan hexachloorbenzeen optredende leverporfyr ie. 
- De resultaten van het onderhavige onderzoek wijzen erop dat niet, zoals 
men aanvankelijk dacht, hexachloorbenzeen zelf aanzet tot het ontstaan van 
leverporfyr ie, maar instabiele reactieve intermediairen van hexachloorben-
zeen. 
- Antioxidantia zijn in staat om in v i t ro volledige bescherming te bieden te-
gen de porfyrinogene werking van hexachloorbenzeen. Dit beschermend ef-
fect van antioxidantia bl i jk t niet op te gaan voor de situatie in v ivo. 
- Bovenstaande conclusies gelden behalve voor hexachloorbenzeen hoogst-
waarschijnlijk ook voor alle overige porfyrinogene polyhalogeen-aromaten, 
aangezien dit voor enkele tot deze groep behorende stoffen kon worden 
aangetoond in dit onderzoek. 
- Primaire culturen van kippeëmbryo-levercellen vormen een geschikt model-
systeem om het porfyrinogene en hepatotoxische werkingsmechanisme van 
xenobiotica te bestuderen. 
- Het onomstotelijke bewijs voor de vorming van reactieve intermediairen uit 
hexachloorbenzeen en de binding hiervan aan functionele SH-groepen van 
het uroporfyrinogeen-decarboxylase is vooralsnog niet geleverd. Hiertoe zal 
men met behulp van een 'spin trap' en elektron spin resonantiemetingen 
(ESR) de vorming van instabiele reactieve deeltjes daadwerkelijk moeten 
aantonen. Bovendien zal het reactieprodukt van het reactief intermediair met 
het enzym uroporfyrinogeen-decarboxylase geïsoleerd moeten worden door 
immuno-adsorptie met specifieke antistoffen tegen het enzym. 
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Samenvatt ing 
Polyhalogeen aromatische koolwaterstoffen veroorzaken hepatische porfy-
rie bij de mens en verschillende diersoorten na chronische blootstelling aan 
deze chemische stoffen. Hepatische porfyrie is een ontregeling van de heem-
synthese in de lever, die kan ontstaan door een erfelijke afwijking of door 
blootstelling aan lichaamsvreemde stoffen. De door polyhalogeen aromatische 
koolwaterstoffen geïnduceerde hepatische porfyrie wordt gekenmerkt door 
een ophoping van porfyrines (de voorstadia van heem) in de lever en een 
excessieve uitscheiding van porfyrines (voornamelijk het uroporfyr ine) in de 
urine. Deze ophoping van porfyrines in de lever wordt veroorzaakt door 
een remming van de activiteit van een enzym dat. betrokken is bij de bio-
synthese van heem: het uroporfyrinogeen-decarboxylase. Het werkingsme-
chanisme dat ten grondslag ligt aan de remming van dit enzym is nog onbe-
kend . 
Het in dit proefschrift beschreven onderzoek werd uitgevoerd om meer 
inzicht te krijgen in het werkingsmechanisme van de door polyhalogeen aro-
matische koolwaterstoffen veroorzaakte leverporfyrie. Hexachloorbenzeen, 
behorend tot deze groep van chemische stoffen, werd gekozen als een mo-
delstof voor di t onderzoek. 
In hoofdstuk 1 worden, voornamelijk op basis van literatuurgegevens, de 
verschillende aspecten van de toxicologie, farmacokinetiek en biotransforma-
tie van polyhalogeen-aromaten besproken in het kader van hun porfyrinoge-
ne werking. Hierbij wordt in het bijzonder aandacht geschonken aan hexa-
chloorbenzeen. 
In hoofdstuk 2 wordt het onderzoek beschreven naar de invloed van pen-
tachloorfenol (een van de voornaamste metabolieten van hexachloorbenzeen) 
op de inductie van porfyrie en het "mixed function oxydase" enzymsysteem 
in de lever van vrouwelijke ratten die chronisch belast werden met hexa-
chloorbenzeen. Het genoemde "mixed function oxydase" enzymsysteem is 
o.a. verantwoordelijk voor de biotransformatie van lichaamsvreemde stoffen. 
De porfyrinogene werking van hexachloorbenzeen in vrouwelijke ratten werd 
versterkt wanneer de dieren geli jkt i jdig pentachloorfenol kregen toegediend. 
Daarentegen bleek chronische belasting met alleen pentachloorfenol geen 
leverporfyrie te kunnen opwekken. Pentachloorfenol bindt sterk aan het 
endoplasmatisch reticulum in de levercel (zie ook hoofdstuk 4) en kan bo-
vendien het in deze membranen ingebouwde hemoproteïn, het cytochroom 
P-450 (een onderdeel van het "mixed function oxydase" systeem), in v i t ro 
omzetten in een inactieve vorm. Op basis van de resultaten kan men con-
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cluderen dat pentachloorfenol als een van de belangrijkste metabolieten van 
hexachloorbenzeen niet verantwoordelijk kan zijn voor het ontstaan van le-
verpor fyr ie . Pentachloorfenol draagt waarschijnlijk indirect bij tot de porfy-
rinogene werking van hexachloorbenzeen, omdat de heemsynthese extra 
wordt gestimuleerd door de afbraak van cytochroom P-450 door pentachloor-
fenol. Een blokkade van de heemsynthese, door remming van het enzym 
uroporfyrinogeen-decarboxylase, zal hierdoor sneller aanleiding geven tot 
ophoping van porfyr ines. 
Hoofstuk 3 handelt over de invloed van stoffen, die aangrijpen op de 
biotransformatie van polyhalogeen-aromaten, op de porfyrinogene werking 
van laatstgenoemde verbindingen in een primaire kweek van kippeëmbryo-
levercellen. Levercelculturen die vooraf behandeld werden met inductoren 
van het "mixed function oxydase" systeem bleken veel gevoeliger te zijn 
voor de porfyrinogene werking van polyhalogeen-aromaten. Remming van het 
"mixed function oxydase" systeem of toevoeging van stoffen die in staat zijn 
om electrofiele deeltjes weg te vangen, voorkwam de ophoping van porfy-
rines in de aan polyhalogeen-aromaten blootgestelde culturen van kippe-
ëmbryo-levercellen. Een verlaging van het intracellulaire gehalte aan gluta-
thion leidde tot een toename in de toxiciteit van polyhalogeen-aromaten in 
deze levercelculturen. De resultaten van deze in v i t ro experimenten met 
levercelculturen leverden sterke aanwijzingen op dat er tijdens de biotrans-
formatie van polyhalogeen-aromaten reactieve intermediaren ontstaan, die 
door binding aan uroporfyrinogeen-decarboxylase leiden tot het ontstaan 
van porfyr ie. 
In hoofdstuk 4 is onderzocht in hoeverre stoffen zoals fenobarbital en 
3-methylcholanthreen, die de lever aanzetten tot een verhoogde activiteit 
van het "mixed function oxydase" systeem, in staat zijn om het ontstaan 
van porfyr ie in aan hexachloorbenzeen blootgestelde ratten te versnellen. 
Uit de resultaten in dit hoofdstuk en in hoofdstuk 2 bl i jkt dat hexachloor-
benzeen een groep microsomale "mixed function oxydase" enzymen induceert, 
die wat betreft eigenschappen overeenkomsten vertoont met zowel de door 
fenobarbital als door 3-methylcholanthreen geïnduceerde groep van biotrans-
formatie enzymen. Gelijktijdige toediening van fenobarbital en hexachloor-
benzeen aan vrouwelijke ratten resulteerde in een stimulatie van de porfy-
rinogene werking van de laatstgenoemde stof. Methylcholanthreen had geen 
invloed op de porfyrinogene werking van hexachloorbenzeen. De resultaten 
wijzen erop dat de door fenobarbital geïnduceerde vormen van cytochroom 
P-450 een belangrijke rol spelen bij de metabole activatie van hexachloor-
benzeen en het daaruit voortvloeiende ontstaan van leverporfyr ie. 
- 154 -
In hoofdstuk 5 wordt aangetoond dat hexachloorbenzeen gemetaboliseerd 
wordt in primaire culturen van kippeëmbryo-levercellen. De in deze celcul-
turen geïdentificeerde metabolieten van hexachloorbenzeen (pentachloorben-
zeen, pentachloorfenol, pentachloorthiofenol) komen overeen met de metabo-
lieten die geïsoleerd werden uit de urine en faeces van met hexachloorben-
zeen belaste ratten (hoofdstuk 6) . Aangezien de diverse metabolieten van 
hexachloorbenzeen geen porfyrie veroorzaakten in di t in v i t ro cel kweek 
systeem, l igt het voor de hand te veronderstellen dat een reactief interme-
diair door covalente binding aan functionele SH-groepen van uroporfyr ino-
geen-decarboxylase verantwoordelijk is voor het ontstaan van porfyr ie. In 
levercelculturen die blootgesteld waren aan radioactief gemerkt hexachloor-
benzeen bleek, na extractie met organische oplosmiddelen, een bepaalde 
hoeveelheid radioactiviteit sterk gebonden te zijn aan eiwitmateriaal. Toe-
voeging van een remmer van het "mixed function oxydase" systeem of as-
corbinezuur (antioxidant) aan het celkweekmedium had een vermindering 
van de hoeveelheid eiwit gebonden radioactiviteit tot gevolg. Uit de experi-
menten kan de conclusie worden getrokken dat de snelheid waarmee hexa-
chloorbenzeen in de lever gemetaboliseerd wordt eerst een kri t iek niveau 
moet bereiken, voordat de remming van uroporfyrinogeen-decarboxylase en 
de hiermee samengaande ophoping van porfyrines kan optreden. 
In hoofdstuk 6 wordt de invloed van antioxidantia op de biotransformatie 
en porfyrinogene werking van hexachloorbenzeen vergeleken in twee ratte-
stammen (Agus en Wistar stam). Vrouwelijke Agus ratten bleken veel gevoe-
liger te zijn voor de porfyrinogene werking van hexachloorbenzeen dan 
vrouwtjes van de Wistar stam. Waarschijnlijk houdt de grotere gevoeligheid 
van de Agus stam voor de porfyrinogene werking van hexachloorbenzeen 
verband met de volgende opmerkelijke verschillen tussen de stammen, die 
werden waargenomen na chronische belasting met hexachloorbenzeen: 
(1) Hexachloorbenzeen stimuleerde het "mixed function oxydase" enzymsys-
teem in de lever van Agus ratten tot een hogere activiteit dan in Wistar 
rat ten. In overeenstemming hiermee vertoonden de Agus ratten een grotere 
biotransformatie snelheid van hexachloorbenzeen. (2) De activiteit van g lu -
tathion-S-transferase in de lever was opvallend lager in Agus ratten. 
(3) Het glutathion gehalte in de lever van Agus ratten was significant lager 
dan in Wistar ratten. Bovenstaande bevindingen ondersteunen de hypothese 
dat binding van tijdens de biotransformatie van hexachloorbenzeen vr i j ko-
mende reactieve intermediairen aan functionele SH-groepen van uropor fyr i -
nogeen-decarboxylase uiteindelijk verantwoordelijk is voor het ontstaan van 
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leverporfyr ie. Het feit dat in dit experiment door de ratten 60% van het 
hexachloorbenzeen werd uitgescheiden via urine en faeces als metabolieten 
met één of meer thio-groepen, bevestigt nogmaals de grote aff initeit van een 
reactief metabool produkt van hexachloorbenzeen voor SH-groepen. 
In tegenstelling tot de resultaten verkregen uit in vi tro experimenten 
met primaire culturen van kippeëmbryo-levercellen (hoofdstuk 3) , konden 
extra antioxidantia in het dieet geen bescherming bieden tegen de por fy r i -
nogene werking van hexachloorbenzeen in de rat. Enkele mogelijke verkla-
ringen voor deze tegenstrijdige resultaten worden gegeven in de discussie 
van het laatste hoofdstuk. 
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